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Abstract 
The aberrant folding and subsequent aggregation of proteins into insoluble plaques known 
as amyloid fibrils is associated with a number of diseases, including Alzheimer’s and 
Parkinson’s diseases.  The exact role that these aggregates play in the disease mechanisms is 
not yet well understood, in part due to the difficulties that arise when attempting to 
visualise the interactions between the carbon-rich protein aggregates and the carbon-rich 
cells due to a lack of contrast.  Traditional strategies to overcome this lack of contrast have 
involved the use of stains or tags that potentially can be either unreliable or intrusive. 
In this work we have taken a fragment of the Alzheimer’s-related Aβ peptide and replaced 
the naturally occurring sulfur that is present in the methionine amino acid with a selenium 
atom.  Human phagocytic cells were exposed to different aggregate species formed from 
the selenium-labelled Aβ fragment and its selenium-free analogue to examine the toxicity, 
uptake and distribution of the aggregates.  The monomeric protein and the fully aggregated 
mature amyloid fibrils did not show significant levels of toxicity whereas aggregation species 
occurring earlier in the aggregation process were found to be highly cytotoxic, in agreement 
with previous studies on similar species. 
Cells exposed to the selenium-labelled aggregates were imaged using high angle annular 
dark field scanning transmission electron microscopy (HAADF-STEM), an electron 
microscopy technique in which only those electrons that are scattered to relatively high 
angles are used to generate an image.  The majority of these electrons have undergone 
Rutherford scattering, the cross-section of which is dependent on Zn (n ~ 2).  HAADF-STEM is 
therefore highly sensitive to local variations in atomic number.  This technique has been 
used to visualise the selenium-labelled protein aggregates inside cells in two and three 
dimensions.  The uptake and intracellular distributions of toxic and non-toxic aggregate 
species have been assessed and distinct differences have been observed correlating with 
the differences in toxicity. 
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“Faith is a fine invention 
When gentlemen can see, 
But microscopes are prudent 
In an emergency.” 
- Emily Dickinson
 4 
 
Table of Contents 
Abstract ...................................................................................................................................... 1 
Acknowledgements .................................................................................................................... 2 
Author’s Declaration .................................................................................................................. 9 
List of Abbreviations ................................................................................................................ 10 
1. Introduction ......................................................................................................................... 12 
2. Literature Review ................................................................................................................. 15 
2.1 Protein Misfolding, Aggregation and Amyloid ............................................................... 15 
2.1.1 Amyloid-β ................................................................................................................ 19 
2.2 Amyloid and Disease ...................................................................................................... 20 
2.2.1 Alzheimer’s Disease and Amyloid β ........................................................................ 21 
2.3 Toxicity of Amyloid ......................................................................................................... 22 
2.4 Macrophages, Cellular Uptake and Inflammation ......................................................... 25 
2.5 Cellular Uptake of Nanoparticles ................................................................................... 28 
2.6 Cellular Uptake of Amyloid ............................................................................................ 30 
2.7 Imaging Cells .................................................................................................................. 31 
2.7.1 Transmission Electron Microscopy ......................................................................... 31 
2.7.2 Imaging Amyloid in Cells ......................................................................................... 34 
 5 
 
3. Materials and Instrumentation ............................................................................................ 41 
3.1 Protein Preparation and Aggregation ............................................................................ 41 
3.1.1 Protein Preparation ................................................................................................ 41 
3.1.2 Protein Aggregation ................................................................................................ 41 
3.1.3 Peptide Sample Preparation for Transmission Electron Microscopy ..................... 42 
3.1.4 Peptide Sample Preparation for Atomic Force Microscopy ................................... 42 
3.1.5 Thioflavin T Fluorescence ....................................................................................... 42 
3.2 Culturing and Exposure of Cells ..................................................................................... 43 
3.2.1 Isolation and culture of human monocyte-macrophages ...................................... 43 
3.2.2 Treatment and fixation of HMMs for TEM ............................................................. 44 
3.2.3 Cell Viability Assays ................................................................................................. 46 
3.3 Electron Microscopy and Analysis ................................................................................. 48 
3.3.1 Introduction to TEM ................................................................................................ 48 
3.3.2 Electron/Specimen Interactions ............................................................................. 49 
3.3.3 TEM Setup ............................................................................................................... 57 
3.3.4 Bright Field TEM Imaging and Mass-Thickness Contrast ........................................ 64 
3.3.5 Scanning Transmission Electron Microscopy .......................................................... 65 
3.3.6 The Titan Microscope ............................................................................................. 66 
3.3.7 Energy Dispersive X-ray Spectroscopy .................................................................... 73 
 6 
 
3.3.8 Electron Tomography.............................................................................................. 76 
3.3.9 Electron Beam Damage ........................................................................................... 80 
3.4 Atomic Force Microscopy .............................................................................................. 82 
4. Aggregation of Aβ(25-36) .................................................................................................... 84 
4.1 Introduction ................................................................................................................... 84 
4.1.1 Protein Folding, Misfolding and Aggregation ......................................................... 84 
4.2 Results and Discussion ................................................................................................... 88 
4.2.1 Conditions for Aggregation ..................................................................................... 88 
4.2.2 Thioflavin-T Fluorescence ....................................................................................... 89 
4.2.3 Transmission Electron Microscopy ......................................................................... 91 
4.3 Conclusions .................................................................................................................... 96 
5. Visualisation of Selenium-labelled Aβ(25-36) in Cells ......................................................... 98 
5.1 Introduction ................................................................................................................... 98 
5.1.1 Visualising Selenium-labelled Proteins ................................................................. 100 
5.2 Results .......................................................................................................................... 102 
5.2.1 Imaging Selenium-labelled Protein Aggregates in Cells ....................................... 103 
5.2.2 Collection Angles Determine the Electron/Specimen Interactions that Dominate 
Image Contrast ............................................................................................................... 107 
5.2.3 EDX of Selenium-enhanced Protein Aggregates ................................................... 111 
 7 
 
5.3 Conclusions .................................................................................................................. 114 
6. Toxicity, Uptake and Intracellular Distribution of Protein Aggregates .............................. 115 
6.1 Introduction ................................................................................................................. 115 
6.2 Results .......................................................................................................................... 116 
6.2.1 Cytotoxicity of Aβ(25-36) ...................................................................................... 117 
6.2.2 Uptake and Distribution of Aβ(25-36) Aggregates at 24 Hours ........................... 122 
6.2.3 Time-dependence of Uptake and Distribution ..................................................... 136 
6.3 Discussion ..................................................................................................................... 147 
6.4 Conclusions .................................................................................................................. 151 
7. Tomography of Cells Exposed to Se-Aβ(25-36) ................................................................. 153 
7.1 Introduction ................................................................................................................. 153 
7.2 Collection, Reconstruction and Visualisation of Tomography Data ............................ 153 
7.3 Results .......................................................................................................................... 154 
7.3.1 Electron Tomography of Cell Sections .................................................................. 154 
7.3.2 Electron Tomography of Whole Cells ................................................................... 162 
7.3.2.2 Cells Exposed to Prefibrillar Aggregates ............................................................ 165 
7.4 Discussion ..................................................................................................................... 169 
7.5 Conclusions .................................................................................................................. 170 
8. Conclusions and Future Work ............................................................................................ 171 
 8 
 
8.1 Aggregation of Aβ(25-36) and Se-Aβ(25-36) ............................................................... 171 
8.2 Visualisation of Selenium-enhanced Peptide Aggregates inside Cells ........................ 171 
8.3 Cytotoxicity of Aggregates ........................................................................................... 172 
8.4 Uptake and Intracellular Distribution of Se-Aβ(25-36) Aggregates ............................. 172 
8.4 Future Work ................................................................................................................. 173 
Appendix A ............................................................................................................................. 176 
Aβ42 Amino Acid Sequence ................................................................................................ 176 
Aβ(25-36) Amino Acid Sequence ....................................................................................... 176 
Appendix B ............................................................................................................................. 176 
Atomic Force Microscopy .................................................................................................. 176 
References.............................................................................................................................182 
  
 9 
 
Author’s Declaration 
I declare that this thesis is a product of the work I have carried out at the Department of 
Materials at Imperial College London and the Department of Chemistry at the University of 
Cambridge.  All the work described herein is my own, unless otherwise stated.   
Some of the results presented in this thesis have been published in the following 
publication: 
E. K. McGuire, M. Motskin, T. P. J. Knowles, C. M. Dobson, D. W. McComb and A. E. Porter, 
Imaging Alzheimer's disease-related protein aggregates in human cells using a selenium 
label, J. Phys. Conf. Ser, 241, 012020 
 10 
 
List of Abbreviations 
1-D  1-dimensional 
2-D  2-dimensional 
3-D  3-dimensional 
Aβ   Amyloid-β 
AD  Alzheimer’s disease 
ADF  Annular dark field 
AFM   Atomic force microscopy 
ANS   1-anilinonaphthalene 8-sulfonate 
APP   Amyloid precursor protein 
BF  Bright field 
BF-TEM  Bright field transmission electron microscopy 
BSA   Bovine serum albumin 
CNS   Central nervous system 
CR  Congo Red 
DF  Dark field 
DIW   Deionised water 
EDX   Energy dispersive X-ray spectroscopy 
EELS  Electron energy loss spectroscopy 
EFTEM  Energy filtered TEM 
FEG   Field emission gun 
 11 
 
HAADF-STEM High angle annular dark field scanning transmission electron microscopy 
HFIP   1,1,1,3,3,3-hexafluoro-2-propanol 
HMM   Human monocyte derived macrophage cell 
HypF-N  The amino-terminal end of E. coli HypF 
MTT  (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) 
Mø-SFM  Macrophage Serum-Free Medium 
NSAIDs  Non-steroidal anti-inflammatory drugs 
NTF  Neurofibrillary tangle 
Se-Aβ(25-36) Selenium-labelled Aβ(25-36)  
SIRT   Simultaneous iterative reconstruction technique 
PBS   Phosphate-buffered saline 
PEG   Polymer polyethylene glycol 
PET   Positron emission tomography 
PI   Propidium iodide 
PI-SH3  Phosphatidyl-inositol-3’-kinase 
SD   Standard deviation 
STEM   Scanning transmission electron microscopy 
TEM   Transmission electron microscopy 
TFA   Trifluoroacetic acid 
ThT   Thioflavin T 
TTR   Transthyretin
 12 
 
1. Introduction 
Proteins (also known as peptides) are long chains of amino acids that carry out the majority 
of functions within a biological system.  In order to carry out its function a protein must first 
fold into a particular conformation known as its native state.  Proteins occasionally misfold; 
when this happens not only will they lose their biofunctionality but they may also start to 
aggregate into insoluble plaques known as amyloid fibrils [1].  The presence of amyloid is 
associated with a number of diseases, including Alzheimer’s and Parkinson’s diseases [2].  
However, the exact role that these aggregates play in the pathogenic process is not yet well 
understood, in part due to difficulties that arise when attempting to visualise their 
interactions with cells or tissue.  This work presents a new technique for the direct 
visualisation of specific protein aggregates within cells and describes results obtained using 
this method. 
In the case of Alzheimer’s disease (AD) the main constituent of the plaques present in the 
brains of sufferers is the peptide amyloid-β (Aβ) [1]. Evidence that Aβ is responsible for the 
pathogenic alterations in AD brain comes from in vitro and in vivo studies as well as human 
clinical trials and studies on human AD sufferers and age-matched healthy individuals [3-9].  
There is an increasing body of evidence that it is not the mature amyloid fibrils, but their 
precursors, that are the pathogenic species in AD and other amyloid-associated conditions 
[2, 7, 10-13].  The precursors to amyloid fibrils, known as prefibrillar aggregates, have been 
found to be significantly more cytotoxic than mature fibrils or monomers of the same 
peptide.  This has been found to be the case in in vitro cell culture studies carried out on a 
range of cell types and with various disease-related and non-disease-related peptides [2, 7, 
11, 14, 15].  Animal model studies have returned similar toxicity results, with prefibrillar 
aggregates exhibiting significantly higher toxicity on injection than fibrils and monomers 
formed from the same peptide [16]. 
The exact role that amyloid and its precursors play in these diseases is not yet well 
understood.  Part of the reason for this is that it is extremely challenging to visualise the 
interactions between the carbon-rich protein aggregates and the carbon-rich cellular 
 13 
 
environment.  Traditional strategies for overcoming this lack of contrast have relied on the 
use of stains or tags that can lack specificity or reliability or that may influence the 
interaction under investigation.  Furthermore, many of these tags do not allow the direct 
visualisation of the aggregates, thus precluding the possibility of assessing aggregate 
structure or stability within the cellular environment. 
In order to visualise protein aggregates within cells in this work, a novel, label-free TEM 
visualisation technique has been developed.  A fragment of the Aβ peptide corresponding to 
amino acids 25-36 has been examined.  This fragment naturally contains a single 
methionine, a sulfur containing amino acid.  This sulfur has been replaced with a selenium 
atom.  Selenium is in the same group of the periodic table of elements as sulfur but it has a 
higher atomic number and therefore a higher electron scattering cross-section on 
interaction with an electron beam.  Thus a selenium-enhanced analogue of the Aβ(25-36) 
peptide is created (Se-Aβ(25-36)), having essentially identical biochemical properties but a 
higher electron scattering cross-section. 
The interactions of human monocyte-derived macrophage cells (HMMs) with Aβ(25-36) and 
Se-Aβ(25-36) aggregates were examined in this work.  HMMs are phagocytic cells that are a 
part of the body’s immune system and also play a role in inflammation.  The cytotoxicity of 
Aβ(25-36) and Se-Aβ(25-36) at different stages in their aggregation was examined.  HMMs 
were treated with toxic and non-toxic aggregates of Se-Aβ(25-36) and examined using high 
angle annular dark field scanning transmission electron microscopy (HAADF-STEM).  HAADF-
STEM generates images using only electrons that are scattered to relatively high angles.  The 
majority of these electrons have undergone Rutherford scattering.  The cross-section for 
Rutherford scattering is dependent on Zn (n ~ 2).  Thus HAADF-STEM is highly sensitive to 
local variations in atomic number.  This technique therefore allows the direct visualisation 
and identification of selenium-enhanced peptide aggregates within the cellular environment 
without the use of any other stains or tags.  Varying the collection angles of the STEM 
detector allows the user to control the electron beam/specimen interactions that dominate 
image contrast.  Thus, it is possible not only to visualise the selenium-enhanced aggregates 
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and assess their structure but also to identify their subcellular location and to assess cell 
structure. 
The aims of this project were: 
 to establish conditions under which Aβ(25-36) and Se-Aβ(25-36) would aggregate; 
 to assess the time over which the peptides aggregate and to assess whether the 
replacement of sulfur with selenium affects the aggregation of the peptide; 
 to assess the structure of the aggregates at different time points and establish 
whether the presence of selenium affects aggregate structure; 
 to assess the cytotoxicity of Aβ(25-36) and Se-Aβ(25-36) to HMMs at different points 
in the peptides’ aggregation process and to assess whether the presence of selenium 
affects the cytotoxicity; 
 to establish whether it is possible to visualise selenium-enhanced protein aggregates 
inside cells using HAADF-STEM and HAADF-STEM tomography; 
 to assess the intracellular distribution and structure of the selenium-enhanced 
Aβ(25-36) aggregates for both toxic and non-toxic aggregate species; 
 to correlate the intracellular distribution of different aggregate species with their 
cytotoxicity at different exposure times. 
This thesis presents the work that was carried out for this PhD project.  Chapter 2 presents a 
review of the literature relevant to this project.  Chapter 3 describes the experimental 
techniques and instrumentation employed in the work.  Chapters 4 to 7 present the results 
of the project.  The results of the aggregation study on the Aβ(25-36) and Se-Aβ(25-36) 
peptides are presented in chapter 4.  The visualisation of the selenium-enhanced peptide 
aggregates within cells is described in chapter 5.  Chapter 6 presents the results of the 
investigation into the cytotoxicity and intracellular distributions of Se-Aβ(25-36) aggregates.  
The visualisation of Se-Aβ(25-36) aggregates within cells in three dimensions is described in 
chapter 7.  Finally, conclusions and suggestions for further work are presented in chapter 8.
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2. Literature Review 
2.1 Protein Misfolding, Aggregation and Amyloid 
Proteins are long chains of amino acids that carry out the majority of biological functions 
within a cell.  The amino acids which make up proteins (also known as peptides or 
polypeptides) all have the same basic structure with an amine group, a carboxyl group and a 
side chain that varies between different amino acids.  These side chains are labelled R1 and 
R2 in figure 2.1.  The only exception to this is the amino acid proline whose structure is 
slightly different in that its side chain links to the amine group.  The amino acids of a protein 
chain are covalently joined by peptide bonds between the carboxyl and amino groups of 
adjacent amino acids.  The formation of a peptide bond results in the loss of a water 
molecule (figure 2.1).  In this thesis the terms protein and peptide are used interchangeably.   
 
Figure 2.1: The hydrolysis reaction that forms the peptide bond that covalently links the amino acids in a 
protein chain. 
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Protein structure has four levels.  The amino acid sequence of a peptide is known as its 
primary structure; this determines how the protein folds into higher level structures.  The 
secondary structure of a peptide refers to its highly ordered local substructure; the two 
main classes of protein secondary structure are alpha helices and beta sheets, formed 
through hydrogen bonding interactions between amide and carbonyl groups of the amino 
acids in the main chain of the peptide [17].  The three-dimensional structure of a single 
protein molecule is referred to as its tertiary structure, and quaternary structure refers to a 
larger assembly of multiple peptide chains.  The folding of the protein chain is driven by 
non-covalent interactions such as hydrogen bonding, ionic bonding, hydrophobic 
interactions and Van der Waals forces [17]. 
In order to carry out its function a protein must first fold into a particular conformation 
known as its native state.  Protein folding occurs spontaneously during or after biosynthesis 
on the ribosome; however, this process may, in some cases, require proteins known as 
chaperones to aid the protein folding.  Proteins usually fold in such a way as to minimise the 
number of hydrophobic side chains exposed to the aqueous surroundings [18], and 
therefore typically have a hydrophobic core with polar residues exposed on the surface.  
Native states of proteins almost always correspond to the structures that are the most 
thermodynamically stable under physiological conditions [18, 19].  Many details of the 
protein folding process depend on the particular environment in which folding takes place 
[1].  The aberrant folding and subsequent aggregation of proteins represent an alternative 
assembly pathway which often leads to the generation of pathogenic species.  The presence 
of misfolded, aggregated proteins, in the form of amyloid fibrils, is associated with a number 
of disease states, including Alzheimer’s disease (AD), Parkinson’s disease, Huntington’s 
disease and the systemic amyloidoses [2].   
Initially it was assumed that only those proteins whose misfolding and aggregation are 
disease-related were capable of forming amyloid.  However, it has since been established 
that, most likely, all proteins can form amyloid fibrils under conditions such as high 
concentration, high temperature and low pH [20]; the conditions required for the formation 
of amyloid of most proteins are often very different to physiological ones.  While their 
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native protein precursors show structural and functional heterogeneity the final products of 
protein aggregation share common biophysical properties [21-23].  Amyloid fibrils are highly 
insoluble in aqueous solvents; this is why they deposit in organs and tissue [1, 24]. 
Amyloid fibrils can be imaged in vitro using either transmission electron microscopy (TEM) 
or atomic force microscopy (AFM).  These high resolution imaging techniques show that the 
fibrils usually consist of a number of protofilaments each about 2-5nm in diameter [25], 
twisted together to form rope-like fibrils that are typically 7-12nm in diameter [26] (figure 
2.2).  X-ray diffraction data illustrate that the fibrils consist of individual protofilaments, with 
protein molecules arranged so that the polypepetide chains form β-strands that run 
perpendicular to the long axis of the fibrils [22, 27].  This cross-β structure is common to the 
core of all amyloid fibrils regardless of their protein constituents [20].    
 
Figure 2.2: The top view and side view of a single protofilament and of multiple filaments twisted into a 
fibril.  The arrows represent beta-sheet structure.  Figure adapted from [28]. 
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Ex vivo amyloid fibrils have been isolated from patients and fibrils that have been produced 
in vitro using natural or synthesised proteins are structurally very similar to those of the ex 
vivo fibrils [24].  The fibrils have been observed to bind to both Thioflavin T (ThT) and Congo 
Red (CR).  The binding of ThT to amyloid results in a change in fluorescence (the emission of 
electromagnetic radiation by an atom or molecule having been excited by electromagnetic 
radiation of a higher energy).  Binding of CR to amyloid is characterised by apple-green 
birefringence (the decomposition of a ray of light into two rays) in polarised light.  However, 
the specificity and reliability of both of the above methods for the detection of amyloid are 
in question.  This is due, in part, to a lack of understanding of the mechanisms by which they 
bind to amyloid [29-32] and the fact that the presence of dyes that interact with growing 
amyloid fibrils can influence the rate of growth [33, 34]. 
The conversion of a protein from its globular, natively folded structure to an aggregated 
fibrillar one represents an alternative folding process to the normal physiological folding 
pathway.  On this alternative pathway partially structured intermediates, including β-sheet-
rich species that are not fibrillar in structure, move towards an aggregated conformation 
[24, 35].  The question of what drives the transformation of a biologically active, soluble 
protein into a pathogenic, misfolded conformation remains open to debate.  A huge amount 
of literature has been published on this subject; the interested reader is directed to some 
particularly useful review articles: [35-38].   
It has been established that amyloid fibril formation has many of the characteristics of a 
“nucleated growth” mechanism [24].  The time course of aggregation typically includes a 
lag-phase followed by a rapid exponential growth phase [39-41].  It is assumed that the lag-
phase is the time required for the “nuclei” to grow.  Once the nuclei are formed, fibril 
growth proceeds rapidly by further association of monomers or oligomers with the 
nucleation site.  As is the case for many other nucleated growth mechanisms, addition of 
pre-formed nuclei, or “seeds”, causes the lag-phase to be significantly shortened or even 
eliminated as the rate of aggregation is no longer limited by a need for nucleation [39, 40].  
A recent study has suggested that secondary nucleation, resulting from the fragmentation 
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of fibrils or aggregates, plays a more dominant role than primary nucleation in aggregation 
kinetics [42]. 
The first phase in amyloid formation involves the creation of oligomers, which often appear 
as small bead-like structures, typically 2 – 5 nm in diameter, sometimes linked together, or 
as amorphous aggregates, which may be larger [24].  These early, prefibrillar aggregates 
then convert into species with more distinctive morphologies, often referred to as 
protofibrils, which are usually short, thin fibrillar species that are thought to assemble into 
mature amyloid fibrils  [24].  It has been found that a specific antibody can bind to the 
prefibrillar species formed from different peptides, while it does not bind to the 
corresponding monomeric or fibrillar states, implying that these species share important 
biophysical properties independent of their constituent proteins [43].  The generation of 
amyloid fibrils can proceed from a number of different prefibrillar conformations [38]. 
2.1.1 Amyloid-β 
The Amyloid-β (Aβ) peptide is the main constituent of the amyloid plaques that are present 
in the brains of AD sufferers [1].  Aβ is a 39 to 43 amino acid long peptide which is produced 
by the proteolytic cleavage of the much longer amyloid precursor protein (APP), a 
transmembrane protein whose function is not yet fully understood [44, 45].  Rare mutations 
in APP, and the secretase that cleaves it to generate Aβ, are implicated in familial AD [46].  
In the normal healthy brain 8% of the total Aβ is synthesised each hour and cleared at a 
roughly equal rate preventing accumulation and deposition [47].  The length of the Aβ 
peptide depends on the gamma secretase cleavage position.  The 40 and 42 amino acid long 
isoforms of Aβ (Aβ40 and Aβ42 respectively) are the most common isoforms of the Aβ 
peptide [48].  Examinations of human cerebrospinal fluid and blood plasma have revealed 
that Aβ40 is the most abundant form of the peptide, Aβ42 is present in smaller amounts 
(about 10%) [3, 49-51].  The more abundant Aβ40 is the less aggregation prone form of the 
peptide, while the less plentiful Aβ42 is more hydrophobic and more prone to fibril 
formation [52] and is the predominant form found in AD plaques [50].  In Alzheimer's 
patients the ratio of Aβ42 to Aβ40 is shifted significantly towards a higher proportion of Aβ42 
[4, 5].  Amyloid deposits of Aβ42 are detected in even the earliest stages of the disease and 
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its overproduction is related to the early onset forms of the disease in familial forms of AD 
and in animal models [3, 6].    
Numerous in vitro studies have been carried out to examine the aggregation of the Aβ 
peptide [53-59].  The peptide can self-assemble to generate disordered aggregates 
containing soluble oligomeric species of variable size and morphology.  These oligomers or 
early, prefibrillar aggregates can then reorganise into protofibrils, which are more ordered 
and larger in size, and these represent the immediate precursors to amyloid fibrils.  The 
mature fibrils consist of two parallel, intermolecular, in-register β-sheets generated by the 
stacking of two β strands of the monomeric Aβ peptide perpendicular to the axis of the 
fibrils [59-61]. 
Both in vitro and in vivo studies to investigate the toxicity of Aβ in its monomeric, prefibrillar 
aggregate and mature fibril forms have been conducted.  The prefibrillar aggregate form of 
the peptide is significantly more toxic than the monomeric or mature fibrils forms [7].  The 
toxicity of aggregates of the Aβ peptide is discussed in further detail in section 2.3.   
It is often not possible to study the full length Aβ40 or Aβ42 peptide due to the high cost of 
purchasing the peptide and difficulties synthesising it.  However, the Aβ(25-35) fragment of 
the Aβ peptide maintains many of the toxicological effects of the full-length chain [62].  The 
25-35 chain induces neuronal cell death, neuritic atrophy and synaptic loss and inhibits 
neurogenesis [63-66].  For this reason Aβ(25-35) is often used as a convenient model for the 
full-length chain in both in vitro and in vivo studies.  In this work we use a peptide that 
differs from the Aβ(25-35) only by the addition of a single amino acid (valine) at its C-
terminus.  It is therefore likely that the Aβ(25-36) peptide possesses many of the toxic 
properties of the 25-35 fragment.  The sequence of full chain Aβ42 and the Aβ(25-36) 
peptides are shown in the appendix. 
2.2 Amyloid and Disease 
The deposition of proteinaceous aggregates in the form of amyloid is associated with more 
than 20 degenerative conditions [2].  These include neurodegenerative conditions such as 
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Alzheimer’s and Parkinson’s diseases as well as the systemic amyloidoses.  Amyloid diseases 
include familial, sporadic and transmissible degenerative conditions [2].  The specific nature 
of the pathogenic species and the molecular basis for their ability to cause cellular damage 
are the subject of debate [7]. 
2.2.1 Alzheimer’s Disease and Amyloid β 
Alzheimer’s disease (AD) is the most common form of  dementia in the world today [67].  Its 
symptoms include the progressive decline of functions such as memory, orientation, 
understanding, judgement, calculation, learning, language and thinking, and a gradual loss 
of the skills required to carry out daily activities [68].  In 1907 Alois Alzheimer described two 
pathological alterations in the brain of a female patient suffering from dementia [69].  One 
of these Alzheimer described as a “peculiar substance” in the extracellular space of specific 
brain regions.  In the mid-1980s it was discovered that these deposits, which are now 
referred to as amyloid plaques, consist of the peptide Aβ [70, 71].  The other alteration 
described by Alzheimer in 1907 was the presence of neurofibrillary tangles (NFTs) which 
appear intracellularly.  It was discovered in the late-1980s that NFTs are composed of 
aggregates of the tau protein [72-75].  Amyloid plaques and NFTs represent the 
pathognomic features of Alzheimer’s disease, and their observation during post-mortem 
examination is still required for the definitive diagnosis of the disease [44].  As well as the 
amyloid plaques and NFTs, a number of other significant pathological changes occur in the 
AD brain, including a significant inflammatory response and oxidative stress [76-79].  The 
consequences of all the pathological changes are severe dysfunction and, ultimately, loss of 
both neurons and their synapses ; the AD brain may weigh one third less than the brain of 
an age-matched, non-demented individual at the time of death [44]. 
While the Aβ plaques in AD brains are observed extracellularly [2], intracellular Aβ build-up 
may be an early event in the pathogenesis of AD [80].  Wirths et al. observed that 
intraneuronal accumulation of Aβ precedes plaque formation in transgenic mice [81].  In 
patients with mild cognitive impairment intraneuronal Aβ immunoreacitvity has been 
reported in regions of the brain that are more prone to the development of early AD 
pathology, such as the hippocampus and the entorhinal cortex [82].  It has been shown that 
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intraneuronal Aβ levels decrease as extracellular plaques accumulate [83].  Transgenic 
mouse models have demonstrated that intracellular Aβ accumulation appears as an early 
event in AD progression, preceding the accumulation of extracellular plaques [81, 84-89].  A 
particular mouse model of AD (3xTg-AD transgenic model of AD) demonstrated that 
intraneuronal Aβ levels decrease as extracellular plaques start to build up [90], consistent 
with studies of the brains of patients with Down syndrome suffering from early-onset AD 
[83, 91].   
It appears that the prefibrillar aggregates of Aβ are the most toxic conformation of the 
peptide [7] and therefore are most likely the main pathogen in the disease.  However, the 
different aggregate species may play different roles at different times in the progression of 
the disease.  It has previously been demonstrated using mouse models that Aβ oligomers 
play a larger role in AD pathogenesis in the early stages of the disease while the fibrils play a 
more important role later on  [92].   
There is significant evidence that neuroinflammation plays a significant role in the pathology 
of AD [93-95].  A history of head trauma is a strong risk factor for the development of AD 
later in life [96-99], possibly due to self-sustaining inflammatory responses resulting from 
injury [99].  Evidence has come from basic research and clinical research that conventional 
non-steroidal anti-inflammatory drugs (NSAIDs) may delay the onset and slow the 
progression of AD (reviewed in [100]).  A recently reported genome-wide study of humans 
suffering from AD and healthy controls suggested that a variation in a gene related to 
inflammation leads to an increased risk of AD [101].  Inflammation is discussed in further 
detail in section 2.4. 
2.3 Toxicity of Amyloid 
The toxicity of aggregates formed from a wide range of peptides, both disease-related and 
non-disease-related, has been investigated.  It has been found in both in vitro and in vivo 
studies that it is the small, heterogeneous aggregates that precede the formation of amyloid 
fibrils that are the most toxic species of protein aggregate [2, 7, 11-13, 15, 16, 102-105].  
This suggests that prefibrillar aggregates contribute more significantly than mature fibrils to 
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the pathological alterations underlying amyloid-related diseases.  The reasons for the higher 
toxicity of the prefibrillar aggregates over the mature fibrils are not yet clear, though they 
appear to have an intrinsic ability to impair fundamental cellular processes by interacting 
with cellular membranes and causing oxidative stress [2].   
Both in vitro and in vivo studies to investigate the toxicity of Aβ in its monomeric, prefibrillar 
aggregate and mature fibril forms have been conducted.  Pike et al. and Lorenzo et al. have 
shown that amyloid fibrils formed from Aβ are toxic to neuronal cells in culture [8, 9].  Aβ 
amyloid fibrils and their precursors have been shown to affect the polarisation and the 
action potential (related to synaptic transmission) of cortical neurons [106].  Parvathy et al. 
have reported that fibrillar and prefibrillar assemblies of Aβ40 and Aβ42 can be taken up by 
microglial cells and that the oligomeric form of the peptide induces an inflammatory 
response [10].   
A number of previous studies have suggested that a likely target of Aβ is the plasma 
membrane, as the peptide may affect many of its physical and biological properties [107-
112].  Moreover, the plasma membrane, and the membranes of intracellular vesicles such 
as lysosomes and endosomes, is postulated as likely target of the toxic prefibrillar 
aggregates formed from any peptide [111, 113-115].  The soluble oligomers of several types 
of proteins, including Aβ, specifically increase the permeability of lipid bilayers, regardless of 
the amino acid sequence of the peptide, whereas no such effect was observed for the fibrils 
and monomers of these peptides [111, 113-115].   
A number of in vivo investigations into the toxicity of Aβ fibrils and their precursors have 
been carried out by examining the effects of injection of aggregates into animal brains.  Aβ 
fibrils have been found to cause neuronal loss and microglial activation when injected into 
the cerebral cortex of rhesus monkeys [116].  Small, soluble oligomers of Aβ disrupt learned 
behaviour and impair cognitive function on injection into rat brains [13].  The results of in 
vivo investigations suggest a role for Aβ, and in particular small oligomers of Aβ, in 
pathogenic conditions. 
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The toxicity of aggregates of proteins related to other amyloid diseases has also been 
investigated.  Karpinar et al. studied the toxicity of aggregates of α-synuclein, the main 
constituent of the protein aggregates present in the brains of patients suffering from 
Parkinson’s disease.  The prefibrillar aggregates were the most cytotoxic to neurons and 
caused the most behavioural defects in two animal models [11].  Zhang et al. exposed four 
different mammalian cell lines to a yeast prion protein in its monomeric, prefibillar and 
fibrillar states.  This study revealed that the cells internalised all three forms of the protein.  
However, the monomeric and fibrillar forms of the peptide displayed little or no 
cytotoxicity, while the prefibrillar form was toxic to all cell lines in a dose-dependent 
manner [14]. 
It has been found that it is not only the prefibrillar aggregates of disease-related proteins 
that are highly cytotoxic, but that the prefibrillar aggregates of non-disease-associated 
proteins also exhibit substantially higher toxicity than the mature fibrils of the same peptide 
[2, 15, 16, 24, 105].  Bucciantini et al. found that the early aggregates of two non-disease-
related peptides – phosphatidyl-inositol-3’-kinase (PI3-SH3) and the amino-terminal end of 
E. coli HypF (HypF-N) – were highly cytotoxic while the mature fibrils of each of the proteins 
showed no significant toxicity to cultured cells (images of these aggregates are shown in 
figures 4.1 and 4.2) [105].  Baglioni et al. injected these two peptides in their monomeric, 
prefibrillar and fibrillar forms into the brains of rats and found that the prefibrillar 
aggregates of both proteins, but not the soluble monomers or mature fibrils, impair neuron 
viability in a dose-dependent manner similar to that observed in cell culture experiments 
[16].  Significant activation and clustering of microglial cells (phagocytic cells in the immune 
system of the central nervous system, described in section 2.4) were observed at the site of 
injection of the prefibrillar aggregates [16].  Activated microglial cells produce potentially 
neurotoxic substances, including cytokines, reactive oxygen species, secreted proteases and 
nitric oxide [93, 117-119]. 
Evidence that it is the prefibrillar aggregates that are the pathogenic agents in amyloid 
disease comes not only from their cytotoxicity in vitro and their toxicity on injection, but 
also from a number of animal model studies, post-mortem studies of human subjects and 
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clinical trials of new medications [120].  For example, using animal model studies of AD, in 
which animals harbour one or more intentionally introduced transgenes bearing mutations 
that result in their developing AD, have indicated that the deposited Aβ plaque burden is a 
poor indicator of cognitive impairment [85, 121].  This observation is consistent with 
findings from neuropathological studies in humans [122-124], showing that many 
apparently healthy older humans have substantial amounts of amyloid brain deposits on 
post-mortem examination [7].  There also exists a correlation between the amount of 
soluble Aβ, including soluble Aβ oligomers, in the brain and cognitive deficits [122, 125-127].  
Furthermore, results from recent clinical trials indicate that removal of existing Aβ plaque 
deposits from the brain does not reverse or even halt cognitive decline [128].  The most 
commonly postulated, and best supported, explanations for the above phenomena are that 
precursors to amyloid formation are primarily responsible for cellular damage in pathogenic 
conditions that are related to the deposition of amyloid, such as AD or Parkinson’s disease. 
It has been reported that soluble oligomers of different proteins share common features of 
both structure and cytotoxicity independent of the protein sequence in question [43].  
Bolognesi et al. observed a correlation between the binding to 1-anilinonaphthalene 8-
sulfonate (ANS), and therefore the exposure of hydrophobic regions of the peptide, and the 
cytotoxicity of aggregates of a number of different proteins, including the AD-related Aβ 
peptide and some mutations of this protein that are implicated in certain hereditary, early-
onset forms of the disease [129].  The toxicity of prefibrillar aggregates of both disease-
related peptides and those that are not connected to any protein misfolding diseases 
implies that the cytotoxicity of these species arises from common characteristics of the 
structures rather than any specific features of the amino acid sequence of the peptide 
involved.    
2.4 Macrophages, Cellular Uptake and Inflammation 
Endocytosis is the process by which cells internalise molecules or particles from the 
extracellular environment.  Endocytosis falls into two broad catogories: phagocytosis (or cell 
eating) and pinocytosis (or cell drinking).  Pinocytosis occurs in all cells and can be grouped 
into at least four categories: macropinocytosis, clathrin-mediated pinocytosis, caveolae-
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mediated pinocytosis and clathrin- and caveolae-independent pinocytosis (which is not well 
understood and most likely includes more than one mechanism) [130]. 
Phagocytosis in mammals is conducted by specialised cells, such as macrophages or 
microglial cells, as a part of the body’s immune system.  Phagocytic cells function to clear 
large pathogens such as bacteria or yeast, the remnants of dead cells and arterial deposits 
of fat [131].  Phagocytosis is an active and highly regulated process involving specific cell-
surface receptors [130].  Cell-surface extensions, known as pseudopodia, envelop a food 
particle and engulf it, forming a phagosome or “food vacuole”.  The phagosome fuses with a 
lysosome, which contains enzymes that can degrade the particle (figure 2.3(a)).  If a 
phagocyte fails to engulf its target, the toxic agents present in the lysosome may be 
released into the extracellular environment where they can be toxic to host cells.  This is 
referred to as “frustrated phagocytosis”. 
Macropincytosis is a form of bulk uptake of fluid phase and solid cargo into large endocytic 
vesicles, known as macropinosomes.  The cell surface or plasma membrane extends circular 
or curved ruffles which collapse onto and fuse with the plasma membrane to generate the 
macropinosome, which can be as large as 5 µm (figure 2.3(b)) [132-134].  Macropinosomes 
have no discernible coat and do not concentrate receptors [135] and therefore 
macropinocytosis is a non-selective mechanism for the internalisation of extracellular 
macromolecules [136].  Clathrin-mediated pinocytosis and caveolae-mediated pinocytosis 
are both highly regulated uptake mechanisms that involve the generation of coated vesicles.  
These processes are receptor-mediated and the vesicles generated are smaller than 
macropinosomes (figure 2.3(c)) [130]. 
 
 27 
 
 
Figure 2.3: Mechanisms of endocytosis: (a) phagocytosis (b) macropinocytosis and (c) clathrin- or caveolae-
mediated endocytosis.  Vesicles are not drawn to scale.  Figure adapted from [137].  
Macrophages are a phagocytic cell of the body’s peripheral system.  The central nervous 
system (CNS) equivalent to the macrophage is the microglial cell.  These two cell types 
perform very similar functions in their respective systems and behave in a very similar 
manner [138, 139].  On activation, due to pathogens or injury, macrophages or microglia 
release inflammatory mediators responsible for the clinical symptoms of inflammation.  The 
question of whether activated microglia exacerbate pathology or aid in tissue repair in 
neurodegenerative diseases such as AD is currently a topic of debate [139].  While they may 
play an important role in the clearance of toxic amyloid species it is possible that long-term 
activation of microglial cells has a toxic effect on the surrounding tissue.   
There is considerable evidence that the activation of phagocytic cells, leading to 
inflammation, may play an important role in the pathogenesis of AD and other amyloid-
related neurodegenerative diseases [10, 93-95, 118, 139].  The deposition of extracellular 
proteinaceous aggregates in both the brain and at peripheral sites in amyloid-related 
pathologies is associated with the recruitment of phagocytic cells [140-145].  Moreover, 
microglia surrounding plaques in AD brains stain positively for activation markers and 
proinflammatory mediators [93].  Parvathy et al. have reported that both fibrillar and 
prefibrillar assemblies of Aβ40 and Aβ42 can be taken up by microglial cells.  However, they 
report that the oligomeric form of the peptide induces an inflammatory response, while the 
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mature fibril elicits no such response [10].  This inflammatory response may be a significant 
pathogenic event in diseases such as AD.   
A ligand which binds specifically to activated microglial cells has been developed and has 
been used in vivo in conjunction with positron emission tomography (PET) to image 
activated microglia in the brain [146, 147].  Using this ligand, known as 11C-R-PK11195, it has 
been found that the signal observed correlates inversely with cognitive function in AD 
patients [148].  Moreover, it was shown that the 11C-R-PK11195 signal increases as cognitive 
function declines over time while the signal from another PET ligand that binds to amyloid 
does not change. 
The ability of phagocytic cells to remove aggregates from the extracellular space or to 
catalyse the production of aggregates may be very important features in the pathogenesis 
of AD [149, 150].  However, little is known about the fate of different types of aggregates 
when they interact with phagocytes, or of how aggregates are able to localise to different 
intracellular compartments. 
2.5 Cellular Uptake of Nanoparticles 
The effect of size, shape and surface chemistry on the cellular uptake of micro- and 
nanoparticles has been examined for phagocytic and non-phagocytic cells [132-134, 144, 
151-156].   
Gratton et al. examined the influence of particle design on the uptake of non-cytotoxic 
polyethylene glycol hydrogel particles by HeLa cells (a non-phagocytic cell line).  Cylindrical 
and cubic particles with dimensions from 100 nm to 3 μm were studied and it was revealed 
that cylindrical particles were internalised more readily than cubic particles of similar 
dimensions [151].  Furthermore, for cylindrical particles with similar volumes, internalisation 
was more efficient for particles with a higher aspect-ratio (particles with aspect-ratios from 
1 to 3 were investigated) [151].  It was also found that particles with a positive surface 
charge were internalised more readily than particles that were negatively charged [151]. 
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A large amount of work has focussed on how the uptake of micro- and nanoparticles by 
phagocytic cells is affected by the size, shape and surface chemistry of the particles in 
question [132-134, 152, 153, 156, 157].  It has been reported that phagocytosis of particles 
is most efficient when particles have dimensions in the range of 1 – 2 μm, with particles 
outside this size range being internalised more slowly [132, 134, 154, 155].   
Recent studies on the effects of particle shape on uptake suggest that this may play a more 
dominant role than particle size in internalisation by phagocytosis [133, 152, 154].  Sharma 
et al. investigated the effects of particle size and shape on the attachment and 
internalisation of polymer particles by mouse macrophage cells [152].  Spheres, prolate 
ellipsoids (in which spheres are extended along a single axis) and oblate ellipsoids (in which 
spheres are extended along two axes) were examined.  Prolate ellipsoids were found to 
attach to macrophages most readily while spheres were the least likely to attach to the cell 
surface [152].  However, of the attached particles, oblate ellipsoids were internalised most 
readily and prolate ellipsoids were the least prone to internalisation [152].  Overall, oblate 
ellipsoids were found to be phagocytosed most readily, spheres were the next most 
efficiently phagocytosed and prolate ellipsoids were the least readily phagocytosed of the 
examined particles [152].  Champion et al. investigated the uptake of polystyrene particles 
by alveolar macrophages.  The internalisation of particles of various shapes and sizes was 
investigated and it was found that particle shape plays a more significant role than size in 
phagocytosis [133, 154].  It was found that local particle shape (dependent on the 
orientation of a non-spherical particle when coming into contact with a cell) plays a 
particularly important role [133, 154]. 
Surface chemistry has also been shown to influence phagocytosis of particles [132, 134, 144, 
156].  The interactions of latex particles with primary human leucocytes and neutrophils 
(both phagocytic cells) have been examined revealing that particles with hydrophobic 
surfaces are phagocytosed more efficiently than those with hydrophilic surfaces [132, 144].  
Tabata et al. investigated the phagocytosis by mouse peritoneal macrophages of 
polystyrene microspheres and modified cellulose microspheres with varying surface 
chemistries.  In this study, again, hydrophobic particles were phagocytosed more readily 
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than hydrophilic ones [134].  Zahr et al. examined the effect of modifying nanoparticle 
surface with the neutral hydrophilic polymer polyethylene glycol (PEG).  They found that the 
presence of PEG on the surface of the nanoparticles reduced uptake by cell-line 
macrophages [156]. 
2.6 Cellular Uptake of Amyloid 
The interactions of amyloid and its precursors with cells have previously been studied using 
confocal or fluorescence microscopy or immunogold labelling for examination in the TEM 
[158-163].  The interactions of protein aggregates with cells are dependent on the species of 
aggregate in question, with prefibrillar aggregates and mature amyloid fibrils entering cells 
via different pathways [145, 158, 159, 164].   
Studies have indicated that the uptake of protein aggregates is dependent on the aggregate 
species involved.  Weltzien and Pachter observed using fluorescence confocal microscopy 
that small aggregates of Aβ (≤ 1,100 µm3) are completely internalised by macrophage cells 
while larger ones remain associated with the plasma membrane in what were described as 
“pits” [158].  It may be that the larger aggregates are too big to be phagocytosed and 
therefore remain at the plasma membrane.  Chafekar et al. found that soluble Aβ oligomers 
are taken up by neuronal cells more readily than larger aggregates and that when uptake is 
inhibited the toxicity of the soluble oligomers is reduced, but inhibition of uptake does not 
affect the toxicity of the larger aggregates [159].  Knauer et al. found, using fluorescence 
microscopy, that aggregated Aβ42 was accumulated in human skin fibroblasts whereas the 
unaggregated peptide was not taken up [163].  Internalisation was prevented by incubating 
cells at 4°C, a temperature at which endocytosis is inhibited [163].   
The uptake of Aβ fibrils by microglial cells has been shown to occur via receptor mediated 
phagocytosis [145, 165].  Bamberger et al. identified a cell surface receptor that mediates 
the binding of microglia to Aβ fibrils leading to uptake by phagocytosis and a 
proinflammatory response [145].  By contrast, the uptake of Aβ oligomers occurs via 
macropinocytosis [164].   
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The increase observed in the permeabilisation of membranes that are affected by 
prefibrillar aggregates [111, 113-115] suggests that these aggregates may enter cells by 
traversing the membrane rather than by active uptake by the cells.  This may explain the 
observations made by Weltzien and Pachter and by Chafekar et al. that smaller aggregates 
internalised more frequently than larger ones [158, 159]. 
These observations, combined with the drastic differences in the toxicity of prefibrillar and 
fibrillar aggregates in both in vitro and in vivo studies, imply that there are dramatic 
differences in the way cells interact with these two types of aggregates. 
The uptake of Aβ in its unaggregated, monomeric form has also been investigated [161, 
166-168].  Studies suggest that the peptide is internalised by different cell types, though 
different mechanisms of uptake have been reported for different cell types.  The monomeric 
peptide is most often observed to be localised in lysosomes or at the plasma membrane 
[161, 166-168].   
2.7 Imaging Cells 
2.7.1 Transmission Electron Microscopy 
The most common mode of electron microscopy used for imaging biological samples is 
bright field transmission electron microscopy (BF-TEM) imaging.  The main source of image 
contrast in BF-TEM is mass-thickness contrast.  BF-TEM and mass-thickness contrast are 
discussed in further detail in chapter 3.  Image contrast generated by biological specimens 
tends to be very poor.  To overcome this heavy metal stains are typically used in order to 
enhance image contrast of thin resin sections.  Osmium tetroxide is a bulk stain which binds 
to lipids and therefore increases contrast at membranes in TEM images because of the high 
atomic number of the osmium atoms.  Other stains, such as uranyl acetate, which 
selectively stains nucleic acids, and lead citrate, which selectively stains amine groups, are 
used to post-stain biological samples to enhance contrast at, for example, proteins.  
Unfortunately, these stains lack the specificity that is required to visualise and identify 
specific molecules or peptides in the subcellular environment. 
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2.7.1.1 TEM Imaging of Biomaterials and Nanoparticles in Cells 
The potential for atomic resolution imaging of biological specimens in the TEM has been 
previously demonstrated by the examination of crystal lattices in dentin [169] and the 
visualisation of carbon nanotubes and C60 within cells [170-173].  The use of electron 
microscopy to examine biological systems at such high spatial resolution has afforded 
important insights into both biological function and the interactions of cells and tissue with 
other materials at the nano- and micro-scale [169, 171-175]. 
Analytical electron microscopy techniques, such as energy filtered TEM (EFTEM) and 
electron energy loss spectroscopy (EELS) have been employed to provide new insights into, 
for example, the chemistry  and bonding at the collagen-hydroxyapatite interface in ivory 
dentin [175].  The use of analytical electron microscopy has also made it possible to 
distinguish unlabelled single-walled nanotubes and C60 from their surrounding environment 
in the cell cytoplasm [171, 172].  This has provided vital information on how such structures 
are taken up, localised and transformed within cells.  BF-TEM has also been used to 
investigate the intracellular distribution of single-walled and multi-walled nanotubes [176, 
177].  Gass et al. utilised HAADF-STEM imaging and EELS analysis to visualise multi-walled 
nanotubes inside macrophage cells and to establish the mode of cell death and the role that 
contaminants present in the nanotubes play in their cytotoxicity [178]. 
2.7.1.2 Electron Tomography 
When operating in imaging mode in the TEM two-dimensional (2-D) projections of the 
sample are generated.  This can lead to the misinterpretation of data due to the lack of 
information about the position at which an object lies along the direction of the electron 
beam.  Tomography is a method for reconstructing a three-dimensional (3-D) volume that 
represents an object from its projections from different angles.  In the case of electron 
tomography the sample is tilted at incremental angles, typically up to 60° or 70° off axis in 
each direction, and images are collected at each tilt angle.  Each of these images is a 2-D 
projection of the sample at a given tilt angle.  A 3-D volume representing the original object 
can be constructed by a method of back-projection [179]. 
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Electron tomography has been widely used to investigate cell structure and to visualise 
cellular organelles in three-dimensions [180, 181].  It is also a useful method for confirming 
that an object is inside a cell and is not simply on top of the TEM sample.  For example, 
Porter et al. utilised this technique to confirm the penetration of an aggregate of C60 
particles into the nucleus of a macrophage cell [172] (figure 2.4).   
 
Figure 2.4: tomographic reconstruction of a cluster of C60 particles penetrating into the nucleus of a cell:  (a) 
Voltex projection and (b) orthoslices at 20 nm height intervals through the cell.  The nucleus, cytoplasm and 
C60 can be seen.  Adapted from [172]. 
Large scale tomography has been carried out by Hoog et al. by acquiring montage 
tomograms from adjacent serial sections in order to examine the microtubules, a 
component of the cytoskeleton, of an entire fission yeast cell at high spatial resolution 
[182].  This method allowed the investigation of not only the microtubule organisation but 
also of the microtubules’ interactions with other organelles such as the mitochondria (figure 
2.5). 
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Figure 2.5: 3-D model of a yeast fission cell showing selected cellular structures.  The model was 
reconstructed from montage tomograms acquired from adjacent serial sections.  Microtubules are shown in 
green, mitochondria are shown in blue and the nucleus is shown in pink.  Adapted from [182]. 
The spatial resolution of a tomography data series is not an unambiguous measure.  
Crowther’s equation is often used as a reference: 
  
  
 
 
Equation 2.1 
where d is the resolution, D is the diameter of the sample and N is the number of 
projections acquired [179].  This expression is only valid for spherical and cylindrical objects, 
which is rarely the case, and a complete angular range, which in practice is impossible.  
However, this equation, in which D is often substituted with the sample thickness, is useful 
as a rough guide for the resolution of a tomographic dataset.  It also indicates two 
important concepts in tomography: the thicker the sample the lower the spatial resolution 
and the greater the number of projections attained the better the resolution.  
The acquisition, reconstruction and visualisation of tomography datasets are discussed in 
greater detail in chapter 3. 
2.7.2 Imaging Amyloid in Cells 
The biggest challenge in visualising the interactions between protein aggregates or amyloid 
fibrils and cells arises from a lack of contrast between the carbon-rich aggregates and the 
carbon-rich cells.  The elements that make up the majority of amino acids (the constituents 
of proteins) are carbon, nitrogen, hydrogen and oxygen.  Two of the standard amino acids, 
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cysteine and methionine, also contain sulfur atoms.  Therefore the elemental composition 
of an amyloid fibril or protein aggregate is not significantly different to the rest of the cell.  
Even when something with the appearance of an amyloid fibril or a protein aggregate is 
observed within a cell it cannot identified with absolute certainty without some sort of 
labelling method.  The two most common techniques for visualising protein aggregates and 
cells are immunofluorescent staining for visualisation in the fluorescent or confocal 
microscope and immunogold staining for visualisation in the TEM.  Studies using these 
methods are discussed below. 
2.7.2.1 Confocal Microscopy 
A number of studies have been carried out using fluorescent or confocal microscopy to 
visualise the uptake of aggregates of a number of different proteins [158, 159, 165, 183].  In 
these studies fluorescent dyes are used to allow visualisation of the cells and fluorescent 
labelling of the protein is required.  Weltzien and Pachter have used confocal microscopy to 
visualise the internalisation of aggregates of immunofluorescently labelled Aβ40 by human 
phagocytic cells, as described in section 2.6.  Figure 2.6 shows 3-D reconstructed images of 
phagocytic cells internalising aggregates of Aβ40.   
          
Figure 2.6: Reconstructed 3D confocal images of human pahgocytic cells internalising aggregates of Aβ1-40.  
(a) Cells exposed to unfractionated aggregates of Aβ1-40.  (b) and (c) show cells exposed to large and small 
aggregates of Aβ1-40 respectively.  Large and small aggregates were separated by centrifugation at 100,000 × 
g for 30 mins.  In all of the above images the scale bar represents 80 µm. Adapted from [158]. 
Chafekar et al. have used a similar method to visualise uptake of fluorescently labelled Aβ42 
by human cell lines using confocal microscopy, also described in section 2.6 [159]. 
The use of fluorescence or confocal microscopy has provided extremely valuable insights 
into the interactions of protein aggregates and cells.  However, the spatial resolution of 
a b c 
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confocal microscopy is limited to 20 nm at best [184, 185].  This means that confocal 
microscopy does not provide a possibility to assess the distribution of the aggregates after 
uptake or to examine the structure of aggregates after uptake and thereby assess the ability 
of the cells to effectively degrade the aggregates.    This method also requires fluorescently 
labelling the Aβ aggregates before cell exposure.  It is not possible to assess the effects of 
this potentially chemically intrusive label on cellular uptake.  Moreover, it has been shown 
that the fluorophores typically used to label Aβ peptides when examining their interactions 
with cells in the confocal microscope are retained within cells even after the peptide has 
been degraded [164], thereby giving potentially misleading results. 
2.7.2.2 Immunogold labelling 
Immunogold labelling has been widely used to identify amyloid within cells and tissue [160-
162].  A primary antibody, whose antigen is the constituent protein of the amyloid, binds to 
the amyloid and a secondary antibody, whose antigen is the primary antibody, binds to the 
primary antibody.  The secondary antibody is attached to a gold nanoparticle.  This allows 
the amyloid to be identified in TEM by the location of the gold nanoparticles.   
Ard et al. have used immunogold labelling to visualise Aβ42 taken up by cultured microglial 
cells from rat spinal cord [161].  Cells were exposed to Aβ42 for a period of 24 hours before 
fixation and embedding.  Immunogold labelling was carried out after sectioning (figure 2.7).  
Aβ42 was observed in lysosomes inside the cells and associated with the cell surface, as 
indicated by the arrows in figure 2.7.  The exact locations of Aβ42 are difficult to interpret in 
this image.  
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Figure 2.7: TEM image of microglial cells exposed to Aβ42 labelled with 15nm immunogold particles.  Arrows 
point to Aβ42, these are part of the originally published image.  Scale bar represents 2 µm.  Vac = vacuole; 
nuc = nucleus.  Adapted from [161]. 
Argilé et al. have used immunogold labelling to identify dialysis-related amyloid in human 
tissue [162].  Macrophage cells are observed phagocytosing the amyloid deposits (shown in 
figure 2.8). 
 
Figure 2.8: TEM images of immunogold labelled dialysis-related amyloid in human tissue.  (a) a macrophage 
cell extends pseudopodia (thin arrows, part of published figure) and encompasses amyloid material.  (b) 
amyloid is observed within the cell in the lysosomes (wide arrows, part of published figure).  
IC = intracellular space, EC = extracellular space.  Adapted from [162], no scale provided in the original 
publication. 
Badman et al. exposed cultured macrophages from mice to pancreatic islet amyloid (found 
in 96% of type II diabetic patients) for examination by TEM.  Immunogold labelling was used 
for the identification of amyloid within the cells (shown in figure 2.9) [160].  No cytotoxic 
a b 
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effects were observed after 72 hours of exposure to the mature fibrils.  Amyloid was 
observed to have been phagocytosed but not degraded by the macrophage cells. 
 
Figure 2.9: TEM image of macrophage exposed to pancreatic islet amyloid and immunogold labelled for 
amyloid identification.  The arrows point to aggregates observed in lysosomes within the cell.  Scale bar 
represents 200 nm.  Adapted from [160]. 
Among the methods for immunogold labelling the most commonly used are pre-embedding 
labelling or post-sectioning labelling.  For pre-embedding labelling, primary antibodies are 
added after fixation but before embedding followed by the secondary antibody.  The 
disadvantages of the pre-embedding labelling method are that only antigens on the plasma 
membrane will be labelled and anything that has been internalised by the cell will not be 
labelled.  Therefore this method is unsuitable for visualising amyloid or protein aggregates 
that have been taken up by cells.  Post-sectioning labelling is carried out after samples have 
been sectioned by placing a section of fixed and embedded tissue or cells on a drop of 
solution containing the primary antibody and then on a drop of solution containing the 
secondary antibody.  This method allows antigens that have been taken up by the cell to be 
identified; however, the primary antibody will only bind to antigens that are at or are very 
close to the surface of the section [186].  Given that an amyloid fibril is typically 7-10nm in 
width [2] and a cell or tissue section prepared for examination by TEM is typically of the 
order of 100nm in thickness, only amyloid very close to or at the surface of the section can 
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be labelled.  This means that it is likely that much of the amyloid within a section will not be 
labelled as demonstrated in figure 2.10. 
 
Figure 2.10: Schematic of immunogold labelling of a section of cells exposed to amyloid fibrils means that 
only amyloid very close to or at the surface of the section will be labelled. 
2.7.2.3 Imaging Selenium-labelled peptide aggregates in cells 
In scanning transmission electron microscopy (STEM) the electron beam is converged into a 
probe and rastered across the sample.  On interaction with the sample many of the incident 
electrons will be scattered.  Electrons interacting with heavier elements will be scattered to 
greater angles than those interacting with lighter elements.  A high angle annular detector 
placed after the sample collects only electrons scattered to higher angles, in other words, 
those interacting with heavier elements in the sample.  This results in an image in which 
intensity is approximately proportional to the square of the atomic number of the element 
in the sample.  This is known as high-angle annular dark field STEM (HAADF-STEM).  This is 
disussed in greater detail in chapters 3 and 5.   
There are two naturally occurring amino acids that contain sulfur atoms – cysteine and 
methionine.  Selenium is in the same group of the periodic table of elements as sulfur and 
therefore has similar properties but its higher atomic number means it has a higher electron 
scattering cross-section.  Thus by replacing the naturally occurring sulfur atom of the 
cysteine or methionine amino acid with a selenium atom a protein with very similar 
properties to its selenium-free analogue [187-189], but that can be easily identified with a 
cell or a tissue, can be synthesised. 
Section 
Gold-labelled 
antibodies 
Amyloid 
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Porter et al. exposed human macrophage cells to amyloid fibrils formed from selenium-
labelled section of the protein transthyretin (TTR), a protein associated with a form of 
systemic amyloidosis [190].  Figure 2.11 shows HAADF-STEM images of macrophage cells 
exposed to amyloid fibrils formed from selenium-labelled and unlabelled TTR fragment 
[191]. 
 
Figure 2.11: (a) HAADF-STEM image of a macrophage cell exposed to amyloid fibrils formed from a fragment 
of TTR without a selenium label.  The fibrils show no contrast.  (b) Macrophage cell exposed to the amyloid 
fibrils formed from a selenium-labelled section of the TTR protein.  The fibrils can easily be seen within the 
cell cytoplasm.  Se-f refers to selenium-labelled fibrils.  Adapted from [191]. 
The Aβ peptide contains one methionine, an amino acid that contains a sulfur atom which 
can be replaced with a selenium atom to create a protein that can be easily identified inside 
a cell making a reliable investigation of its intracellular distribution possible without the use 
of chemically intrusive markers.  
A section of the Aβ protein in which the sulfur atom in the methionine amino acid has been 
replaced with a selenium atom has been synthesised by Bachem (Weil am Rhein, Germany).  
The section contains the amino acids 25-36 of the natural Aβ protein.  This includes the 
Aβ(25-35) fragment which, as mentioned previously, possesses many of the characteristics 
of the full Aβ42 chain and is therefore often used as a convenient model for the full-length 
chain.  This selenium-labelled peptide has been used to visualise protein aggregates inside 
human macrophage cells [192]. 
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3. Materials and Instrumentation 
This chapter describes the materials, instruments and techniques used to carry out the 
experiments presented in this thesis.  Particular emphasis is placed on electron microscopy 
and analysis and the theory behind these techniques.  The methods utilised in the 
preparation of proteins and cells are also discussed. 
3.1 Protein Preparation and Aggregation 
3.1.1 Protein Preparation 
All Aβ proteins were purchased from Bachem, who produce the peptides synthetically.  
1 mg of lyophilised protein was dissolved in 1 ml trifluoroacetic acid (TFA) and sonicated for 
30 seconds on ice.  The TFA was removed by lyophilisation overnight.  A second dissolution 
step was performed in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) and the peptide solution 
was divided into aliquots.  The HFIP was evaporated through rotary evaporation for three 
hours at room temperature.  Quantitative amino acid analysis was carried out on the first, 
last and middle aliquots.  The average of these was calculated and assumed to be the 
amount of peptide present in each aliquot. 
3.1.2 Protein Aggregation 
During the aggregation study of Aβ(25-36) the protein was dissolved in 50 mM sodium 
phosphate buffer at pH 7.4 at various protein concentrations, with different concentrations 
of sodium chloride, in an eppendorf which was shaken for one minute to ensure that the 
protein had dissolved.  The protein solution was then maintained at a constant temperature 
throughout the experiment.  The exact concentrations and temperatures used in these 
experiments are discussed in chapter 4. 
Once an aggregation protocol had been established for the preparation of Aβ(25-36) 
aggregates for exposure to cells the protein was dissolved in a 50 mM sodium phosphate 
buffer, 100 mM sodium chloride, at a final protein concentration of 100 µM.  The solution 
was then maintained at 37°C for the desired time.  
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3.1.3 Peptide Sample Preparation for Transmission Electron Microscopy 
Samples of the peptide solution before, during and after the aggregation process were 
prepared for examination by TEM or STEM.  400 mesh copper grids, coated in continuous 
carbon film (Agar Scientific), were placed film side down on top of a 5 μl drop of protein 
solution for two minutes and placed face up on filter paper to dry.  The grids were then 
washed twice in distilled water to remove any salt that may have been in the buffer and 
placed face up on filter paper to dry. 
Selected grids were then negatively stained to enhance image contrast.  These grids were 
placed face down on a 5 μl drop of 2% uranyl acetate and covered for two minutes before 
being placed face up on filter paper to dry.  
3.1.4 Peptide Sample Preparation for Atomic Force Microscopy 
Samples were prepared for atomic force microscopy (AFM) examination by dropping liquid-
phase peptide solutions onto freshly cleaved mica.  Samples were placed face up to dry.  
Samples were then dried twice in distilled water to remove any salt  and placed face up to 
dry. 
3.1.5 Thioflavin T Fluorescence 
Thioflavin-T (ThT) binds to beta sheet structures and undergoes a shift of its excitation 
spectrum so that it excites at 442 nm and emits at 482 nm.  In the absence of any beta sheet 
structure excitation and emission occur at 342 and 430 nm respectively [193].  An increase 
in beta sheet structure, and therefore amyloid, is characterised by an increase in ThT 
fluorescence at its excited spectrum. 
ThT was introduced by Vassar and Culling in 1959 as a dye that shows enhanced 
fluorescence on binding to amyloid in tissue sections [194].  Despite its common use in 
identifying fibrils in ex vivo, in vitro and animal model studies, the mechanisms of ThT 
binding to amyloid are not well understood [32].   
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ThT Fluorescence measurements were carried out on an OPTIMA plate reader.  96-well half 
volume COSTAR plates were used.  A total volume of 40 – 50 μl was added to each well for 
each measurement.  Excitation was carried out at 440 nm and emission was detected at 
480 nm. 
ThT was added, at a concentration of 20 μM, directly to the protein/buffer solution in the 
wells of the plate reader.  The plate reader was maintained at a constant temperature and 
fluorescence measurements were taken at set intervals.   
3.2 Culturing and Exposure of Cells 
The cells used in this study were human monocyte-derived macrophage (HMMs) isolated 
from buffy coat, the fraction of a blood sample that, after centrifugation, contains most of 
the white blood cells and platelets.  The cells were isolated, cultured, treated and fixed by 
Michael Motskin in the Multi-Imaging Centre in the Anatomy Department at the University 
of Cambridge. 
3.2.1 Isolation and culture of human monocyte-macrophages 
Buffy coat residue from the National Blood Service, Brentwood, UK, was washed once with 
phosphate-buffered saline (PBS) and the resulting cell sediment was mixed with an equal 
volume of fresh PBS.  30 ml of diluted buffy coat residue was layered onto 15 ml of 
LymphoPrep (Axis-Shields, Oslo, Norway) and after centrifugation at 20ºC for 30 minutes at 
700 g the opaque interphase of mononuclear cells was removed and washed three times 
with PBS containing 4 mg/ml bovine serum albumin (BSA) to remove platelets. Monocytes 
were then enriched by an additional centrifugation step in a Percoll gradient [195].  
Mononuclear cells were resuspended in 4 ml of PBS and mixed with 8 ml of Percoll: Hanks’ 
Balanced Salt Solution (10 × concentrate; 6:1, at pH 7.0).  After centrifugation at 20ºC for 
30 min at 450 g, the monocytes were collected from the top of the gradient, washed in 
PBS/BSA and seeded using Macrophage Serum-Free Medium (Mø-SFM) (Invitrogen, Paisley, 
UK).   
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3.2.2 Treatment and fixation of HMMs for TEM 
Cells were cultured for 1 to 2 weeks in Mø-SFM before prefibrillar aggregates or amyloid 
fibrils were added.  Aβ(25-36) aggregates were added at a concentration of 10 µM.  After a 
specified amount of time the cells were fixed.  Two methods of cell fixation were used: resin 
embedding and freeze-drying. 
3.2.2.1 Resin Embedding 
The method of resin-embedding was used to prepare ultra-thin sections of cells that had 
been exposed to Aβ(25-36) aggregates.  The low thickness of these samples allowed 
transmission electron microscopy imaging with a high spatial resolution, making it possible 
to determine the exact intracellular location of the aggregates.  Cells were fixed by adding 
gluteraldehyde to the cell culture medium; this acts as a fixative by cross-linking the 
proteins in the cells.  Some cells were bulk stained with osmium tetroxide to enhance image 
contrast and highlight cell structure.  Osmium tetroxide is a strong oxidant that cross-links 
lipids; therefore it acts not only as a secondary fixative of membranes but also increases 
contrast in TEM images because of the high atomic number of osmium.  A resin embedding 
preparation method without the use of stains was also utilised.  Using this approach no 
heavy elements are introduced into the sample at the point of fixation and embedding.   
Cells for examination by TEM were seeded in 6-well tissue culture plates at between 4 × 106 
and 8 × 106 cells/well.  After a period of 2, 6 or 24 hours of exposure to Aβ(25-36) or Se-
Aβ(25-36) the cell culture medium was removed and the cells were washed twice in 0.9% 
saline buffer.  Washed cell monolayers were fixed with 4% gluteraldehyde in PIPES buffer 
(0.1 M, pH 7.4) for 1 hour at 4°C.  Cells were then rinsed three times in PIPES buffer, scraped 
with a cell scraper and washed once more with PIPES buffer.  Scraped cells were transferred 
to 15 ml Falcon tubes (BD, Erembodegem, Belgium) and a pellet was formed by 
centrifugation for 5 minutes at 1500 g.   Fixed cells were rinsed 3 times in 0.1 M PIPES 
buffer.  Cells that were to be bulk stained were then osmicated by incubation for 1 hour in 
1% osmium tetroxide with 1.5% potassium ferricyanide.  They were rinsed 6 times in 
deionised water (DIW) and bulk stained in 2% uranyl acetate in 0.05 M maleate buffer at 
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pH 5.5.  Cells were then rinsed 3 times in DIW.  Both stained and unstained cells were then 
dehydrated by three exchanges of ethanol solutions, using progressively higher ethanol 
concentrations 70%, 95% and 100%.  Unstained cells were then infiltrated under vacuum in 
LR white resin, hard (Agar Scientific, UK), for three days.  The LR white resin was changed 
every 24 hours.  Bulk stained cells were washed twice in dry 100% acetonitrile, they were 
then incubated in 50% acetonitrile, 50% epoxy resin overnight.  This was followed by four 
daily changes of full resin with catalyst.  The epoxy resin used was Quetol 651, an Ethylene 
glycol diglycidyl ether monomer (Agar Scientific, UK). The resin mixture contained 9 g 
Quetol, 11.6 g Nonenyl Succinic Anhydride (NSA) hardener, 5 g Methyl-5-Norbornene-2,3-
Dicarboxylic Anhydride (MNA) hardener and 0.5 g Benzyldimethylamine (BDMA) catalyst . 
After 4 days of resin changes quetol embedded samples were cured in a 60° C oven for 
24 hours. 
Fixed and embedded samples were cut with a Power Tome XL from RMC Products by 
Boeckeler, Tucson, Arizona, USA, using a 35° diamond knife, prior to examination by TEM.  
Microtomed sections were cut 70-100nm thick for examination by TEM.  In order to increase 
volume information thicker sections (200 – 300 nm) were prepared for the collection of 
tomographic data sets. 
Sections were collected on 400 mesh copper grids with lacy carbon support film or on 300 
to 600 mesh copper grids with no support film; all grids were purchased from Agar, 
Stansted, UK. 
Some sections were then coated with a 5 – 10 nm layer of carbon with an Emitech K975X 
High Vacuum Evaporation System from Quorum Technologies, Ashford, UK. 
3.2.2.2 Freeze Drying 
Freeze-drying of cells was carried out to create TEM samples in which whole cells could be 
imaged at once, in particular for electron tomographic studies. 
HMMs were seeded on formvar coated gold grids, at a concentration of 1 x 106 to 2 x 106 
cells/grid, and exposed to Aβ(25-36) for a period of 24 hours before cryofixation  by rapid 
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immersion into liquid propane cooled by liquid nitrogen.  The samples were freeze-dried by 
raising the temperature over 24 hours at a pressure of 5 x 10-6 bar. 
3.2.3 Cell Viability Assays 
In order to assess the cytotoxicity of the Aβ(25-36) peptide, the viability of HMMs exposed 
to the peptide at different stages in its aggregation was examined using two different assays 
– the MTT assay and the live/dead assay. 
3.2.3.1 MTT Viability Assay 
The viability of HMMs was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT) assay, which measures the intracellular enzymatic conversion of 
MTT by mitochondrial dehydrogenase into formazan in viable cells.  MTT viability assays 
were carried in 48-well plates in which cells were cultured at a density of 0.5 x 106 to 1 x 106 
cells/well for one to two weeks.  Five different concentrations of protein monomer or 
aggregates were then added to the cell culture medium.  Protein concentrations ranging 
from 0 to 20 µM were examined for the assessment of the cytotoxicity of the Aβ(25-36) 
monomer, early aggregates and mature fibrils.   
Conversion of MTT was examined after 2, 6 and 24 hours and compared with control cells - 
cells which were not exposed to any Aβ(25-36).  Sample solutions were removed after 
incubation and MTT was added at a concentration of 0.5 mg/ml in medium for 2 hours at 
37oC.  Cells were rinsed with PBS and 500 µl of extracting solution (0.04 M HCl in 
isopropanol) was added to each well.  Plates were incubated for 15 minutes at room 
temperature to dissolve the dye and 200 µl of dye solution was transferred to 96 well 
plates.  Absorbance was measured at 570 nm (ASYS HiTech Expert plate reader) and cell 
viability was expressed as a percentage relative to the control.  Statistical analysis was 
performed using a two-tailed type 2 t-test with significance set at p < 0.0001. 
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3.2.3.2 Live-Dead Assay 
The live-dead assay measures cell viability using two different fluorescent dyes: Hoechst and 
propidium iodide (PI).  Hoechst binds to the nuclei of cells; it can permeate the membranes 
of healthy cells and can therefore dye the nuclei of all cells, both dead and alive.  PI also 
binds to the cells’ nuclei; however, it is membrane impermeant and therefore only stains 
the nuclei of dead cells.  On examination in the confocal microscope, those nuclei that are 
stained with Hoechst appear blue and those that have been co-stained with Hoechst and PI 
will appear blue or red depending on the acquisition parameters. 
To perform the live-dead assay HMMs were cultured on glass cover slips (No.1 thickness, 
13 mm diameter) at 1 x 106 to 2 x 106 cells/well for one to two weeks.  Cells were then 
exposed to Aβ(25-36) at different stages in its aggregation.  Hoechst was added to the 
medium to achieve a concentration of 8.0 µM, 5 hours before imaging to stain the nuclei of 
all cells present.  Before imaging PI was added at a concentration of 7.4 µM to label the 
nuclei of dead cells.  The cover slips were then removed for imaging.  Cells were viewed 
using a Leica TCS SP2 confocal microscope, with a 63 x, 1.2 NA, water immersion objective 
lens.  Randomly selected areas of the cover slips were viewed and the numbers of cells with 
blue nuclei were counted as the total number of cells present and the number of cells with 
nuclei co-stained blue and red were counted as the number of dead cells.  The percentage 
of dead cells was calculated as follows: 
             
                
           
     
Equation 3.1 
At least eight cover slips were examined for each preparation and at least ten fields of view 
were imaged for each cover slip.  Each field of view contained at least twenty cells.  
The live-dead assay typically returns lower cytotoxicity results than the MTT assay, which 
can return lower viability results for cells that are stressed, but still alive.  In the live-dead 
assay, only cells that are actually dead, not just stressed, are counted as dead and dead cells 
are no longer adherent, hence when the cell culture medium is removed for the live-dead 
assay, many of the dead cells are also removed. 
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3.3 Electron Microscopy and Analysis 
Three transmission electron microscopes were used to carry out the work in this thesis; a 
JEOL 2000, a JEOL 2010 and an FEI Titan 80/300 aberration corrected TEM/STEM 
microscope, all located in the Materials Department of Imperial College London.   
3.3.1 Introduction to TEM 
It was first theorised by Louis de Broglie in 1925 that the electron possessed wave-like 
characteristics with a wavelength much smaller than that of visible light [196].  The term 
electron microscope was first used in a published paper by Knoll and Ruska in 1932 when 
the idea was proposed as a means of improving image resolution [197]. 
The resolution of a microscope can be defined as the shortest distance between two points 
which can be clearly seen as separate entities.  In theory this resolution is limited only by 
the wavelength of the light or the electrons in the beam (depending on whether a light or 
electron microscope is being used).   
Electrons have both wave-like and particle-like characteristics and these are both exploited 
in the electron microscope.  Following de Broglie’s theories on wave-particle duality the 
wavelength, λ, of a particle can be related to its momentum, p, via Planck’s constant, h [198, 
199]: 
  
 
 
 
Equation 3.2 
In the TEM the electrons are accelerated through a potential, V, giving them kinetic energy, 
eV, so: 
   
 
 
   
  
Equation 3.3 
where m0 is the rest mass of the electron. 
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             Equation 3.4 
  
 
      
 
Equation 3.5 
This treatment neglects relativistic effects which cannot be ignored at the velocities 
electrons in the TEM travel.  Taking relativistic effects into account [198]: 
  
 
         
  
     
 
 
Equation 3.6 
where c is the speed of light.  Visible light has a wavelength of 400 – 700 nm while the 
electrons that are used in the electron microscope typically have wavelengths over the 
range of 0.001 to 0.01 nm.  Clearly the resolution of an electron microscope will be far 
better than that of a light microscope.  In reality, however, the resolution of the electron 
microscope is limited by the electromagnetic lenses rather than the wavelength of the 
electrons.  The imperfections in the electromagnetic lenses limit the resolution of the 
microscope.  The main lens defects that compromise microscope resolution are discussed in 
section 3.3.3.2. 
3.3.2 Electron/Specimen Interactions 
While electrons were initially utilised in microscopy merely as a means of improving image 
resolution it soon became apparent that there are a number of advantages to using 
electrons as they produce a wide range of secondary signals that can be exploited to gain 
information about material in the specimen.  A selection of these secondary signals is shown 
in figure 3.1 below. 
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Figure 3.1:  Some of the signals generated when a beam of high speed electrons interacts with a thin 
specimen. Figure adapted from [198]. 
In TEM and STEM a thin sample is imaged, typically less than 100 nm, though some of the 
results presented in this thesis were gained using samples greater than 200 nm in thickness.  
For such a thin specimen most of the incident electrons do not interact with the sample and 
travel straight through as the direct beam.  However, a small number of electrons are 
scattered to different angles, either elastically or inelastically.  This results in an angular 
distribution of electrons emerging from the specimen. 
3.3.2.1 Elastic Scattering 
Elastically scattered electrons are scattered through an angle θ and are no longer a part of 
the direct beam, but they do not lose a detectable amount of energy on interaction with the 
specimen.  Elastic scattering can occur either as a result of the incident electron interacting 
with the electrons of the atoms in the specimen, resulting in relatively low scattering angles 
(figure 3.2 (a)), or interacting with the atomic nucleus, resulting in a much greater angle of 
scatter (figure 3.2 (b)).  Scattering by the atomic nucleus is referred to as Rutherford high 
angle scattering and is discussed in further detail in section 3.3.2.4.  
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Figure 3.2: Elastically scattered electrons may be scattered through (a) small angles by interaction with the 
electron cloud or (b) through larger angles on interaction with the atomic nucleus. Figure adapted from 
[198]. 
3.3.2.2 Inelastic Scattering 
Electrons that lose energy on interaction with the sample are known as inelastically 
scattered electrons.  The energy-losses of these electrons can be used to gain information 
about the specimen.  By examining these energy-losses the elements present in the sample 
can be determined.  Information on their chemical structure/bonding can also be gained.  
The examination of the energy-losses of electrons on interaction with the specimen is 
known as electron energy-loss spectroscopy (EELS).  Many of the inelastic scattering events 
in the electron microscope result in the generation of X-rays that have energies that are 
characteristic of the elements present in the sample; inspection of these X-rays is known as 
energy dispersive X-ray spectroscopy (EDX) and is discussed further in section 3.3.7. 
3.3.2.3 The Interaction Cross-Section 
The interaction cross-section (ς) is the probability of a particular electron in the electron 
beam undergoing any type of interaction with an atom in the sample.  The total interaction 
cross-section is the sum of the elastic and inelastic cross-sections: 
                           Equation 3.7 
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For an interaction with a single atom the cross-section (which has the units of area) can be 
defined in terms of the effective radius (r) of the atom [198]: 
      Equation 3.8 
The effective radius (r) has a different value for each type of interaction the electron can 
undergo. For elastic electron-electron and electron-nucleus scattering r can be defined as 
[198]: 
          
 
  
 Equation 3.9 
         
  
  
 
Equation 3.10 
where Z is the atomic number, e the charge on the electron, V is the potential through 
which the incoming electron is accelerated (volts) and θ is the angle through which the 
electron is scattered (mrad).  Electrons are scattered to higher angles by the atomic nucleus 
than by the electron shells of atoms in the sample (figure 3.2).  Therefore equation 3.10 is of 
greater interest than equation 3.9, as many of the electrons that undergo electron-electron 
scattering will be collected as part of the direct beam.  This expression for rnucleus ignores any 
screening effects of the electron cloud around the nucleus which acts to reduce the effect of 
Z. 
Equations 3.9 and 3.10 demonstrate that electrons are scattered less strongly at higher 
accelerating voltages, that heavier atoms scatter electrons more strongly than lighter 
atoms, and the scattering cross-section decreases as the scattering angle increases.  For 
electron-electron interactions the scattering cross-section depends primarily on the beam 
energy whereas for electron-nucleus interactions, the cross-section is dependent on both 
the beam energy and the atomic number of the atom in the sample [198]. 
The total scattering cross-section (QTotal) of a specimen and the probability of an electron 
passing through it undergoing a scattering event (p) can be defined for a specimen of 
thickness t and density ρ [198]:  
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Equation 3.11 
where N0 is Avogadro’s number and A is the atomic weight.  The product (ρt) is the “mass-
thickness” of the sample.  The effect of doubling the density is the same as that of doubling 
the thickness. 
3.3.2.4 The Rutherford Scattering Cross-section 
The high-angle electron-nucleus interaction shown schematically in image 3.2(b) is 
analogous to the backscattering of α particles from a thin metal foil observed by Rutherford 
in 1911 and used to deduce the existence of the nucleus.  Rutherford derived the following 
expression for this type of scattering [198]:  
     
  
 
    
           
 
 
 
Equation 3.12 
where e is the charge on the electron and E0 is the energy of the incident particles.  This 
equation can be used to describe the scattering of high speed electrons interacting with the 
nucleus of an atom in a target.  The expression assumes that the electrons do not lose any 
energy on interaction with the specimen, i.e. that E0 does not change.   
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Figure 3.3: Incident electrons are scattered through an angle θ into a solid angle Ω.  Figure adapted from 
[198]. 
Figure 3.3 shows how electrons are scattered through a scattering angle θ into a solid angle 
Ω.  The relationship between θ and Ω is as follows [198]:  
             Equation 3.13 
Therefore 
            Equation 3.14 
So the differential scattering cross-section, dς/dΩ is:  
  
  
 
 
      
  
  
 
Equation 3.15 
By integrating from a particular scattering angle θ to the maximum possible scattering angle, 
π, we can calculate ς for  all angles that are greater than θ [198]:  
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Equation 3.16 
Integrating the expression for Rutherford scattering (equation 3.12) from 0 to π we get the 
total elastic nuclear scattering cross-section:  
                
    
 
  
 
 
    
 
 
 
Equation 3.17 
The variations with scattering angle in the Rutherford scattering cross-section are shown in 
figure 3.4 for some of the elements present in the samples examined in this work.  Higher 
scattering cross-sections are observed for heavier elements but all cross-sections decrease 
with increasing scattering angle. 
 
Figure 3.4: The Rutherford scattering interaction cross-section for a selection of the elements present in the 
samples examined in this work for an acceleration voltage of 300keV. 
Equation 3.17 is for scattering from a single isolated atom; it can be modified to give the 
scattering cross-section from atoms in a specimen of thickness t:  
0 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
0 50 100 150 
lo
g 1
0
σ
 
Scattering Angle θ (degrees) 
Selenium 
Sulphur 
Oxygen 
Carbon 
 56 
 
           
      
 
          
Equation 3.18 
                 
    
      
 
  
 
  
 
 
     
 
 
  
Equation 3.19 
The “mass-thickness” dependence (ρt) is still present but there is now a much stronger 
dependence on Z.  Doubling the mass-thickness value will double the cross-section whereas 
doubling the value of Z will quadruple the cross-section.   
All the interaction cross-sections presented here have ignored the screening effects of the 
electron cloud.  In order to account for this the [sin2(θ/2)] term in equation 3.12 should be 
replaced with [sin2(θ/2) + (θ0/2)], where θ0 is the screening parameter [198]:  
   
      
 
 
  
 
 
 
Equation 3.20 
Here E0 is in units of keV.  The screening of the electron cloud means that beam electrons 
that do not pass close to the nucleus do not undergo nuclear scattering and are scattered to 
low angles.  When the scattering angle is greater than θ0 the electron-electron scattering 
can be ignored and nuclear scattering is dominant.  At 300 keV the value of θ0 for selenium 
is ~ 22 mrad, and less for lighter atoms.  Therefore at scattering angles greater than this it 
can be assumed that variations in atomic number are dominating variations in the scattering 
cross-section. 
3.3.2.5 The Mean Free Path 
The mean free path (λ) is the average distance that an electron travels between scattering 
events and can be expressed as the inverse of the total scattering cross-section (equation 
3.11) [198]:  
  
 
      
 
 
         
 
Equation 3.21 
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If an incident electron undergoes more than one scattering event it is said that plural 
scattering takes place.  A TEM specimen must be considerably thinner than λ in order to 
reduce the amount of plural scattering that takes place.  This makes the interpretation of 
TEM images considerably easier. 
3.3.3 TEM Setup 
A schematic diagram of a typical TEM is shown in figure 3.5.  Electrons are emitted from an 
electron source either by thermionic or field emission.  Emitted electrons are accelerated 
through an electric field, typically between 80 kV and 300 kV.  The electron beam passes 
through a series of two or three condenser lenses (only one condenser lens is shown in 
figure 3.5).  The JEOL microscopes each have two condenser lenses, whereas the Titan has 
three.  The 3-condenser lens system of the Titan is discussed in further detail in section 
3.3.6.   Condenser apertures are placed below each condenser lens and are centred on the 
optical axis.  The objective lens focuses electrons emerging from the sample into a 
diffraction pattern on the back focal plane.  Adjusting the strength of the objective lens 
focuses the image formed on the viewing screen.  An objective aperture can be inserted at 
the back focal plane to select the angular range of the electrons contributing to the final 
image.  After the back focal plane the first intermediate image is formed.  By varying the 
strength of the intermediate lens an image or a diffraction pattern may be viewed 
depending on whether the user wishes to operate in imaging mode or diffraction mode 
(figure 3.5 shows a TEM operating in image mode).  The projection lens is used to vary the 
magnification of the image or diffraction pattern on the viewing screen.  The entire 
microscope column is kept under vacuum to minimise electron scattering from gas 
molecules and to protect the electron source. 
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Figure 3.5: A schematic diagram of a TEM operating in imaging mode.  A parallel beam of 
electrons passes through a thin specimen and is focused by a series of electromagnetic 
lenses onto a viewing screen. Figure adapted from [198]. 
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3.3.3.1 Electron Sources 
Two kinds of electron sources are used in TEMs: thermionic and field emission.  The JEOL 
microscopes used for the work in this thesis have thermionic electron sources whereas the 
Titan microscope uses a field emission source. 
The most important characteristics of the TEM that are controlled by the electron source 
are the brightness and the coherency, or energy spread (ΔE), of the electron beam.  The 
brightness of the beam is defined as the current density per unit area per unit solid angle as 
the beam leaves the gun.  The smaller the energy spread of the electrons in the beam the 
more coherent the beam is as the electrons’ wavelength is better defined.   
A thermionic emission electron source (figure 3.6) produces electrons when heated to a 
sufficient temperature that the electrons in the material gain enough energy to overcome 
the work function of the material.  The material must therefore have a relatively low work 
function, such as lanthanum hexaboride (LaB6), or a high melting point, e.g. tungsten.  The 
JEOL 2010 microscope contains a LaB6 electron source and the JEOL 2000 uses a tungsten 
source. 
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Figure 3.6: A schematic diagram of a thermionic electron source.  Figure adapted from [198]. 
The Titan microscope uses a field emission gun (FEG), consisting of a fine tungsten tip 
coated with a thin layer of zirconia (ZrO2) to lower its work function.  This type of emitter is 
known as a “Schottky” emitter or “thermal field emission gun”.  
A FEG produces electrons when an intense electric field is applied to it.  The field emission 
tip acts as a cathode with respect to two anodes (figure 3.7).  The first anode extracts 
electrons from the tip and is positive with respect to it by a few kV.  The strength of an 
electric field E is considerably increased at a sharp point.  The electric field at the emitter tip 
follows the equation:  
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Equation 3.22 
where V is the applied voltage and r is the spherical radius of the tip (~ 1 µm).  The 
operating extraction voltage range used in these experiments is 3.8 – 4.5 kV.  The second 
anode accelerates the electrons in the beam. 
 
Figure 3.7: A schematic diagram of a field emission gun (FEG): electrons are extracted from the sharp tip by 
applying a high electric field at the first anode; the electron beam is then focussed and accelerated by the 
second anode.  Figure adapted from [198]. 
The Schottky tip is heated, typically reaching temperatures of 1800°C, to assist in electron 
emission, and is kept under ultra high vacuum (~ 10-12 Torr) to keep it free from 
contaminants [198]. 
FEG sources give more coherent electron beams than thermionic sources; a typical energy 
spread for a beam from a cold FEG is ~ 0.25 eV, or ~ 0.5 eV for a Schottky FEG, compared 
with 3 eV for a thermionic source [198].  FEG sources are therefore more suitable for 
STEM/EELS applications.  FEG sources also produce a beam with greater current density and 
brightness (defined as current density per unit solid angle) than thermionic sources; 
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however, the source is smaller so it is not possible to illuminate large areas of the sample 
without losing current density on the screen. 
3.3.3.2 Electron lenses 
The lenses used to focus electrons are electromagnets made of a polepiece with a coil of 
copper wire surrounding it.  The polepiece is a cylindrically symmetric core of soft iron with 
a bore drilled through it.  When a current is passed through the coil a magnetic field is 
created in the bore.  The field is inhomogeneous along the length of the lens but it is axially 
symmetric.  The strength of the magnetic field controls the paths of the electrons travelling 
through it.  Electrons travelling closer to the edge of the bore are deflected more than those 
travelling through its centre. 
As mentioned in section 3.3.1 electromagnetic lenses have some imperfections, the defects 
present in the lenses in the TEM leading to a reduction in the imaging resolution of the 
microscope.  There are three main defects that limit the resolution: spherical aberration, 
chromatic aberration and astigmatism. 
3.3.3.2.1 Spherical Aberration 
Spherical aberration results from the field in an electromagnetic lens acting 
inhomogeneously on the off-axis rays.  The further off-axis an electron is travelling, the 
more strongly it is deflected back toward the axis which results in a point object being 
imaged as a disc of finite size.  Figure 3.8 (a) shows a perfect lens in which a point source is 
imaged as a point.  Figure 3.8 (b) demonstrates how a lens suffering from spherical 
aberration images a point as a disc known as the “disc of least confusion”.  
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Figure 3.8: Ray diagrams demonstrating spherical aberration. (a) A perfect lens in which a point is imaged as 
a point.  (b) A lens suffering from spherical aberration, those rays travelling further off-axis are deflected 
more strongly.  This results in a “disc of least confusion”. 
This effect is what ultimately limits the resolution of the modern TEM.  Spherical aberration 
in the objective lens has the greatest effect on imaging in TEM, whereas spherical 
aberration in the condenser lens has the greatest effect on imaging in STEM as this is the 
lens that is used to form the finest beam with the most current. 
The effects of spherical aberration Cs are reduced in the Titan by the addition of a Cs 
corrector.  This is discussed in section 3.3.6. 
3.3.3.2.2 Chromatic Aberration 
The electrons in the beam are not completely monochromatic (they do not all possess 
exactly the same energy, and thus wavelength).  There is a spread in the energies of 
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electrons leaving the source; however, the main source of energy spread comes from 
interaction with the sample.  When passing through the sample some electrons will lose 
more energy than others leading to a greater spread in energy, typically 15 – 25 eV for a 50 
– 100 nm thick specimen [198].  The objective lens bends electrons with lower energies 
more strongly and thus electrons from a point in the object will form a disc of finite size in 
the image. 
3.3.3.2.3 Astigmatism 
Astigmatism in the TEM or STEM occurs when electrons sense a magnetic field that is not 
circularly symmetric as they spiral round the optic axis.  It is not possible to manufacture 
perfectly cylindrical pole pieces and the soft iron may also have microstructural 
inhomogeneities, which result in local variations in the magnetic field strength.  The field 
may also be disturbed by the apertures if they are not precisely centred on the axis and 
contamination on the apertures can charge up and deflect the beam.  Astigmatism can be 
corrected using stigmators, small octupoles that introduce a compensating field to balance 
the non-uniformities causing the aberration. 
As the above lens defects (spherical aberration, chromatic aberration and astigmatism) 
cause a point object to degrade into a disk of finite size in the image, it is the lenses that 
limit the resolution of the microscope rather than the wavelength of the electrons.  In TEM 
the image resolution is governed by the objective lens, while in STEM the image resolution 
is limited by the condenser lens.  In both cases aberrations limit the resolution. 
3.3.4 Bright Field TEM Imaging and Mass-Thickness Contrast 
The direct beam is used to generate bright field TEM images.  The insertion of an objective 
aperture selects the angular range of electrons contributing to the image and may greatly 
improve image contrast as demonstrated in Figure 3.9 (a). 
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Figure 3.9: (a) The insertion of an objective aperture to select the direct beam removes most scattered 
electrons and may greatly increase image contrast. (b) The mechanism by which differences in mass and 
thickness create image contrast in a bright field TEM image. Figure adapted from [198]. 
Mass-thickness contrast is the contrast mechanism that is normally used for imaging 
biological samples.  As electrons pass through the sample they are scattered off-axis by 
elastic scattering events.  Electrons that interact with the electron clouds of atoms in the 
sample are scattered through relatively small angles (figure 3.2 (a)) and may still contribute 
to the image, but electrons that are scattered due to interactions with an atomic nucleus 
(figure 3.2 (b)) are scattered through a higher angle and are less likely to contribute to the 
image generated.  The cross-section of scattering depends on the atomic number, Z, and on 
the density and thickness of the sample (equations 3.11 and 3.19).  The mechanism by 
which contrast in a bright field TEM image is formed from differences in mass and thickness 
is demonstrated in figure 3.9 (b) above.  The areas of the sample that have higher mass-
thickness (ρt) produce areas of lower intensity in the resulting TEM image than areas of 
lower mass-thickness. 
3.3.5 Scanning Transmission Electron Microscopy 
In the case of scanning transmission electron microscopy (STEM) the incident electron beam 
is focused to a probe and scanned across the sample.  Detectors placed at different post-
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specimen locations can collect different scattered or unscattered beams.  The scattered (or 
unscattered) electrons are collected serially and the image is displayed pixel by pixel.  The 
Titan’s STEM detectors are discussed in section 3.3.6. 
3.3.5.1 HAADF-STEM Imaging 
The Rutherford scattering cross-section is discussed in section 3.3.2.4.  Rutherford scattered 
electrons are scattered to higher angles than electrons that have interacted with the 
electron cloud (figure 3.2).  The screening parameter, θ0, serves to reduce the probability of 
a beam electron interacting with an atomic nucleus.  At scattering angles greater than θ0 
(equation 3.20) the effect of the electron cloud is negligible and nuclear scattering 
dominates. 
The HAADF detector has a large central aperture [200] and collects only electrons that are 
scattered to relatively high angles (e.g. > 30 mrad, the exact range of scattering angles being 
determined by the camera length and the geometry of the detector).  At these angles the 
screening effect of the electron cloud can be ignored.  The intensity of a HAADF STEM image 
is therefore dependent on Zn (n ~ 2).  As the detector collection angles are reduced the 
effect of the screening parameter is reintroduced and the contribution of mass-thickness 
(ρt) increases.  Thus it is possible for the user to control the kinds of electron/specimen 
interactions that contribute to an image. 
3.3.6 The Titan Microscope 
A schematic diagram of the column of the Titan microscope is shown in figure 3.10. 
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Figure 3.10: The column optics of the Titan, not to scale. Not all of the STEM detectors are shown.  Adapted 
from [201]. 
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The electron source in the Titan is a Schottky FEG, as described in section 3.3.3.1, resulting 
in an energy beam with a relatively small spread in electron energies leaving the source.  
The gun lens is an electrostatic lens that is positioned after the field emitter and extractor.  
Increasing the strength of the gun lens increases the demagnification of the source and 
leads to a lower current in the beam.   
The gun of the Titan is fitted with a Wien-filter monochromator [202].  The monochromator 
acts as an energy filter.  The electron beam passes through an electromagnetic field which 
disperses the electrons according to their energies.  Only those within a specific energy 
range can pass through the monochromator slit (figure 3.11).  The energy spread, ΔE, is 
greatly reduced after the electrons have passed through the monochromator resulting in a 
more coherent electron beam [202-204]. 
 
 
Figure 3.11: Diagram of the monochromator.  Electrons are dispersed according to their energies and then 
pass through a monochromator slit, only those within a specific range of energies remaining part of the 
beam. 
Unlike most TEMs the Titan contains three condenser lenses, marked C1, C2 and C3 in figure 
3.10.  The term ‘zoom system’ is used to refer to two neighbouring lenses with an image 
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between them that can be moved up and down without changing the positions of either the 
object of the first lens or the image of the second.  Figure 3.12 shows a zoom system in 
three different positions, in each of which the object of the first lens and the image of the 
second are in the same position but the intermediate image moves.  This has the effect of 
changing the convergence angle at the image of the second lens. 
 
Figure 3.12:  Schematic diagrams of a zoom system in three different zoom conditions.  In each case the 
object of the first lens and the image of the second lens are in the same positions.  Figure adapted from 
[205]. 
In the Titan the gun lens determines the position of the object of C1.  The image position of 
C3 is fixed and changes only with the mode of operation of the Titan (TEM/STEM).  
Therefore the Titan has a double zoom condenser system – C1-C2 zoom and C2-C3 zoom. 
Figure 3.13 shows a ray diagram of the Titan operating in TEM mode (figure 3.13 (a)) and in 
STEM mode (figure 3.13 (b)).  The C1-C2 zoom varies the beam current by varying the 
diameter of the beam when it passes through the C2 aperture.  Changing the C2-C3 zoom 
system varies the beam diameter at the C3 lens thus varying the size of the illuminated area 
at the specimen.  This alters the beam diameter in TEM mode and varies the convergence 
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angle in STEM mode.  Most TEMs do not have a third condenser lens; this lens gives greater 
control over the electron beam diameter and convergence angle. 
 
Figure 3.13: Ray diagram of the electron beam in the Titan in (a) TEM mode and (b) STEM mode (not to 
scale).  Only the C2 aperture is shown.  Adapted from [205]. 
The specimen sits in the centre of the objective lens so its magnetic field acts both above 
(upper objective lens) and below (lower objective lens) the specimen.  In TEM mode the 
mini-condenser lens focuses the beam to a cross-over point just above the upper objective 
lens which the focuses the beam onto the sample as a parallel beam (figure 3.14 (a)).  In 
STEM mode the mini-condenser lens ensures that all the electrons in the beam are parallel 
to the optic axis.  The upper objective lens then focuses the beam down to a spot on the 
sample (figure 3.14 (b)). 
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Figure 3.14: (a) TEM mode and (b) STEM mode.  Adapted from [205]. 
The Titan is fitted with a spherical aberration (Cs) corrector.  Spherical aberration is dicussed 
in section 3.3.3.2.2.  Scherzer showed in 1936 that round electron lenses suffer from 
spherical aberration [206] and at the time a number of remedies were suggested.  It was not 
until much later, however, that the computer technology was available to implement any of 
these solutions.  A Cs corrector consists of non-round lenses that are not subject to 
Scherzer’s law of spherical aberration [207-209].  The Titan’s Cs corrector is of a dual-
hexapole type; it consists of two electromagnetic hexapoles and four additional lenses 
(figure 3.15).  Correction is achieved based on the principle that non-rotationally symmetric 
aberrations introduced by the first hexapole are compensated by the second hexapole 
[210].  The hexapoles induce an additional spherical aberration that is rotationally 
symmetric and is proportional to the square of the hexapole strength.  This induced 
spherical aberration has a sign opposite to that of the objective lens.  Therefore the 
spherical aberration of the system can be minimised by exciting the hexapoles 
appropriately. 
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Figure 3.15: A schematic diagram of the Titan’s Cs corrector.  OL is the objective lens; the specimen sits 
within its field.  HX1 and HX2 refer to the two hexapoles.  The other lenses in the diagram are round lenses.  
In order to compensate for the non-spherical aberrations of the hexapoles, HX1 is imaged into HX2 with unit 
magnification.  The hexapoles also induce a spherical aberration that is proportional to the square of the 
strength of the hexapole.  The total spherical aberration of the imaging system is corrected by exciting the 
hexapoles appropriately.  Figure adapted from [211].  
The Titan’s STEM detectors are at the bottom of the column, located above and below the 
viewing screen.  Figure 3.16 shows the layout of the STEM detectors in the Titan (not to 
scale).  The bright field (BF) detector collects electrons that are scattered to low angles or 
have undergone no scattering at all (direct beam).  Annular detectors collect only scattered 
electrons thus creating dark field (DF) images where thicker or denser areas of the specimen 
appear bright against a dark background.  The inner and outer collection angles of the DF 
detectors are labelled βin and βout respectively.  The high angle annular dark field (HAADF) 
detector is located closest to the sample, thus it collects the electrons scattered to the 
highest angles.  In the Titan there are two annular dark field (ADF) detectors below the 
HAADF detector, only one of which is shown in figure 3.16.  The ADF detectors collect 
electrons that are scattered to lower angles than the HAADF detector. 
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Figure 3.16: The STEM detectors of the Titan microscope (not to scale).  There are two ADF detectors, only 
one of which is shown here. 
The convergence semi-angle of the electron beam, α, is determined by the condenser lenses 
and apertures.  The camera length can be adjusted by the user, controlling the exact range 
of scattering angles collected by each detector. 
3.3.7 Energy Dispersive X-ray Spectroscopy 
X-rays are generated as electrons pass through a sample.  There are two main types of X-
rays that are emitted from the sample – characteristic X-rays, which have energies that are 
element specific and can be used for chemical analysis, and Bremsstrahlung X-rays [198, 
199].  The word Bremsstrahlung is derived from the German for “braking radiation”.  These 
X-rays are emitted when incident electrons are slowed down by the sample as they interact 
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inelastically with the nuclei in the sample.  These electrons can undergo an interaction of 
any strength and therefore suffer any amount of deceleration.  Thus their energies are 
continuous across the spectrum and they are not characteristic of the species in the sample. 
Figure 3.17 demonstrates the generation of characteristic X-rays: an accelerated electron in 
the incident beam may penetrate through the outer electron shells of an atom in the 
sample and interact with the inner-shell electrons.  If the incident electron transfers enough 
energy to an electron in the inner shell, the latter may be ejected.  This leaves the atom in 
an excited state.  It can return almost to its ground state by filling the space left by the inner 
electron with an electron from one of its outer shells.  This electron transition is 
accompanied by the emission of either an Auger electron or an X-ray.  The emitted X-ray will 
possess energy equal to the energy difference of the electron shells involved in the 
transition.  By examining the energies of the X-rays emitted by the sample on interaction 
with the electron beam, it is possible to identify the elements present in the sample.  This is 
known as energy dispersive X-ray spectroscopy or EDX. 
 
Figure 3.17: Generation of characteristic X-rays by electrons incident on the sample [198]. 
The emitted X-rays are detected using a semiconductor detector.  An X-ray incident on the 
detector excites electrons from the valence to the conduction band, creating electron-hole 
pairs.  Each incident X-ray creates thousands of electron-hole pairs hence the number of 
electrons or holes created is proportional to the energy of the incident X-ray.  The intrinsic 
semiconductor region of the detector is inserted between a p-type and an n-type 
semiconductor region.  When this diode is reverse biased – a negative charge is placed on 
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the p-type region and a positive charge is placed on the n-type region – the electrons and 
holes are separated and the charge pulse of electrons can be measured.  The magnitude of 
this pulse is proportional to the energy of the incident X-ray.   
Pulses produced from incident X-rays are amplified and assigned to specific energy 
channels. The energy dispersion of the detector can be selected by the user.  Typically there 
are 2048 channels available so an energy dispersion of 10 eV/px would result in an X-ray 
energy detection range of 20 keV which usually allows the user to display the entire 
detected spectrum.  It is only possible for the detector to process one incident X-ray at a 
time so each time an X-ray is incident on the detector there is a short time when it 
effectively “switches off” and incident X-rays are not processed, resulting in what is known 
as “dead time”.  The dead time can be expressed as:  
           
        
   
      
Equation 3.23 
where Rin is the input count rate and Rout is the output count rate. 
In order to collect an EDX spectrum on the Titan it is necessary first to tilt the sample to the 
appropriate angle to maximise the EDX signal detected. In the case of the Titan this angle is 
+18° due to the geometry on the EDX detector and column 
The X-rays collected by the detector are plotted over a range of energies.  Peaks in the 
spectrum can be used to determine the elements present due to the characteristic energies 
of electron transitions.  The peaks for a number of electron transitions within one atom 
result in a “fingerprint” for that element.  Characteristic X-rays are labelled in such a way as 
to indicate the electron transition that generated the X-ray.  For example, a Kα X-ray refers 
to the X-ray that is generated when a hole in the K-shell is filled with an electron from the L-
shell.  Similarly, when an electron in the M-shell fills a hole in the K-shell a Kβ X-ray is 
generated and an Lα X-ray is generated when a hole in the L-shell is filled with an electron in 
the M-shell.   
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3.3.8 Electron Tomography 
TEM and STEM imaging creates 2-D projections of a specimen.  One disadvantage of this is 
that structural details from different depths within the specimen are superimposed on top 
of one another.  This process of image formation is demonstrated in figure 3.18 (a) in which 
a 2-D image of a “smiley” face is projected onto a 1-dimensional (1-D) line.  Peaks are 
recorded in those segments of the line in which the imaging “rays” have passed through the 
eyes and nose and a background to this is created by the mouth.  It is impossible from this 
projection alone to determine the structure of the original object.  For this reason we carry 
out electron tomography – the process of taking a large number of 2-D electron 
micrographs of a specimen at different tilt angles and then reconstructing these to generate 
a volume that represents the original object. 
 
Figure 3.18: (a) A single projection of a 2-D object onto a 1-D line.  Peaks are observed due to the nose and 
eyes.  The broken lines represent selected projected rays. (b) Different projections are generated at different 
tilt angles. 
The collection of a tomographic dataset produces a large number of 2-D projections of the 
region of interest which can be reconstructed into a 3-D volume that closely resembles the 
original object.  The correlation between the 3-D reconstructed volume and the original 
object is limited by the data collected – the quality of the images and number of images 
collected – and the technique used to reconstruct the dataset. 
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3.3.8.1 Data Collection for Electron Tomography 
Data collection for electron tomography involves tilting the specimen around an axis 
perpendicular to the electron beam, and collecting images at successive angles.  Specimen 
shift must be minimised during data acquisition, in particular in the direction parallel to the 
tilt axis, as only the area that is in every image can be used for the reconstruction of the 
data.  Images are collected up to tilt angles as high as possible to minimise the size of the 
missing “wedge” in the dataset.  It is impossible to take images of the specimen at tilt angles 
up to ±90°, therefore there will always be some information missing from the dataset. 
All electron tomography data presented in this thesis was collected on the Titan microscope 
operating in STEM mode.  Images of the region of interest, either an area of a relatively 
thick section (200 – 300 nm) of resin embedded cells or a freeze-dried whole cell, were 
collected at successive tilt angles.  Tilt angles increased in 2° steps from 0° to ±50° and in 1° 
increments from ±50° to ±70°.  A smaller tilt increment was employed at high tilt angles to 
compensate for the increased thickness of the sample [212].  The tomographic data was 
then reconstructed into a 3-D volume using the simultaneous iterative reconstruction 
technique (SIRT) [213, 214] with Inspect 3D reconstruction software.   
3.3.8.2 Reconstruction of Electron Tomography Datasets 
Before it can be reconstructed the dataset must first be aligned and the angle of the tilt axis 
determined.  Inspect 3D performs automatic alignment of a tilt series based on cross-
correlation.  During cross-correlation part of or an entire image is compared to the previous 
image in the series and any shifts between these two images are compensated for.  This is 
carried out sequentially throughout the entire tilt-series.  A filter, such as a Fourier filter, 
may be used to enhance certain features or to reduce low or high frequency components 
when executing cross-correlation.  The angle of the tilt axis is entered by the user; it can be 
roughly determined by examining the original dataset and then improved by inspecting 
cross-sections of the tilt series.  Figure 3.19 shows TEM images of gold spheres on a carbon 
support film taken at different tilt angles and cross-sections through the tilt series when the 
tilt axis is incorrect (d) and when it is correct (e).  A poorly selected axis will result in visible 
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asymmetric streaking in a cross-section of the tilt series.  Unfortunately there will always be 
some streaking present due to the missing wedge in the original dataset but this should be 
as symmetric as possible.   
 
Figure 3.19: TEM images of gold spheres on a carbon support film taken at tilt angles of -50° (a), 0° (b) and 
+50° (c).  Cross-sections through the reconstruction when the angle of the tilt axis is poorly selected (d) and 
well chosen (e).  Figure adapted from [215]. 
The alignment and selection of a tilt axis result in a dataset in which the image shifts 
between images have been removed.  However, it is still a tilt series and must be 
reconstructed into a 3-dimensional volume. 
A STEM micrograph records intensities that are generated by the interactions between the 
electron beam and the sample.  While the paths of the electrons in the beam can be 
computed, it is unknown how the interactions that resulted in the 2-D micrograph are 
distributed along these paths.  In order to overcome this, back-projection algorithms are 
employed.  The approach of a back-projection algorithm is to project the collected 2-D 
images back along the paths of the rays that generated them.  If this is done simultaneously 
for a number of projections taken at different tilt angles the back-projection rays from the 
different images will intersect and reinforce one another at the points where interactions 
were encountered when generating the original projections (figure 3.18 (b)).  Given a 
sufficient number of projections in different angles, the superposition of the back-
projections will display the shape of the original object [179, 216-218]. 
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A schematic diagram representing the acquisition of tomographic data and the SIRT 
reconstruction process is shown in figure 3.20.  The original projections are back-projected 
and superimposed on one another to form the initial reconstruction.  This enters the 
iterative loop where projections of this reconstruction are compared to the original 
projections.  Difference projections are generated by dividing the original projections by the 
projections of the reconstruction.  These difference projections are then back-projected to 
give a difference reconstruction which is multiplied by the reconstruction to generate the 
next reconstruction.  This process is repeated until the number of iterations specified by the 
user is reached. 
 
Figure 3.20: A schematic representation of the SIRT reconstruction process. Figure adapted from [219]. 
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3.3.8.3 Visualisation of Electron Tomography Data 
The last step in this process is the visualisation of the reconstructed dataset.  This was 
carried out using Amira 3D visualisation software (Visage Imaging GmbH).  The three 
methods used to visualise the data were slicing, surface rendering and voltex projection.   
Slicing a dataset means a series of 2-D images is made from the 3-D volume by slicing the 
data perpendicular to the viewing direction.  The slices resemble projections; however, the 
image information is not averaged over the thickness of the volume and is generated from 
the volume at that exact position.  In surface rendering a surface is generated that 
encompasses all data that is greater than a particular intensity level.  Surfaces can be either 
opaque or transparent and two or more such surfaces can be visualised at once.  These 
surfaces are sometimes referred to as isosurfaces.  Voltex projection or volume rendering 
generates an image based on the projection of a dataset at any angle.  Each point in a data 
volume is assumed to emit and absorb light and the transmission of light through the 
volume is simulated [220]. 
3.3.9 Electron Beam Damage 
Many of the electron/specimen interactions that produce useful signals in the TEM result in 
damage of the specimen that can lead to structural and chemical changes in the sample 
[198].  This means that the region of the specimen under examination is no longer 
representative of the original sample and interpretation of the images and spectra is more 
difficult.  Electron beam damage can be the limiting factor in the TEM study of some 
materials.  Damage can result from both elastic and inelastic scattering of electrons.  There 
are two main mechanisms of electron beam damage in the TEM: radiolysis and knock-on 
damage. 
Radiolysis or ionisation damage results in the breaking up of chemical bonds in the sample 
[198].  Organic solids, such as polymers and biological materials, are most prone to 
radiolysis [198, 221].  Incident electrons can break down the main chain of a molecule 
resulting in the loss of mass or can break off side chains which may in turn react with other 
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molecules in the sample and cross-link to form a new structure.  Loss of mass results in a 
thinning of the sample or even the drilling of holes in the sample.  Crystalline samples can 
lose their crystallinity due to ionisation damage.  The extent of damage due to radiolysis can 
be minimised by increasing the accelerating voltage as this decreases the interaction cross-
section (equations 3.9 and 3.10.  However, this leads to a reduction in image contrast, as 
less electron scattering takes place on interaction with the sample, and can result in an 
increase in knock-on damage. 
Knock-on or atomic displacement damage occurs when electrons in the beam transfer 
enough energy to atoms in the sample to knock them out of their atomic sites leading to the 
creation of vacancies in the specimen [198].  Electrons in the beam must possess enough 
kinetic energy to knock a specimen atom out of its site; this energy depends on the type of 
sample and is known as the threshold energy.  This type of damage therefore increases with 
increasing accelerating voltage.  Knock-on damage is not expected at an acceleration 
voltage of 100 kV (unless hydrogen atoms are present) but it is anticipated at higher 
voltages [221].  Cooling the specimen will not reduce the effects of knock-on damage.  
Keeping the energy of the electron beam low is the only way to avoid this type of damage.  
If energies above the threshold energy must be used the total electron dose should be 
minimised by minimising the time the electron beam is incident on the sample. 
Heat is also a major cause of damage in the TEM.  Much of the energy that is transferred to 
the sample when beam electrons collide with specimen electrons ends up as heat within the 
specimen [221].  Organic specimens are particularly susceptible to heat damage as they 
have low thermal conductivity so the region of interest cannot dissipate the thermal energy 
it gains under the beam.  Even at low current densities heating effects can be significant 
[222].  Heat damage can be minimised by using a higher accelerating voltage as this 
minimises the interaction cross-section (equations 3.9 and 3.10).  
A relatively high acceleration voltage (300 kV) was used in STEM experiments in this work in 
order to reduce the effects of radiolysis and heat damage.  In order to minimise the total 
damage to the sample the times during which the beam was incident on the sample were 
kept as low as possible and the beam was blanked when imaging was not taking place. 
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3.4 Atomic Force Microscopy 
All atomic force microscopy (AFM) measurements presented in this thesis were carried out 
by Shane Bergin in the Chemistry Department at Imperial College London. 
AFM operates by “feeling” rather “seeing” a surface.  This imaging technique yields not just 
a topographical outline of the surface but also information on its texture [223, 224].  Figure 
3.21 outlines of the crucial components of a typical AFM setup. 
 
Figure 3.21: A schematic diagram of a typical AFM setup.  Figure adapted from [225]. 
An AFM tip, which consists of a micro-fabricated sharp spike mounted on the end of a 
cantilever, feels the surface of the specimen.  The sharpness of the tip determines the 
resolution of the instrument [223].  The cantilever on which it is mounted allows the tip to 
move vertically.  The entire cantilever-tip is made from silicon or silicon nitride [223].  The 
AFM specimen is scanned by means of a piezoelectric transducer that converts an applied 
potential difference into a physical force. 
The motion of the tip as it traverses the surface of the sample must be monitored.  An 
optical lever system is employed for this purpose.  A laser beam is focussed onto the end of 
the cantilever, over the tip, and reflected onto a photodiode detector, which is split into 
four segments or quadrants.  As the tip moves in response to the sample’s topography the 
angle of the reflected beam changes.  This change is monitored by the changes in intensity 
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in each quadrant of the detector.  The quadrants produce an electrical signal which 
quantifies the vertical motion of the tip [223, 226].  The difference between the left 
intensity in the left and right pairs of quadrants quantifies the lateral motion of the tip [223, 
226]. 
As the sample is scanned the topography of the sample causes the cantilever to bend as the 
force between the tip and the samples is changed.  In the simplest operating mode, the 
cantilever’s deflection is maintained at a constant pre-defined level by a control loop which 
moves the sample or the cantilever-tip in the appropriate direction at each imaging point 
[223, 224, 226].  Thus, the feedback loop is crucial to the generation of an AFM image. 
Different imaging modes are possible in the AFM.  These are differentiated by the force 
interaction involved in each case.  In contact mode the tip scans the sample in close contact 
with the surface.  This is the most common mode used in the AFM.  The force at the tip is 
repulsive and has a mean value of 10-9 N [226].  Atomic resolution imaging is possible using 
contact mode.  However, problems may arise due to excessive tracking forces applied by the 
probe on the sample [226].  Non-contact mode is employed in situations where tip contact 
may alter the sample [223].  In non-contact mode the tip hovers 50 – 150 Å above the 
sample surface.  Attractive Van der Waals forces acting between tip and the sample are 
detected.  Topographic images are generated by scanning the tip above the sample surface.  
Unfortunately, the attractive forces from the sample are substantially weaker than the 
forces used by contact mode and as such image quality is poorer than in contact mode 
[223].  Finally, tapping mode allows topographic imaging of samples that are easily 
damaged, loosely held to their substrate, or difficult to image with other AFM techniques.  
Tapping mode overcomes problems associated with friction, adhesion, electrostatic forces 
and other difficulties that arise with other AFM scanning techniques by alternately placing 
the tip in contact with the surface and then lifting the tip off to avoid dragging the tip across 
the surface [223, 224, 226]. 
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4. Aggregation of Aβ(25-36) 
4.1 Introduction 
Proteins are long chains of amino acids which carry out many biological functions within the 
cell.  In order to carry out its function a protein must first fold into a particular 
conformation, its native state, that is unique to its amino acid sequence.  The failure of a 
protein to fold correctly results not only in a loss of the functionality of the protein, but may 
also result in the aggregation of the misfolded protein into highly ordered fibrillar 
aggregates known as amyloid plaques or amyloid fibrils [24].  The presence of amyloid is 
associated with a number of degenerative conditions including Alzheimer’s and Parkinson’s 
diseases [1, 24].  However, the exact role that these aggregates play in the disease is not yet 
well understood [2, 227].  In this work we aim to examine the interactions of aggregates 
formed from a fragment of the Aβ peptide – the main constituent of the plaques present in 
the brains of Alzheimer’s sufferers – and human phagocytic cells.  The Aβ fragment used in 
this work, corresponding to residues 25-36 of the full chain peptide, had not previously been 
studied.  It was therefore necessary to carry out an investigation to determine the 
conditions and time under which it aggregates.  It was also essential to determine the 
aggregate structures that are generated at different times in the aggregation process, and 
to investigate whether the replacement of the naturally occurring sulfur atom in the peptide 
with a selenium atom affects the rate of aggregation or the structure of the aggregates 
produced. 
4.1.1 Protein Folding, Misfolding and Aggregation 
The aggregation of proteins into prefibrillar aggregates and amyloid fibrils has been studied 
for a wide range of proteins using a diverse range of techniques.  Knowles et al. have 
characterised the aggregation of bovine insulin amyloid fibrils by direct measurements of 
changes in fibril mass using a quartz crystal microbalance [228] as well as by measuring 
changes in surface stress induced by the growth of fibrils on silicon microcantilevers [229].  
Ban et al. have applied total internal reflection fluorescence microscopy,  along with TEM 
and thioflavin-T fluorescence, to measure the growth and inhibition of amyloid fibrils of the 
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full chain Aβ42 peptide and the fragment of the chain, Aβ(25-35) [56].  Laczkó et al. have 
employed infrared spectroscopy and circular dichroism to examine the aggregation of Aβ42 
[230].  There have been numerous computer simulation studies to characterise theoretically 
the rates of protein aggregation and the effects of conditions and protein chain mutations 
on aggregation [150, 231-236].  The studies described above are by no means an exhaustive 
list of the methods used for the examination of protein aggregation but are mentioned here 
merely to demonstrate that a wide variety of methods has been used. 
TEM is commonly used to examine the appearance and growth of protein aggregates and to 
study variations in the structure of amyloid fibrils or aggregates formed from different 
proteins or under different conditions.  Proteins and protein aggregates are often negatively 
stained using heavy metal stains such as uranyl acetate to increase image contrast on 
examination by TEM.  Uranyl salts and uranyl ions bind to both positively and negatively 
charged residues in proteins and nucleic acids; this is expected because uranyl acetate is 
only weakly dissociated and therefore a variety of ionic uranyl complexes (cationic, anionic 
and neutral) coexist in aqueous solution.   
The aggregation of different proteins tends to follow similar trends, with prefibrillar 
aggregates being formed initially, and mature fibrils appearing after a longer period of time 
under the conditions that lead to aggregation [38].  However, depending on the protein in 
question and the solution conditions involved the time over which aggregation occurs varies 
dramatically.  Bucciantini et al. have found that the non-disease related bovine 
phosphatidyl-inositol-3’-kinase (PI3-SH3) forms granular aggregates after one hour which 
grow into mature amyloid fibrils after one month (shown in figure 4.1).  In comparison the 
non-disease-related amino-terminal end of the E. coli HypF (HypF-N) protein forms 
unbranched aggregates after 6 hours and mature fibrillar structures after 20 days under the 
same conditions (shown in figure 4.2) [105]. 
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Figure 4.1: Bright field TEM images of negatively stained aggregates of PI3-SH3 showing (a) granular 
structure after one hour and (b) fibrillar structure after one month in solution. Adapted from [105]. 
 
Figure 4.2: Bright field TEM images of negatively stained aggregates of HypF-N showing (a) small aggregates 
after 6 hours and (b) long, thin, fibrillar structures after 20 days in solution. Adapted from [105]. 
The solution conditions under which a protein is maintained during aggregation can have a 
huge influence over the structure of the aggregates that are produced.  The phenomenon of 
polymorphism – the fibrillation of a single amyloidogenic protein resulting in the 
appearance of multiple forms of amyloid fibrils, depending on their induction conditions – 
has been observed by a number of researchers, [38, 57, 104, 237-240].  For example, 
Bharathi et al. have observed significantly different aggregate structures for amyloid fibrils 
formed from the Parkinson’s Disease-related protein alpha synuclein when aggregates are 
formed in the presence of copper or iron (figure 4.3) [240].   
 
a b 
a b 
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Figure 4.3: Aggregates formed from alpha synuclein display distinct morphologies depending on the 
aggregation conditions. (a) Aggregates formed in the presence of copper and (b) aggregates formed in the 
presence of iron.  Scale bar represents 100nm.  Adapted from [240]. 
It is also possible that protein maintained under a single solution condition can produce 
more than one fibril structure.  Jimenez et al. have used cryo-electron microscopy to image 
the protofilament structure of amyloid fibrils formed from bovine insulin prepared via two 
different methods [25].  Varying structures were observed, as shown in figure 4.4, with each 
preparation method producing more than one structure.  Twisting ribbon-like structures of 
different width and pitch were observed as well as repeating variations in width, indicative 
of a helical arrangement of protofilaments [25]. 
 
 
a b 
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Figure 4.4: Negatively stained amyloid fibrils formed from bovine insulin showing a variety of fibril 
structures.  Twisting ribbon-like structures with repeating variations in width were observed.  Scale bar = 
500Å.  Adapted from [25]. 
4.2 Results and Discussion 
4.2.1 Conditions for Aggregation 
The experimental method followed initially for the aggregation of Aβ(25-36) was that used 
by the Dobson Group at the University of Cambridge for the aggregation of Aβ42 (30 µM 
protein concentration in 50 mM phosphate buffered saline, pH 7.4, at 29°C) [129, 236].  
However, this method was found not to work for the Aβ(25-36) fragment; on examination 
using ThT fluorescence and TEM no evidence of aggregation was observed.   
The Aβ(25-36) fragment is approximately a quarter of the length of the full-length Aβ42 
chain, therefore even when the molar concentration of the protein is the same the crowding 
in solution is lower for the Aβ(25-36) protein.  The effect of macromolecular crowding has 
been observed to have a significant effect on protein aggregation [58, 241]. 
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A number of protocols for the aggregation of the Aβ(25-35) fragment have been reported in 
the literature [56, 242-246].  Many of these use higher protein and salt concentrations and 
higher temperature than those described above [56, 243].  The Aβ(25-36) peptide is very 
similar in size to the Aβ(25-35) peptide; the amino acid sequence is exactly the same except 
for the addition of the amino acid valine at the C-terminus of the peptide chain.  It is 
therefore logical to assume that the conditions conducive to the aggregation of Aβ(25-36) 
would be closer to those that are suitable for the aggregation of Aβ(25-35) than Aβ40 or 
Aβ42. 
A number of combinations of higher protein concentration, higher temperature and the 
addition of sodium chloride were tested.  Aggregation occurred when the protein was 
dissolved in 50 mM phosphate buffered saline (PBS) at pH 7.4 with 100 mM sodium chloride 
maintained at 37°C.  The results of this aggregation study are presented below. 
4.2.2 Thioflavin-T Fluorescence 
Figure 4.5 shows the results from a thioflavin T (ThT) fluorescence experiment conducted 
with varying concentrations of protein in 50 mM PBS at pH 7.4, with 100 mM NaCl, kept at 
37°C over a period of 15 hours.  The data series have been offset vertically for clarity.  No 
change in fluorescence was observed for protein concentrations of 40 or 60 µM.  For a 
protein concentration of 80 µM a small change in fluorescence was observed after 7 hours 
and 15 minutes which peaks at 8 hours and 25 minutes and then returns to the same level 
observed before the increase.  The fluorescence for the solution containing a protein 
concentration of 100 µM begins to increase after 7 hours; this lag phase is consistent with 
what has previously been observed for the aggregation of proteins [39-41].  This increase in 
fluorescence continues until it peaks at 12 hours and the signal then begins to drop off.   
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Figure 4.5: The change in thioflavin-T fluorescence for varying concentrations of Aβ(25-36) in 50mM PBS at 
pH 7.4, with 100mM NaCl, kept at 37°C over a period of approximately 15 hours.  The data series have been 
offset vertically. 
The effect on the rate of aggregation of replacing the sulfur atom of the methionine amino 
acid at residue 35 with a selenium atom was investigated.  The change in ThT fluorescence 
over time was examined simultaneously for Aβ(25-36) and selenium-enhanced Aβ(25-36) 
(Se-Aβ(25-36)) under the same conditions.  Figure 4.6 demonstrates that no change in 
aggregation was observed for the protein with or without a selenium atom. 
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Figure 4.6: The change in ThT fluorescence for Aβ(25-36) and selenium-enhanced Aβ(25-36) at a 
concentration of 100 µM in 50 mM PBS at pH 7.4, with 100 mM NaCl, kept at 37°C over a period of 
approximately 15 hours. 
4.2.3 Transmission Electron Microscopy 
TEM was used to assess the appearance and growth of aggregates.  Samples of the Aβ(25-
36) solutions were taken throughout the course of the ThT experiments described above, as 
well as during other aggregation experiments, for examination by TEM.  Bright field TEM 
images of samples of the peptide taken from solution at different stages during its 
aggregation are shown in figure 4.7. The sizes of the observed entities were measured using 
ImageJ software [247] to examine the changes in image intensity across a region containing 
protein.  The edge of a structure was measured as the point at which the image intensity 
drops to half the difference between the background image intensity and the image 
intensity of the structure.   
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Figure 4.7: Bright field TEM images of samples of Aβ(25-36) taken at different stages during its aggregation 
at a protein concentration of 100 µM in 50 mM PBS, pH 7.4, with 100 mM NaCl.  The solution was 
maintained at 37°C throughout the experiments.  Samples were taken (a) immediately after dissolution of 
protein in buffer, (b) and (c) after 3 hours, (d) after 6 hours, (e) and (f) after 10 hours, (g) after 13 hours, (h) 
after 15 hours and (i) after 24 hours in solution. 
Figure 4.7 (a) shows an image of a sample of Aβ(25-36) taken immediately after dissolution 
in 50 mM PBS, pH 7.4 with 100 mM sodium chloride to a final protein concentration of 
100 µM.  No aggregates are observed.  As no difference in the Th-T fluorescence was 
observed when comparing freshly dissolved protein to buffer alone, and the peptide was 
prepared using a method that has previously been demonstrated to remove all pre-formed 
aggregates [248], it was assumed that no aggregates were present at this time point. 
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The protein solution was maintained at 37°C and samples were taken for examination by 
TEM at different time points.  Figures 4.7 (b) and (c) show TEM images of samples taken 
after 3 hours in solution.  A range of aggregate structures are observed at this time point.  
Figure 4.7 (b) illustrates the presence of aggregates which appear to be meshed together.  
However, since the aggregates are clumped together, it was not possible to assess the sizes 
of the individual aggregates.  Figure 4.7 (c) shows more dispersed and branched aggregates 
of various sizes from 7 to 70 nm (n = 68).  These early aggregates are similar to those 
observed in the literature [105, 240, 249] and are also similar to those in figure 4.2 (a) [105].  
However, no fibrillar structure was ever observed after 3 hours of incubation, implying that 
all species observed are prefibrillar early aggregates.   
After 6 hours (figure 4.7 (d)) long, thin, branched fibrillar aggregates with lengths of up to 
several hundreds of nanometres and widths of 5 to 20 nm (n = 78) were observed bundled 
or meshed together.  After 10 hours fibrillar aggregates with widths of 5 to 25 nm and 
lengths of up to several hundreds of nanometres were observed (n = 85) (figures 4.7 (e) and 
(f)).  The aggregates were observed in mesh-like bundles.  Less branching was observed 
after 10 hours than after 6 hours, though it was difficult to tell the extent of branching 
observed because of the bundling of the fibrils.  These observations are consistent with 
what has previously been reported for the aggregation of other proteins [26].   
Contrast from the fibrils was sometimes enhanced by staining with uranyl acetate, a stain 
that binds to the amino acids in the proteins and increases electron scattering due to the 
high atomic number of the uranium atoms.  Figure 4.8 shows bright field TEM images of 
uranyl acetate stained samples of the peptide taken from solution at different stages during 
its aggregation. 
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Figure 4.8: Bright field TEM images of uranyl acetate stained samples of Aβ(25-36) taken at different stages 
during its aggregation at a protein concentration of 100 µM in 50 mM PBS, pH 7.4, with 100 mM NaCl.  The 
solution was maintained at 37°C throughout the experiments.  Samples were taken (a) immediately after 
dissolution of protein in buffer, (b) after 3 hours, (c) after 10 hours, (d) and (e) after 12 hours and (f) after 
24 hours in solution. 
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Figure 4.8 (c) to (f) demonstrate a rope-like, twisted structure in the mature fibrils. This is 
consistent with what has previously been reported for mature amyloid fibrils [20, 25, 26] 
and is similar to the structures shown in figure 4.4 [25]. 
The evidence gained from ThT fluorescence and TEM imaging experiments indicates that the 
aggregation of Aβ(25-36) into mature amyloid fibrils is completed within ten hours.  The 
fibrils that were formed after aggregation over longer periods of time were also examined in 
order to assess whether the aggregates retained their fibrillar structure after longer periods 
of time in solution.  Figures 4.7 (g), (h) and (i) show TEM images of samples of Aβ(25-36) 
that were taken after the peptide had been maintained in aggregation inducing conditions 
for periods of 13, 15 and 24 hours, respectively.  At each of these time-points, aggregates 
similar to those observed after 10 hours in solution were found.  Therefore, Aβ(25-36) that 
was maintained at 37°C  in a solution of 100 μM protein concentration in 50 mM PBS with 
100 mM NaCl for a period of 10 hours or more was assumed to be in the form of mature 
amyloid fibrils.   
The effect of selenium on the structure of the aggregates was also examined.  The 
replacement of the sulfur atom with a selenium atom did not have any discernible effect on 
the aggregate structure as shown in figure 4.9.  The aggregates observed after 3 hours of 
aggregation did not show any fibrillar structure and appear as disordered aggregates that 
are sometimes meshed together (figures 4.9 (a) and (b)).  After 20 hours of aggregation 
long, thin amyloid fibrils were observed, often in bundles (figures 4.9 (c) and (d)). 
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Figure 4.9: Bright field TEM images of selenium-enhanced Aβ(25-36) after it has been aggregating for (a) and 
(b) 3 hours or (c) and (d) 20 hours. 
From this point on, Aβ(25-36) or Se-Aβ(25-36) that was in a solution of 50 mM PBS, at pH 
7.4 with 100 mM NaCl, at a protein concentration of 100 μM, maintained at 37°C for a 
period of three hours, is referred to as prefibrillar aggregates.  Peptide that has been at 
these conditions for 10 hours or more is referred to as mature fibrils. 
4.3 Conclusions 
The Aβ(25-36) peptide aggregates in a solution of 50 mM phosphate buffered saline, with 
100 mM NaCl, at pH 7.4 at a protein concentration of 100 µM, when incubated at 37°C.  
Branched, amorphous aggregates of various sizes with no distinct structure are formed after 
3 hours.  After 10 hours, long, thin amyloid fibrils, with lengths of up to several hundred 
nanometres and which tend to bundle together, are generated.  The structure of these 
fibrils does not change after longer periods in solution.  The replacement of the naturally 
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occurring sulfur atom in the methionine amino acid at residue 35 of the peptide does not 
affect the rate of aggregation of the protein or the structure of the aggregates. 
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5. Visualisation of Selenium-labelled Aβ(25-36) in Cells 
5.1 Introduction 
A number of challenges arise when attempting to image the interactions between amyloid 
or other protein aggregates and cells or tissues.  The most significant of these is a lack of 
contrast between the carbon-rich protein aggregate and the carbonaceous cellular 
environment, making the aggregates extremely difficult to distinguish and identify with 
confidence.  A variety of strategies has previously been employed to overcome this.   
Fluorescent labelling of proteins has been used to visualise their association with and 
uptake by cells in the confocal microscope [158, 159, 165, 250, 251].  While important 
insights into the interactions of protein aggregates with cells have been gained using this 
technique, the fluorescent labelling of proteins for visualisation in the confocal microscope 
presents a number of limitations.  There is a lack of spatial resolution, meaning that it is not 
possible to gain detailed structural information on the aggregates or to specify the exact 
subcellular location of a protein aggregate after uptake.  The tagging of proteins with a 
fluorescent label may influence the protein’s behaviour during aggregation and the 
interactions between the protein aggregates and the cells, making data more difficult to 
interpret.  Furthermore, the fluorophores that are typically used for the labelling of Aβ 
peptides have been found to be retained within cells after the peptide has been degraded 
leading to potentially misleading data [164]. 
Heavy metal stains, such as osmium tetroxide or uranyl acetate, are often used in the 
electron microscopy of biological samples [252].  Unfortunately, these sorts of stains lack 
the specificity that is required to map protein aggregates within a cellular environment.  For 
example, uranyl acetate will stain all the proteins in a sample indiscriminately, which will not 
aid in the identification of amyloid or other protein aggregates. 
A common tactic for the identification of protein aggregates within cells and tissue is the 
use of immunogold labelling [160-162, 253].  This technique involves using an antibody that 
will identify the protein in the aggregates and bind to them.  Gold nanoparticles that have 
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been labelled with antibodies that will identify and bind to the first antibodies are then used 
to identify the locations of the protein aggregates [186].  This allows the visualisation of cells 
and protein aggregates in the electron microscope, thus providing the spatial resolution 
required to identify specific subcellular locations.  Unfortunately, this technique does not 
make possible the direct visualisation of the protein aggregates, meaning that no structural 
information can be gained on them.  Figure 5.1 shows an image published by Friedrich et al. 
in which a TEM image of immunogold-labelled Aβ aggregates in a cell has been falsely 
coloured to demonstrate the potential location and shape of the aggregates.  The black dots 
that are visible throughout the image are the gold nanoparticles that are immunolabelled to 
bind to Aβ.  Using this method it is possible only to hypothesise the exact position or 
structure of the protein aggregates.  
 
Figure 5.1: Immunogold labelling of Aβ aggregates in cells.  The image has been falsely coloured to 
demonstrate the possible locations of the aggregates (arrows) within the cell.  V = vesicular structure; Cyt = 
cytoplasm; Mit = mitochondria; MVB = multivesicular body; ER = endoplasmic reticulum.  Figure adapted 
from [253]. 
Also, this method will only identify those protein aggregates that are at or are very close to 
the surface of a section.  Given that the typical thickness of an amyloid fibril is 7 – 10 nm [2] 
while a section of embedded cells for examination by TEM or STEM typically has a thickness 
of 70 – 100 nm, the process of immunogold labelling will not identify all the aggregates 
within a specimen. 
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In this work we have developed a novel technique for the visualisation of specific protein 
aggregates within the cellular environment at a sufficiently high spatial resolution for the 
assessment of the aggregates’ structure as well as the examination of the intracellular 
distribution of aggregates [191, 192]. 
5.1.1 Visualising Selenium-labelled Proteins 
The Rutherford scattering of electrons by the atomic nucleus is discussed in chapter 3.  The 
unscreened Rutherford scattering cross-section for the interaction between a high speed 
electron and a single atom is [198]: 
                
    
 
  
 
 
    
 
 
 
Equation 5.1 
where Z is the atomic number of the scattering atom, E0 is the energy of the incoming 
electron (in keV) and θ is the scattering angle.  This can be modified to give the scattering 
cross-section from atoms in a specimen of thickness t [198]: 
                 
    
      
 
  
 
  
 
 
     
 
 
  
Equation 5.2 
where t is the thickness of the sample, N0 is Avogadro’s number, ρ is the density of the 
sample and A is the atomic mass of the scattering atom.  The electrons of the scattering 
atom screen the incoming electrons from the effect of the nucleus.  In order to take this 
screening into account a variable known as the screening parameter is introduced into the 
Rutherford scattering cross-section (equation 5.2); this is discussed in further detail in 
chapter 3.  The screening parameter, θ0, is described by the equation [198]: 
   
         
  
   
 
Equation 5.3 
At scattering angles greater than θ0 the screening effects of the electron shells are negligible 
and the cross-section for the scattering of electrons follows equation 5.2. 
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The Alzheimer’s-related Aβ peptide naturally contains a sulfur atom in its methionine amino 
acid (figure 5.2).  In this work we have taken a fragment of the Aβ peptide which 
corresponds to residues 25 to 36 of the full chain and replaced the naturally occurring sulfur 
with a selenium atom, which is in the same group of the periodic table of elements.  This 
creates an amino acid that has a larger electron scattering cross-section than its natural 
counterpart but is chemically essentially identical to it [187-189].   
 
Figure 5.2: The methionine amino acid naturally contains a sulfur atom which can be replaced with a 
selenium to create a molecule that is chemically essentially identical but has a higher electron scattering 
cross-section. 
Sulfur has an atomic number of 16 whereas selenium has an atomic number of 34.  
Therefore the scattering cross-section of this atom is increased by a factor of: 
   
 
  
      
Equation 5.4 
Therefore, when examining samples of cells that have been exposed to selenium-enhanced 
Aβ(25-36) (Se-Aβ(25-36)) in STEM at collection angles greater than θ0, Z-contrast dominates 
the image.  At an accelerating voltage of 300 kV, θ0 for selenium is approximately 22 mrad, 
and has lower values for lighter elements.  At lower collection angles variations in atomic 
number will still influence image intensity, however, variations in the density and thickness 
of the sample will also contribute to image contrast. 
In unstained samples of cells and protein aggregates, other than the selenium introduced in 
the Aβ fragment, there are no heavy elements present, except for some small amounts of 
iron, which is found in ferritin molecules, protein cages that store iron in the cell.  Ferritin is 
easily identifiable in TEM/STEM images as it is circular with a hollow core, having an outer 
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diameter of ~ 12 nm and an inner diameter of ~ 8 nm [254].   Figure 5.3 shows a HAADF-
STEM image of ferritin in the cytoplasm of a human cell. 
 
Figure 5.3: HAADF STEM images of ferritin in the cytoplasm of human cells.  The ferritin appears as bright 
circular regions with a diameter of approximately 12 nm with a hollow core, approximately 8 nm in 
diameter.  Figure adapted from [254]. 
This means that for electron micrographs acquired while operating in STEM, with high 
collection angles, regions of particularly high intensity indicate the presence of the 
selenium-labelled peptide. 
The presence of selenium can be confirmed by the use of energy dispersive X-ray 
spectroscopy (EDX).  The energies of the X-rays generated by the interactions between the 
electron beam and the atoms in the sample can be examined for peaks at energies 
characteristic of specific elements.  EDX is discussed in further detail in chapter 3. 
5.2 Results 
All of the cells used in the experiments presented in this chapter are human monocyte-
derived macrophage cell (HMMs).  All the cell exposures presented here were HMMs 
exposed to aggregates of Aβ(25-36) or Se-Aβ(25-36) at a protein concentration of 10 µM for 
a period of 24 hours.  All cell sections examined for this chapter were between 70 and 
100 nm in thickness.  All bright field TEM images were acquired at an accelerating voltage of 
120 kV.  All STEM images were acquired at an acceleration voltage of 300 kV and were 
collected with a probe size of ~ 0.24 nm and, unless otherwise stated, inner and outer 
collection angles of approximately 13 and 64 mrad, respectively. 
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5.2.1 Imaging Selenium-labelled Protein Aggregates in Cells 
Figure 5.4 (a) shows a bright field TEM image of a cell exposed to aggregates formed from 
Aβ(25-36) in which the sulfur atom of the methionine amino acid has not been replaced 
with a selenium atom.  The cell was bulk stained with osmium tetroxide during fixation.  It is 
difficult to identify these aggregates within the cellular environment with any level of 
certainty.  Entities within the cells that appear dark and which may be peptide aggregates 
have been circled.  However, it is not possible to ascertain whether or not these are actually 
Aβ(25-36) aggregates without some other method of labelling.   
Figure 5.4 (b) shows a bright field TEM image of an unstained cell that was exposed to 
aggregates of selenium-enhanced Aβ(25-36) (Se-Aβ(25-36)).  Dark inclusions that may be 
the selenium-enhanced aggregates have been circled.  Due to the high atomic number of 
the selenium atom these objects are more clearly visible against the background of the 
cellular environment than those in figure 5.4 (a); however, it is still not possible to be certain 
of their identity without the use of further chemical analysis. 
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Figure 5.4: (a) A bright field TEM image of bulk stained cells exposed to unlabelled Aβ(25-36) aggregates.  
Inclusions which may be the peptide aggregates are circled; however, it is not possible to identify these with 
certainty. (b) A bright field TEM image of unstained cells exposed to Se-Aβ(25-36) aggregates.  Entities which 
may be protein aggregates are circled.  The protein aggregates are more easily identifiable than in (a) but it 
is still not possible to confirm them as Aβ(25-36) aggregates without further chemical analysis.  N = nucleus; 
C = cytoplasm; ES = extracellular space. 
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A HAADF-STEM image of a bulk stained cell exposed to selenium-free Aβ(25-36) aggregates 
is shown in figure 5.5 (a).  The image was collected from cells that were stained with 
osmium tetroxide which binds to lipids and therefore highlights the membranes of cell 
organelles and other lipid-rich inclusions such as lipofuscin, marked L in figure 5.5 (a).  
Entities which may be the aggregates are circled; however, it is not possible to be certain 
that these are Aβ(25-36) aggregates. 
Figure 5.5 (b) shows a HAADF-STEM image of a 100 nm section of bulk stained cells exposed 
to Se-Aβ(25-36) aggregates.  Here, the selenium-labelled aggregates are quite easily 
identifiable within the cellular environment and these are circled in the figure.  The 
presence of the osmium tetroxide stain makes the identification of the Se-aggregates more 
difficult as the high atomic number of the osmium atoms means that some cell organelles 
appear brightly against the background of the cellular environment and therefore the Se-
peptides are not the only highly scattering regions in the sample. 
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Figure 5.5: (a) A HAADF-STEM image of a cell exposed to unlabelled Aβ(25-36) aggregates.  Entities which 
may be peptide aggregates are circled.  It is not possible to identify these aggregates with confidence.  (b) 
HAADF-STEM image of a bulk stained cell exposed to Se-Aβ(25-36) aggregates.  Potential aggregates are 
circled.  The aggregates are more easily identifiable than in (a).  However, the presence of the bulk stain 
means that cell organelles could be mistaken for peptide aggregates.  C = cytoplasm; ES = extracellular 
space; L = lipofuscin; N = nucleus. 
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Figure 5.6 shows a HAADF-STEM image of unstained cells exposed to aggregates formed 
from Se-Aβ(25-36).  The selenium-enhanced aggregates can be clearly seen within the 
cellular environment due to the high atomic number of the selenium atoms incorporated 
into the Aβ(25-36) peptide.  The cell is unstained so cell organelles do not appear brightly in 
this image and therefore the only highly scattering regions are the selenium-enhanced 
peptides. 
 
Figure 5.6: HAADF-STEM image of a cell exposed to Se-Aβ(25-36) aggregates.  The aggregates can be easily 
identified within the cellular environment due to the high atomic number of the selenium atom. 
5.2.2 Collection Angles Determine the Electron/Specimen Interactions that Dominate 
Image Contrast 
As discussed in chapter 3 the exact range of collection angles at the HAADF detector can be 
controlled by the user.  As the interaction cross-section for beam electrons interacting with 
atoms in the sample decreases with increasing scattering angle, the total number of 
electrons contributing to an image is less for higher HAADF collection angles.  Altering the 
collection angles also varies the amount of influence different electron/specimen 
interactions have over the image contrast.  At lower collection angles variations in mass-
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thickness have a far greater effect on image contrast than at higher collection angles.  This 
means that in HAADF images areas of the specimen that are thicker, denser or contain 
heavier elements appear brighter than areas that are thinner, less dense or contain lighter 
elements.  At collection angles that are much lower than the screening parameter, θ0 
(equation 5.3) for the elements in the sample, interactions between beam electrons and 
both the electron shells and the nuclei of atoms in the sample influence image contrast.  At 
collection angles that are much greater than θ0 nuclear scattering events dominate image 
contrast.  For the unstained samples examined in this work the heaviest element that is 
present in significant quantities is selenium which has a screening parameter of 
approximately 22 mrad when operating with an acceleration voltage of 300 keV.  Therefore, 
at collection angles greater than 22 mrad the electron-shell scattering of beam electrons can 
be considered to be negligible and nuclear scattering events will dominate image contrast. 
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Figure 5.7:  (a) A HAADF-STEM image of cells exposed to Se-Aβ(25-36) aggregates acquired with relatively 
low collection angles.  (b) A HAADF-STEM image of the same region acquired with much higher collection 
angles.  N = nucleus; C = cytoplasm; A = aggregates; K = knife mark; βin = inner collection angle; βout = outer 
collection angle. 
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Figure 5.7 demonstrates how variations in collection angles at the HAADF collector change 
the electron/specimen interactions that dominate image contrast.  Figure 5.7 shows images 
of cells that were exposed to Se-Aβ(25-36) aggregates.  Figure 5.7 (a) was obtained with a 
collection angle range of approximately 8 to 41 mrad.  This range of collection angles means 
that the contrast observed in the image will be influenced by both electron/electron and 
electron/nucleus scattering.  Therefore the brightness of the image is affected by the 
thickness, the density and the atomic number of elements in the specimen.  Thus, in this 
image it is possible to identify not only the aggregates (marked A) in the cellular 
environment but also denser organelles within the cells such as the cell nucleus (marked N) 
which appears brighter than the cell cytoplasm (marked C).  It is even possible to identify 
the knife mark (marked K) in the image as this produces a variation in the thickness of the 
specimen.   
Figure 5.7 (b) shows a HAADF-STEM image of the same region of the sample that was 
acquired with an inner collection angle of ~ 33 mrad and an outer collection angle of 
~ 161 mrad, higher collection angles than figure 5.7 (a).  In this image it is still possible to 
identify the cells against the background of the resin and the selenium-enhanced aggregates 
within the cellular environment due to the high atomic number of the selenium atoms.  
However, it is no longer possible to identify cell organelles, such as the nucleus, or the knife 
mark that was visible in figure 5.7 (a).  At collection angles between 8 and 41 mrad both 
electron and nuclear scattering contribute to image contrast, whereas for scattering angles 
of 33 – 161 mrad nuclear scattering events dominate. 
Figure 5.7 demonstrates how cell structure is visible without the use of any stain when 
operating in STEM mode at low collection angles.  By collecting images of regions of cells 
exposed to selenium-enhanced aggregates at both low and high collection angles, it is 
possible to identify the exact subcellular locations of the aggregates by examining images 
collected at low scattering angles while at the same time confirming the presence of the 
selenium-enhanced aggregate from the examination of images acquired at higher collection 
angles. 
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5.2.3 EDX of Selenium-enhanced Protein Aggregates 
In order to confirm the presence of selenium, energy dispersive X-ray spectroscopy (EDX) 
was performed on selected regions of the specimens.  The characteristic energy of selenium 
Lα X-rays is 1.38 keV.  Point spectra can be collected to verify the presence of selenium at a 
single location or 1-dimensional spectrum images can be acquired to assess variations in 
selenium concentration along a line by collecting EDX point spectra at successive points 
along the line. 
 
Figure 5.8: (a) A HAADF-STEM image of an Se-Aβ(25-36) aggregate.  An EDX spectrum was collected at the 
point marked with a red dot in the image. (b) The EDX spectrum obtained at the point marked with a red dot 
in (a). 
Figure 5.8 (a) shows a HAADF-STEM image of an Se-Aβ(25-36) aggregate.  An EDX spectrum 
was acquired at the point marked with a red dot.  Figure 5.8 (b) shows the EDX spectrum 
collected from the point marked in figure 5.8 (a).  The presence of selenium is confirmed by 
the characteristic peak marked Se. 
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Figure 5.9:  (a) A HAADF-STEM image of cells exposed to Se-Aβ(25-36) aggregates.  The red dot indicates the 
point at which an EDX spectrum was collected.  (b) The EDX spectrum collected at the point marked in (a).  
The characteristic peak for the selenium Lα transition can be clearly seen.  A = aggregate; ES = extracellular 
space. 
Figure 5.9 (a) shows a HAADF-STEM image of cells that were exposed to Se-Aβ(25-36) 
aggregates.  Sections were mounted onto 400 mesh copper grids with a lacy carbon support 
film.  The selenium-enhanced aggregates are indicated by the letter A.  An EDX spectrum 
was collected from the point indicated.   This EDX spectrum is shown in figure 5.9 (b), the 
presence of selenium being confirmed by the selenium Lα peak. 
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Figure 5.10:  (a) A HAADF-STEM image of cells exposed to Se-Aβ(25-36) aggregates.  (b) A higher 
magnification HAADF-STEM image of the boxed area indicated in (a).  A 1-dimensional EDX spectrum image 
was acquired along the line XY.  (c) The EDX spectrum acquired at the point of highest HAADF intensity on 
the line XY in which the characteristic peak for selenium is observed.  The green window around this peak 
indicates the energy window within which all X-rays were extracted and counted for each point along the 
line.   (d) The change in selenium concentration and HAADF intensity along XY.  The peak in HAADF intensity 
corresponds to the peak selenium concentration.  N = nucleus; C = cytoplasm; ES = extracellular space; A = 
aggregate. 
Figures 5.10 (a) and (b) show HAADF-STEM images of cells that were exposed to Se-Aβ(25-
36) aggregates.  Ten EDX spectra were collected along a line (XY) through the cell cytoplasm 
(C), a selenium-enhanced aggregate (A) and the extra-cellular space (ES) marked in red in 
figure 5.10 (b).  Figure 5.10 (c) shows the EDX spectrum collected at the point of highest 
selenium concentration.  An energy window around the selenium peak was drawn (marked 
in green in figure 5.10 (c)).  All the X-rays within this window were counted for each 
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spectrum in the spectrum image.  Figure 5.10 (d) shows these X-ray counts plotted against 
the displacement along the line XY.  The variation in HAADF intensity along XY is plotted on 
the same graph.  The peak in HAADF intensity corresponds with the peak in selenium 
concentration, confirming that the increase in image intensity is indeed due to the presence 
of the selenium in the Aβ(25-36) peptide. 
All the EDX data displayed here show peaks characteristic of elements other than selenium.  
The presence of oxygen and carbon is to be expected in both the cells and the Aβ(25-36) 
peptide.  All samples were mounted on copper grids for imaging and analysis, thus copper 
peaks were observed in some of the spectra.  Silicon peaks are also visible in some of the 
spectra presented here.  The silicon is present due to contaminants on the TEM grids that 
were used to mount the samples.  Where silicon was detected its presence and 
concentration did not vary with the presence of aggregates or cells. 
5.3 Conclusions 
The results presented in this chapter demonstrate that the substitution of the naturally 
occurring sulfur atom in the methionine amino acid of the Aβ(25-36) peptide facilitates the 
visualisation of the selenium-enhanced aggregates within the cellular environment without 
the use of the any other stains or tags.  Variations in collection angles can be utilised to 
confirm the presence of heavy elements at specific locations or to observe variations in the 
density of the cellular environment corresponding to different cell organelles.  EDX can also 
be used to confirm the presence of selenium. 
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6. Toxicity, Uptake and Intracellular Distribution of Protein Aggregates 
6.1 Introduction 
The deposition of extracellular proteinaceous fibrils in both the brain and at peripheral sites 
in amyloid-related pathologies is associated with the recruitment of phagocytic cells [140-
143].  This inflammatory response may be a significant pathogenic event in diseases such as 
AD.  The ability of phagocytic cells to remove aggregates from the extracellular space or to 
catalyse the production of aggregates may be very important features in the pathogenesis 
of AD [149, 255].  However, the fate of different types of aggregates when they interact 
with phagocytes is not clear; we do not know the subcellular compartments to which 
aggregates are localised or how the cells’ degradation mechanisms deal with them.   
Previous studies on the interactions of amyloid fibrils and their precursors with cells have 
revealed that cellular uptake occurs in a manner that is highly dependent on the aggregate 
species involved [145, 158, 159, 164, 165].  It has been established that the fibrillar form of 
Aβ is internalised by microglial cells via receptor-mediated phagocytosis [145, 165].  In 
contrast, oligomeric forms of the Aβ peptide are internalised by microglial cells via 
macropinocytosis [164].   
Confocal microscopy studies have revealed a size-dependence in the uptake of aggregates 
of Aβ in different types of cells.  Chafekar et al. observed that Aβ oligomers were taken up 
by neuronal cells more readily than larger aggregates and that the cytotoxicity of these 
oligomers was greatly reduced by inhibiting uptake, while the inhibiting uptake had no 
effect on the cytotoxicity of larger aggregates [159].  Weltzien and Pachter also found that 
small Aβ aggregates were completely internalised by macrophage cells whereas larger 
aggregates remained at the cell’s plasma membrane [158].   
While confocal microscopy studies have provided invaluable information on how protein 
aggregates interact with and are taken up by cells, confocal microscopy lacks the necessary 
spatial resolution to image the structure of A aggregates inside cells or their fate within the 
cell.  The most advanced methods of confocal microscopy provide a spatial resolution of 
 116 
 
20 nm [185].  Confocal microscopy requires the modification of the Aβ peptide with 
fluorophores which may alter their interactions with biological systems.  Moreover, the 
fluorophores that are commonly used to label Aβ peptides are retained within cells after the 
peptide has been degraded [164], thereby giving potentially misleading results. 
The replacement of the naturally occurring sulfur with a selenium atom in a fragment of the 
Aβ peptide allows the direct visualisation at high spatial resolution of protein aggregates 
inside cells, as discussed in chapter 5.  The aggregation of this peptide (Se-Aβ(25-36)) and its 
selenium-free analogue (Aβ(25-36)) was described in chapter 4.  In this chapter the 
interactions between aggregates of the peptide and human monocyte derived macrophage 
cells (HMMs) are examined.  The cytotoxicity to HMMs of the peptide in its monomeric, 
prefibrillar aggregate and mature fibril forms is investigated and the cytotoxicities of the 
different aggregate species compared.  The internalisation of prefibrillar and fibrillar Se-
Aβ(25-36) by HMMs and the pathways of entry of the different aggregates are examined.  
The intracellular distributions of the aggregates are assessed and their change over time 
analysed.  Finally, the stability of each aggregate form within the cellular environment is 
studied. 
6.2 Results 
HMMs were exposed to the Se-Aβ(25-36) peptide and its selenium-free analogue in 
different aggregation states.  The cytotoxicity of the peptide in its monomeric, prefibrillar 
and fibrillar forms was assessed using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide) viability assay and the live-dead viability assay.  MTT viability assays 
were carried out in 48-well plates with between 3 and 8 wells used for each exposure.  
When a high level of cytotoxicity was measured for a particular exposure the experiment 
was repeated, in order to ensure that the observed toxicity had not arisen due to 
contamination or unhealthy cells.  Live-dead assays were carried out on cover slips with at 
least 8 cover slips prepared for each exposure.  At least ten randomly located fields of view 
were examined for each cover slip.  Each field of view contained at least twenty cells.  
Statistical analysis of each exposure was performed for both kinds of viability assays using a 
two-tailed type 2 t-test with statistical significance set at p < 10-4.  HMMs were exposed to 
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prefibrillar and fibrillar Se-Aβ(25-36) and subsequently fixed, embedded in resin and 
microtomed for examination by HAADF-STEM in order to assess the uptake and intracellular 
distribution of the aggregates.  Further details of the experimental methods are in chapter 
3. 
6.2.1 Cytotoxicity of Aβ(25-36) 
The cytotoxicity of the Aβ(25-36) peptide to HMMs was assessed using the MTT viability 
assay.  Monomeric peptide, prefibrillar aggregates or mature fibrils were added to the cell 
culture medium in order to compare the cytotoxicity of the different aggregate species.  
The peptide was prepared as described in chapter 3.  Monomeric peptide was added to the 
cell culture medium immediately after the protein was dissolved in buffer.  Prefibrillar 
aggregates and mature fibrils were prepared by maintaining the peptide under the 
aggregation inducing conditions described in chapter 4 for a period of three hours or at 
least twelve hours, respectively, before cell exposure.  Each form of the peptide 
(monomeric, prefibrillar aggregate and mature fibril) was added to the cell culture medium 
with protein concentrations from 1.25 to 20 µM.  After a period of 24 hours the viability of 
the cells was measured and compared with cells that were treated with buffer alone.  
Figure 6.1 shows the viability of cells that were exposed to different concentrations of the 
Aβ(25-36) peptide in three different aggregation states.  
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Figure 6.1: The viability of HMMs exposed to different aggregate species of Aβ(25-36).  Cells were 
incubated with the peptide or with buffer alone for 24 hours.  Then cell viability was measured using the 
MTT viability assay.  Values represent the mean ± standard deviation (SD); n = 8. Statistical significance (p < 
10
-4
) when compared with cells exposed to buffer alone is indicated by an asterisk above the bar.   
The cytotoxicity of all three aggregation states, as measured by the MTT assay, was found to 
be concentration-dependent (figure 6.1).  At a protein exposure concentration of 20 μM 
(the highest exposure concentration examined) all three aggregate species were found to be 
cytotoxic after an exposure time of 24 hours (cell viability 39.3 ± 4.9%, 9.6 ± 2.6% and 25.0 ± 
8.4% for cells exposed to monomeric peptide, prefibrillar aggregates and mature fibrils, 
respectively).  At exposure concentrations of 5 μM and 10 μM the monomeric peptide and 
the mature fibrils did not show significant levels of toxicity, whereas the prefibrillar 
aggregates were found to be toxic at these concentrations (cell viability 72.9 ± 9.3% and 
62.6 ± 10.9% for cells exposed to 5 μM and 10 μM peptide concentrations, respectively).   
A protein exposure concentration of 10 μM was chosen for the imaging studies carried out 
in this work.  At this exposure dose significant, but not complete, cytotoxicity was observed 
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for the most toxic aggregate species (the prefibrillar aggregate) and no significant levels of 
cytotoxicity were observed for the other species examined after 24 hours of exposure [171]. 
The time-dependence of the cytotoxicity of the peptide at an exposure concentration of 
10 μM was investigated.  The viabilities of cells exposed to three different aggregate species 
of the peptide at this exposure dose for periods of 2, 6 and 24 hours were assessed using 
the MTT viability assay.  The results of the time-dependent study of the toxicity of Aβ(25-36) 
in its monomeric, prefibrillar aggregate and mature fibril forms are shown in figure 6.2. 
 
Figure 6.2: The viability of HMMs that were exposed to different aggregate species of the Aβ(25-36) 
peptide for varying exposure times.  Cells were incubated with the peptide at a concentration of 10 µM or 
with buffer alone for 2, 6 or 24 hours.  Cell viability was measured using the MTT viability assay.  Values 
represent the mean ± SD; n = 8.  Statistical significance (p < 10
-4
) when compared with the control cells, 
which were exposed to buffer alone, is indicated by an asterisk above the bar. 
None of the aggregate species of the Aβ(25-36) peptide showed significant levels of toxicity 
after 2 or 6 hours exposure.  However, HMMs exposed to prefibrillar aggregates showed 
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significantly decreased viability after 24 hours (cell viability 62.6 ± 10.9%; p < 10-4).  Neither 
the monomeric peptide nor the mature fibril was found to be toxic at this time point.   
The cytotoxicity of the Aβ(25-36) peptide and the Se-Aβ(25-36) peptide were compared in 
order to assess whether the substitution of the naturally occurring sulfur atom with a 
selenium atom affected the toxicity of the peptide.  Cells were exposed to each peptide in 
its monomeric, prefibrillar aggregate and mature fibril forms at a protein concentration of 
10 μM for a period of 24 hours and their viabilities were assessed using the MTT assay.  
Figure 6.3 shows the results of these viability assays. 
 
Figure 6.3: The viability of HMMs exposed to different aggregate species of Aβ(25-36) and Se-Aβ(25-36).  
Cells were incubated with the peptide at a concentration of 10 µM or with buffer alone for 24 hours.  Then 
cell viability was measured using the MTT viability assay.  Values represent the mean ± SD; n = 3.  Statistical 
significance (p < 10
-4
) when compared with control cells, which were exposed to buffer alone, is indicated 
by an asterisk above the bar. 
The presence of selenium in the Aβ(25-36) peptide was not found to affect the cytotoxicity 
of the peptide (figure 6.3).  The monomeric and mature fibrillar forms of both peptides did 
not show significant levels of cytotoxicity at an exposure concentration of 10 μM for 
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24 hours.  However, the prefibrillar aggregates formed from both peptides were cytotoxic 
under the same exposure conditions (cell viability 62.6 ± 10.9% for cells exposed to the 
selenium-free peptide, and 58.4 ± 4.9% for cells exposed to the selenium-enhanced peptide; 
p < 10-4).  T-tests were carried out comparing each form of the Se-Aβ(25-36) peptide with its 
selenium-free analogue in order to examine for statistically significant variations in the 
cytotoxicity.  In each case a p-value of greater than 0.1 was returned, indicating no 
statistically significant differences between the viability of cells exposed to Aβ(25-36) or Se-
Aβ(25-36) in each aggregation state. 
The toxicity of the Aβ(25-36) peptide was also investigated using the live-dead assay.  This 
assay is based on the incorporation of propidium iodide into dead cells as measured using 
the confocal microscope as described in chapter 3.  Cells were exposed to three different 
forms of the Aβ(25-36) peptide – monomeric peptide, prefibrillar aggregates and mature 
fibrils – at a protein concentration of 10 μM for different periods of time.  The results of this 
study are shown in figure 6.4. 
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Figure 6.4: The viability of HMMS exposed to different aggregate species of Aβ(25-36) for 2, 6 or 24 hours.  
Cells were incubated with the peptide at a concentration of 10 µM.  Cell viability was assessed using the 
live-dead viability assay.  Values represent the mean ± SD; n = 8.  Statistical significance (p < 10
-4
) when 
compared with cells exposed to buffer alone is indicated by an asterisk above the bar. 
The live-dead viability assay returned similar results to the MTT viability assay (figure 6.4).  
At this exposure concentration the monomeric peptide and the mature fibrils were found 
not to be toxic at any of the exposure times examined.  The prefibrillar aggregates were 
found not to be toxic at this concentration after a 2 hour or 6 hour exposure period.  
However, significant toxicity was observed after an exposure time of 24 hours (cell viability 
79.6 ± 9.9%; p < 10-4).   
6.2.2 Uptake and Distribution of Aβ(25-36) Aggregates at 24 Hours 
HAADF-STEM imaging of HMMs exposed to aggregates of Se-Aβ(25-36) for a period of 
24 hours was carried out.  Cells were exposed to prefibrillar aggregate or mature fibril forms 
of Se-Aβ(25-36).  As these two aggregate species displayed significantly different levels of 
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cytotoxicity it was hypothesised that variations would be observed in their uptake by cells 
and their intracellular distribution after uptake.  Prefibrillar aggregates were generated by 
maintaining the peptide under the aggregation conditions described in chapter 4 and 
mature fibrils were generated by maintaining the peptide under these conditions for at least 
12 hours before cell exposure.  The selenium-emhanced aggregates were added to the cell 
culture medium at a protein concentration of 10 μM.  After 24 hours the cells were fixed, 
embedded in resin and ultramicrotomed into thin sections for examination by HAADF-STEM.  
At least two cell exposure experiments were carried out for each set of exposure conditions 
and each of these generated at least two blocks of embedded cells.  Each block was used to 
create multiple sections.  Sections for imaging were between 70 nm and 100 nm in 
thickness.  The preparation of samples for examination by HAADF-STEM is described in 
greater detail in chapter 3.  HAADF-STEM images were acquired with inner collection angles 
of between 8 and 13 mrad and outer collection angles from 42 to 64 mrad.  At this range of 
collection angles both variations in the thickness or density of the sample and variations in 
atomic number affect the intensity of the image generated.  This means that the selenium-
enhanced aggregates can be identified with confidence, that their subcellular locations can 
be recognised and that cell structure can be assessed.  Cells in multiple regions of multiple 
sections were examined for each exposure condition. 
6.2.2.1 Cells Exposed to Mature Aβ(25-36) Fibrils for 24 Hours 
The interactions of cells with mature Se-Aβ(25-36) fibrils after 24 hours were examined 
using HAADF-STEM.  At this exposure time the mature fibrils of both Aβ(25-36) and Se-
Aβ(25-36) did not show significant levels of toxicity when added to the cell culture medium 
at a protein concentration of 10 μM.  Bright field TEM images of mature fibrils of Aβ(25-36) 
are shown in figures 4.7 (e) to (i).  Fibrils have widths of 5 to 25 nm and lengths up to several 
hundred nanometres.  These fibrils were often observed meshed together in bundles.  No 
structural differences were observed when mature fibrils of Se-Aβ(25-36) were compared 
with mature Aβ(25-36) fibrils.  Representative bright field TEM images of mature Se-Aβ(25-
36) fibrils are shown in figure 4.9 (c) and (d).  A HAADF-STEM image of a mature Se-Aβ(25-
36) fibril is shown in figure 5.8. 
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Regions of particularly high intensity in HAADF-STEM images of cells exposed to mature Se-
Aβ(25-36) fibrils indicate the presence of the selenium-enhanced peptide.  Examination of 
HMMs exposed to mature fibrils for a period of 24 hours before fixation revealed that the 
fibrils were predominantly located associated with the exterior surface of the plasma 
membrane, in regions of the extracellular space and in intracellular vesicles.  After this 
exposure time the protein aggregates appear to have lost their fibrillar nature.  Instead they 
are observed to be lacking in any distinct structural pattern, are granular in appearance and 
varying in size (figures 6.5, 6.6 and 6.7). 
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Figure 6.5: HAADF-STEM images of HMMs exposed to mature Se-Aβ(25-36) fibrils.  Aggregates of the 
selenium-enhanced peptide (regions of high intensity) are associated with the exterior face of the plasma 
membrane.  The aggregates do not appear to have retained their fibrillar structure.  Boxed regions in (a) 
and (c) are shown at higher magnification in (b) and (d).  C = cytoplasm; ES = extracellular space; PM = 
plasma membrane; A = aggregate. 
Areas of high image intensity, indicating the presence of a high Z species i.e. the selenium-
enhanced peptide, were frequently observed in the extracellular space and associated with 
the plasma membrane.  Aggregates associated with the plasma membrane did not appear 
fibrillar in structure.  Instead, they appeared as irregular, disconnected regions with no 
distinct structure (figure 6.5). 
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Figure 6.6: HAADF-STEM images of cells exposed to mature Se-Aβ(25-36) fibrils.  Aggregates of the 
selenium-enhanced peptide are observed in intracellular vesicles; no fibrillar structure is apparent in these 
aggregates.  Boxed regions in (a) and (c) are shown at higher magnification in (b) and (d).  C = cytoplasm; ES 
= extracellular space; A = aggregate; IV = intracellular vesicle; N = nucleus. 
Selenium-enhanced peptide aggregates were also observed in intracellular vesicles, which 
may be lysosomes or endosomes (figure 6.6).  As with those aggregates that were observed 
at the plasma membrane the aggregates in intracellular vesicles do not appear to have a 
fibrillar structure and are granular in appearance.  Aggregates were defined as having been 
observed in an intracellular vesicle when resin (having intensity similar to that of the 
extracellular space) was visible between the aggregate and the cell cytoplasm. 
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Figure 6.7: (a) HAADF-STEM image of cells exposed to mature Se-Aβ25-36 fibrils for 24 hours. (b), (c) and (d) 
HAADF-STEM images of selenium-enhanced aggregates in the extracellular space at increasing 
magnification. 
Examination of the selenium-enhanced aggregates that appear in the extracellular space of 
cells that had been exposed to mature Se-Aβ(25-36) fibrils for 24 hours revealed that no 
fibrillar structure was present in the aggregates (figure 6.7).  No distinct structural pattern 
is apparent in these regions even at high magnification (figure 6.7 (d)). 
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6.2.2.2 Cells exposed to Prefibrillar Aβ(25-36) Aggregates for 24 Hours 
Prefibrillar aggregates of both Aβ(25-36) and Se-Aβ(25-36) were found to show significant 
levels of cytotoxicity after 24 hours at an exposure concentration of 10 μM.  The 
interactions of cells with prefibrillar Se-Aβ(25-36) aggregates after 24 hours were examined 
using HAADF-STEM.    Representative bright field TEM images of prefibrillar Aβ(25-36) 
aggregates are shown in figures 4.7 (b) and (c).  The aggregates appear as branched 
structures of various shapes having sizes from 7 to 70 nm.  TEM images of these aggregates 
revealed that they are frequently observed to be agglomerated.  TEM images of prefibrillar 
Se-Aβ(25-36) aggregates displayed no structural differences when compared with 
prefibrillar aggregates of the selenium-free peptide.  Representative bright field TEM images 
of prefibrillar aggregates of Se-Aβ(25-36) are shown in figures 4.9 (a) and (b). 
In HMMs that were exposed to these aggregates regions of high electron scattering 
intensity, corresponding to the Se-Aβ(25-36) aggregates, were located in the extracellular 
space, associated with the plasma membrane, and in intracellular vesicles (figure 6.8) as was 
observed for HMMs exposed to mature fibrils.  These intracellular vesicles may be 
lysosomes or endosomes.  The aggregates observed in intracellular vesicles had maintained 
a dense, compact structure (figure 6.8 (b) and (c)), and do not display the scattered, 
granular appearance of the aggregates that were observed after cells were treated with 
mature fibrils of Se-Aβ(25-36) for the same period of time (figures 6.5, 6.6 and 6.7).  The 
aggregates were usually observed to be associated with the vesicular membrane and 
occasionally appeared to have traversed this membrane and entered the cytoplasm (figure 
6.8 (b)) 
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Figure 6.8: HAADF-STEM images of cells that were exposed to prefibrillar Se-Aβ(25-36) aggregates.  The 
selenium-enhanced aggregates were observed in intracellular vesicles.  The boxed regions in (a) are shown 
at higher magnification in (b) and (c).  C = cytoplasm; N = nucleus; A = aggregate; IV = intracellular vesicle. 
In contrast to cells exposed to mature fibrils, however, exposure to prefibrillar aggregates 
also resulted in selenium-enhanced aggregates being observed in the cell cytoplasm and 
occasionally in the cell nucleus.  Aggregates were defined as having been observed in the 
cytoplasm when there was no resin visible between the aggregate and the cytoplasm.  
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Aggregates that were observed inside the cell cytoplasm did not appear to have lost their 
structure following interaction with the cells; they are observed as compact, dense 
structures (figure 6.9). 
 
Figure 6.9: HAADF-STEM images of cells exposed to prefibrillar Se-Aβ(25-36) aggregates.  Aggregates were 
observed in the cell cytoplasm.  These aggregates were observed as compact, dense structures.  Boxed 
regions in (a) and (c) are shown at higher magnification in (b) and (d).  C = cytoplasm; N = nucleus; ES = 
extracellular space; A = aggregate. 
Aggregates that were observed in the nuclei of cells also appeared as dense, compact 
structures (figure 6.10).   
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Figure 6.10: HAADF-STEM images of cells exposed to prefibrillar Se-Aβ(25-36) aggregates.  Dense, compact 
aggregates were observed in the nucleus.  The boxed regions in (a) and (b) are shown at higher 
magnification in (c) and (d), respectively.  C = cytoplasm; N = nucleus; ES = extracellular space; A = 
aggregate. 
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In summary, examination of HMMs exposed to mature Se-Aβ(25-36) fibrils for 24 hours 
revealed that aggregates were predominantly located at the plasma membrane and in 
intracellular vesicles.  For HMMs that were exposed to prefibrillar aggregates of Se-Aβ(25-
36) for 24 hours, aggregates were observed at the plasma membrane and in intracellular 
vesicles; however, aggregates were also observed in the cell cytoplasm and occasionally in 
the cell nucleus. 
6.2.2.3 Quantification of Uptake and Intracellular Distribution 
In order to quantify the differences in uptake and distribution of these two aggregate 
species, and assess how these correlate with the observed differences in toxicity, it was 
necessary to examine large areas of cell sections while maintaining the spatial resolution 
required to observe the aggregates and to assess their structure and subcellular location.  
For the purpose of performing this analysis, randomly located areas of sections of cells 
exposed to either prefibrillar or fibrillar Se-Aβ(25-36) were mapped out by acquiring a large 
number of overlapping images at a relatively high magnification (× 20,000; approximately 
6 nm per pixel).  Images were acquired in STEM mode with inner and outer collection 
angles of 8 and 42 mrad, respectively, so that both atomic number and sample 
thickness/density would affect image contrast.  These images were then stitched together 
to create maps of the area in question.  An example of a mapped region of a section of cells 
that had been exposed to prefibrillar Se-Aβ(25-36) aggregates for 24 hours is shown in 
figure 6.11. 
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Figure 6.11: An area of a section of HMMs exposed to prefibrillar Se-Aβ(25-36) aggregates mapped out by 
collecting HAADF-STEM images at high magnification.  N = nucleus; C = cytoplasm; A = aggregate. 
The amount of cell volume that was being examined was then assessed based on variations 
in image intensity using ImageJ [247] in order to measure the area of the sections that 
contained cells.  The area containing cells was then multiplied by the cell section thickness, 
a value that is set by the user when preparing sections, in order to determine the volume 
of cell that had been examined.  The number of aggregates having at least one dimension 
of at least 50 nm was then counted for four different subcellular locations: in an 
intracellular vesicle, in the cell cytoplasm, in the cell nucleus or associated with the plasma 
membrane. 
 134 
 
A minimum dimension of 50 nm was chosen in order to preclude the possibility of counting 
other subcellular species that may contain heavy elements, such as ferritin which has 
dimensions of approximately 12 nm and would appear bright in HAADF-STEM imaging due 
to the presence of iron [254].  Due to the lengths of mature fibrils that have been reported 
in this and other studies [2, 20, 26] the majority of fibrils present in a sample will be 
counted in this study in spite of the fibrils’ narrow widths.  The dimensions of the 
prefibrillar aggregates that have been measured in this study and in other investigations 
[105, 240, 249] mean that, while it is likely that some of the aggregates present in a sample 
will be overlooked, the majority will be counted.  It is necessary to overlook some of the 
aggregates present in a specimen in order to avoid counting other species, such as ferritin, 
which would result in misleading data. 
The numbers of aggregates counted in each subcellular location were then calculated as a 
function of the cell volume that was examined.  The intracellular distribution of aggregates 
in cells that were exposed to prefibrillar aggregates or mature fibrils of Se-Aβ(25-36) for 
24 hours is shown in figure 6.12. 
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Figure 6.12: The intracellular distribution of the prefibrillar aggregates and mature fibrils of Se-Aβ(25-36) in 
HMMs after 24 hours of exposure.  The frequency with which aggregates were observed in each location 
was expressed as a function of the cell volume examined.  Values represent the mean ± standard error (SE); 
n = 10. 
The frequency with which each kind of aggregate was observed in each subcellular location 
was calculated by separating the total cell volume examined into ten roughly equal 
volumes.  The frequencies with which aggregates were observed in each location in each of 
these sub-volumes were used to evaluate the mean frequency.  The chart in figure 6.12 
shows the mean frequencies that were calculated in this way.  Error bars show the 
standard error. 
Prefibrillar aggregates (blue bars) were observed in the cell cytoplasm with the highest 
frequency (0.64 ± 012 aggregates/μm3), whereas mature fibrils (red bars) were most 
frequently observed associated with the plasma membrane (0.47 ± 0.11 aggregates/μm3).  
The prefibrillar aggregates were occasionally observed in the nucleus (0.03 ± 0.01 
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aggregates/μm3), but the mature fibrils were never found in this location.  Both types of 
aggregates were observed in intracellular vesicles but the mature fibrils were found in 
these locations more frequently (0.34 ± 0.08 aggregates/μm3 compared with 0.18 ± 0.06 
aggregates/μm3).   
6.2.3 Time-dependence of Uptake and Distribution 
Since differences were observed in the uptake and distribution of prefibrillar and fibrillar 
forms of the Aβ(25-36) peptide at 24 hours, a time-dependent study of the interactions of 
these aggregates with cells was carried out.  Cells were exposed to prefibrillar Se-Aβ(25-36) 
aggregates or mature Se-Aβ(25-36) fibrils at a protein concentration of 10 μM for 2 or 
6 hours.  The quantification of intracellular distribution described above was repeated for 
each of these exposure times.  Distinct intracellular distributions of prefibrillar and fibrillar 
aggregates were observed at every time point. 
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Figure 6.13: The intracellular distribution of the prefibrillar aggregates and mature fibrils of Se-Aβ(25-36) in 
HMMs after 2 hours of exposure.  The frequency with which aggregates were observed in each location is 
expressed as a function of the cell volume examined.  Values represent the mean ± SE; n = 10. 
Figure 6.13 shows the intracellular distribution of prefibrillar aggregates (blue bars) and 
mature fibrils (red bars) of Se-Aβ(25-36) after 2 hours.    Mature fibrils were observed to be 
associated with the plasma membrane with the highest frequency (0.40 ± 0.07 
aggregates/μm3) and in intracellular vesicles with the next highest frequency (0.28 ± 0.09 
aggregates/μm3).  Prefibrillar aggregates were found in these locations with far lower 
frequencies (0.05 ± 0.03 aggregates/μm3 in intracellular vesicles and 0.04 ± 0.01 
aggregates/μm3 at the plasma membrane).  Both kinds of aggregates were found in the cell 
cytoplasm, though the prefibrillar form is observed in this location more frequently (0.12 ± 
0.03 aggregates/μm3 compared with 0.07 ± 0.04 aggregates/μm3).  Neither kind of 
aggregate was observed in the nucleus after 2 hours of cell exposure. 
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Figure 6.14: The intracellular distribution of the prefibrillar aggregates and mature fibrils of Se-Aβ(25-36) in 
HMMs after 6 hours of exposure.  The frequency with which aggregates were observed in each location is 
expressed as a function of the cell volume examined.  Values represent the mean ± SE; n = 10. 
The intracellular distribution of prefibrillar aggregates (blue bars) and mature fibrils (red 
bars) of Se-Aβ(25-36) after 6 hours is shown in figure 6.14.    The mature fibrils were 
observed to be associated with the plasma membrane with the highest frequency (0.79 ± 
0.08 aggregates/μm3) and in intracellular vesicles with the next highest frequency (0.46 ± 
0.12 aggregates/μm3).  Prefibrillar aggregates were found in these locations with far lower 
frequencies (0.09 ± 0.03 aggregates/μm3 in intracellular vesicles and 0.06 ± 0.03 
aggregates/μm3 at the plasma membrane).  Both kinds of aggregates were found in the 
cytoplasm, though the prefibrillar form of Se-Aβ(25-36) was observed in this location more 
frequently (0.14 ± 0.03 aggregates/μm3 compared with 0.07 ± 0.02 aggregates/μm3).  
Prefibrillar aggregates were occasionally observed in the cell nucleus at this time point (0.12 
0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
0.7 
0.8 
0.9 
1 
intracellular 
vesicle 
cytoplasm nucleus plasma 
membrane 
Fr
e
q
u
e
n
cy
 (
ag
gr
e
ga
te
s/
μ
m
3
) 
Prefibrillar 
aggregates 
Mature fibrils 
 139 
 
± 0.09 aggregates/μm3) whereas the mature fibrils were never found in the nucleus at this 
time point. 
 
Figure 6.15: The change in the intracellular distribution of mature Se-Aβ(25-36) fibrils over time.  The 
frequency with which aggregates were observed in each location is expressed as a function of the cell 
volume examined.  Values represent the mean ± SE; n = 10. 
Figure 6.15 shows how the intracellular distribution of mature fibrils changes with time.  The 
frequencies with which aggregates were observed in intracellular vesicles (blue line) or 
associated with the plasma membrane (purple line) rise between 2 hours and 6 hours but 
drop at 24 hours.  However, the frequency with which fibrils were found in the cell 
cytoplasm (red line) does not change noticeably between 2 and 6 hours, but increases 
significantly at 24 hours 
0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
0.7 
0.8 
0.9 
1 
0 5 10 15 20 25 30 
Fr
e
q
u
e
n
cy
 (
ag
gr
e
ga
te
s/
μ
m
3
) 
Time (hours) 
intracellular 
vesicles 
cytoplasm 
nucleus 
plasma 
membrane 
 140 
 
 
Figure 6.16: The change in the intracellular distribution of prefibrillar Se-Aβ(25-36) aggregates over time.  
The frequency with which aggregates were observed in each location is expressed as a function of the cell 
volume examined.  Values represent the mean ± SE; n = 10. 
The change in intracellular distribution of prefibrillar aggregates is shown in figure 6.16.  At 
every time point aggregates were observed in the cytoplasm (red line) with the highest 
frequency.  The frequency with which aggregates were observed in every subcellular 
location increases with time, with this increase being most marked in the cell cytoplasm. 
The number of observed aggregates in each subcellular location was calculated as a 
percentage of the total number of aggregates counted in each exposure.  The total cell 
volume that had been examined was divided into ten approximately equal sub-volumes 
and the proportion of counted aggregates that had been observed in each location was 
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calculated for each sub-volume.  The mean and standard error for the total volume were 
calculated from these sub-volumes. 
 
Figure 6.17: The proportion of the observed aggregates found in each subcellular location for cells exposed 
to mature Se-Aβ(25-36) fibrils for three different exposure times.  Values represent the mean ± SE; n = 10. 
Figure 6.17 shows the proportions of aggregates that were observed in each subcellular 
location for cells exposed to mature Se-Aβ(25-36) fibrils for 2, 6 or 24 hours.  After a 2 or 
6 hour exposure time (blue and red bars, respectively) the majority of fibrils were observed 
associated with the plasma membrane (64.4 ± 8.9% and 64.6 ± 5.1% at 2 hours and 
6 hours, respectively).  After 24 hours (green bar) the proportion of aggregates is highest at 
the plasma membrane, though this is less marked.  The proportion of aggregates in 
intracellular vesicles did not change for the three time points examined (29.7 ± 8.4%, 31.3 ± 
5.1% and 29.6 ± 5.2% at 2 hours, 6 hours and 24 hours, respectively).  The proportion of 
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aggregates observed in the cell cytoplasm increases at each successive exposure time (5.9 
± 3.1%, 10.1 ± 6.5% and 27.0 ± 5.0% at 2 hours, 6 hours and 24 hours respectively). 
 
Figure 6.18: The proportion of the observed prefibrillar Se-Aβ(25-36) aggregates counted in each 
subcellular location for three different exposure times.  Values represent the mean ± SE; n = 10. 
The proportions of aggregates observed in each subcellular location for cells exposed to 
prefibrillar Se-Aβ(25-36) aggregates for 2, 6 or 24 hours are shown in figure 6.18.  The 
majority of aggregates were observed in the cell cytoplasm at every exposure time 
examined (57.7 ± 10.9%, 50.0 ± 5.7% and 66.4 ± 6.8% at 2, 6 and 24 hours respectively).  
The proportions of aggregates observed in intracellular vesicles or associated with the 
plasma membrane do not change significantly over time (19.5 ± 9.1%, 21.6 ± 4.3% and 18.5 
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± 4.9% in intracellular vesicles at 2, 6 and 24 hours and 22.8 ± 10.6%, 15.2 ± 4.1% and 12.0 
± 6.0% at 2, 6 and 24 hours respectively). 
In summary, the majority of mature fibrils were observed associated with the plasma 
membrane at all time points examined.  These aggregates were observed in intracellular 
vesicles with the next highest frequency.  The majority of prefibrillar aggregates were 
observed in the cell cytoplasm at all time points examined.  Prefibrillar aggregates were 
also observed associated with the plasma membrane and in intracellular vesicles.  These 
aggregates were occasionally found in the nuclei of cells.  Prefibrillar aggregates appeared 
to enter cells in a time-dependent manner. 
6.2.3.1 Cells Exposed to Mature Fibrils for 2 hours 
Examination of HMMs treated with mature Se-Aβ(25-36) fibrils for 2 hours revealed that 
aggregates were located in the extracellular space and associated with the plasma 
membrane (figure 6.19).  The aggregates had often maintained their fibrillar appearance; 
they did not have the broken, granular appearance of the aggregates that were observed 
on examination of cells that were exposed to mature fibrils for 24 hours (as shown in 
figures 6.5, 6.6 and 6.7).  These aggregates were occasionally found to be aligned with the 
plasma membrane (figure 6.19).   
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Figure 6.19: (a) HAADF-STEM image of cells exposed to mature Se-Aβ(25-36) fibrils for 2 hours.  Fibrils were 
observed associated with the plasma membrane.  (b) A magnified image of the boxed region in (a).  An 
aggregate associated with the exterior face of the plasma membrane, the aggregate appears to have 
maintained its fibrillar structure and is aligned with the plasma membrane.  C = cytoplasm; N = nucleus; ES 
= extracellular space; A = aggregate; PM = plasma membrane. 
6.2.3.2 Cells Exposed to Prefibrillar Aggregates for 2 Hours 
In order to examine the interactions of prefibrillar aggregates of Se-Aβ(25-36) with cells, 
and in particular with cellular membranes, at short exposure times, cells were exposed to 
prefibrillar Se-Aβ(25-36) aggregates for 2 hours.  These cells were then bulk stained with 
osmium tetroxide, a heavy metal stain that binds to lipids and therefore increases image 
intensity at membranes, allowing the plasma membrane to be visualised more clearly than 
unstained cells. 
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Figure 6.20: (a) HAADF-STEM image of cells exposed to prefibrillar Se-Aβ(25-36) aggregates for 2 hours.  
Cells were osmicated during fixation in order to increase contrast at the plasma membrane.  (b) A 
magnified image of the boxed region in (a).  Aggregates were observed associated with the plasma 
membrane and did not appear to have compromised the integrity of the membrane.  ES = extracellular 
space; N = nucleus; C = cytoplasm; A = aggregate; PM = plasma membrane. 
Examination of osmicated HMMs that had been treated with prefibrillar aggregates of Se-
Aβ(25-36) for 2 hours allowed the easy identification of the plasma membrane due to the 
high atomic number of the osmium atoms present (figure 6.20).  Aggregates were observed 
associated with the plasma membrane and often appeared to have crossed the membrane 
(figure 6.20).  No disruption or invagination of the membranes was apparent. 
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Figure 6.21: HAADF-STEM images of cells exposed to prefibrillar Se-Aβ(25-36) aggregates for 2 hours.  Cells 
were osmicated during fixation in order to specifically increase contrast at the plasma membrane.  In each 
image selenium-enhanced aggregates are observed at or close to the plasma membrane.  
Figure 6.21 shows a number of representative high magnification images of aggregates at or 
close to the plasma membranes of cells that were exposed to prefribillar Se-Aβ(25-36) 
aggregates for 2 hours before fixation and osmication.  The aggregates did not appear to 
have caused disruption of the membranes and the aggregates appear as compact, dense 
structures with dimensions of tens of nanometres up to approximately 100 nm, comparable 
to the dimensions of prefibrillar aggregates described in chapter 4. 
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6.3 Discussion 
The prefibrillar aggregate form of the Aβ(25-36) peptide was found to be the most cytotoxic 
of the aggregate species examined.  This is consistent with previous studies of similar 
aggregate species [2, 15, 16, 105, 256, 257].  The cytotoxicity of the prefibrillar aggregates, 
as well as the cytotoxicity of the monomeric and mature fibril forms of the protein, was 
found to be concentration-dependent.  No significant cytotoxicity was observed after 
24 hours for an exposure dose of 2.5 μM or less for the prefibrillar aggregates, but 
significant cytotoxicity was exhibited for exposure concentrations of 5 μM and above.  The 
monomeric and mature fibril aggregation states did not show significant levels of 
cytotoxicity at exposure concentrations of 10 μM or less (figure 6.1).  The cytotoxicity of the 
prefibrillar aggregates was found to be time-dependent with significant levels of cytotoxicity 
for an exposure concentration of 10 μM detected after 24 hours and no significant 
cytotoxicity observed for exposure times of 2 or 6 hours (figure 6.2).  The presence of a 
selenium atom in place of the naturally occurring sulfur atom in the Aβ(25-36) peptide did 
not affect the cytotoxicity of the peptide in any of the aggregate forms examined (figure 
6.3).   
The substantial differences in the cytotoxicities of the prefibrillar and fibrillar forms of the 
peptide would suggest that differences in the uptake and intracellular distribution of these 
two forms of the peptide are to be expected.  In this work it was found that the prefibrillar 
and fibrillar forms of the peptide are taken up by cells at different rates and distribute 
throughout the cells differently. 
It has previously been reported that oligomeric and fibrillar Aβ enter cells via distinct 
pathways [145, 158, 159, 164].  The prevention of uptake by cells has been reported to 
inhibit the toxicity of Aβ oligomers but not that of fibrils [159] suggesting that Aβ oligomers 
have the potential to exert their toxicity intracellularly, whereas the fibrillar form does not 
require internalisation in order to effect its toxic potential, which is considerably lower.  
Weltzien and Pachter observed a size-dependence of cellular uptake of Aβ aggregates, with 
smaller aggregates being internalised more readily than larger ones, which remained 
associated with the plasma membrane [158].  These observations correspond with the 
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findings presented here.  The differences in intracellular distribution imply the aggregates 
exert their toxicity via different mechanisms.  The results presented here indicate that entry 
into the cell may arise via distinct pathways for the two types of aggregate examined in this 
study.   
In this study the majority of the prefibrillar aggregates were observed in the cell cytoplasm 
(figure 6.18) where they may interact with and damage cytoplasmic molecules and cell 
organelles.  The proportions of prefibrillar aggregates in the different sub-cellular locations 
do not fluctuate significantly over time suggesting some sort of equilibrium is reached at an 
early time point (less than 2 hours).  This may be an indication of frustrated phagocytosis, 
which occurs when the proteins and small-molecule inflammatory mediators that control 
infection are released into the extracellular environment due to the failure of a phagocytic 
cell to efficiently engulf and degrade its target.  However, the frequency (aggregates/µm3) 
of aggregates in all locations increases over time; but this increase is most striking in the cell 
cytoplasm (figure 6.16), indicating that the aggregates reach the cytoplasm in a time-
dependent manner.  The changes in frequency for prefibrillar aggregates appearing in 
intracellular vesicles, which may be endosomes or lysosomes, and associated with the 
exterior surface of the cell plasma membrane, follow the same trend, though the trend for 
the appearance of aggregates in the cell cytoplasm is independent of these.  This suggests 
that there may be two pathways of entry into the cell – one via the plasma membrane and 
another via the intracellular vesicles – resulting in a large increase in the appearance of 
aggregates in the cell cytoplasm over time.  It has previously been reported that the 
accumulation of Aβ leads to a disruption in the impermeability of endosomal and lysosomal 
membranes [113, 114].  Kayed et al. have reported that oligomers formed from several 
different peptides specifically increase lipid bilayer permeabilisation whereas fibrils have no 
such effect [111].    Therefore, it is possible that aggregates taken into intracellular vesicles 
may increase the permeability of the membranes of these vesicles allowing the aggregates 
to escape into the cytoplasm.  The prefibrillar aggregates were observed to associate with, 
and traverse, the plasma membrane after just 2 hours of exposure (figures 6.20 and 6.21) 
demonstrating a great capacity for membrane penetration.  This suggests that the 
mechanisms by which extracellular aggregates exert their toxicity may include intracellular 
 149 
 
or even intranuclear targets.  This is compounded by the occasional appearance of 
prefibrillar aggregates in the nucleus, implying that the aggregates have traversed two lipid 
bilayers.  However, it is possible that the cells in which intranuclear aggregates were 
observed were in the early stages of apoptosis or necrosis when the aggregates entered the 
nucleus and therefore membrane impermeability had already decreased. 
In contrast to the prefibrillar aggregates, the majority of mature fibrils are observed to be 
associated with the plasma membrane at all time points examined (figure 6.17), implying 
that these aggregates associate with the membrane and remain associated with this site for 
a significant amount of time.  This may indicate that aggregates bind to specific receptors 
[145, 258-261].  The fibrils appear to be strongly associated with the membrane (figure 6.5).  
The prefibrillar aggregates, on the other hand, show much less association with the plasma 
membrane (figures 6.16 and 6.18).  After the plasma membrane, fibrils are observed with 
the highest frequency in intracellular vesicles (figure 6.15).  The predominantly membrane 
bound or vesicular localisation of these aggregates suggests a primarily phagocytic mode of 
entry of fibrils into the cells and is consistent with other evidence suggesting that fibrils are 
taken up via receptor mediated phagocytosis [145, 165].  This is compounded by the 
granular, broken appearance of the regions of high image intensity on examination of cells 
that were exposed to the mature fibrils for a period of 24 hours (figures 6.5, 6.6 and 6.7).  
This suggests that interaction with HMMs for a period of 24 hours results in loss of the 
aggregates’ fibrillar structure.  Fibrillar structure is observed, though not in all regions of 
high image intensity, for cells that were exposed to mature fibrils for just 2 hours (figure 
6.19), implying that an exposure period of 2 hours is not sufficient for complete degradation 
of the aggregates’ fibrillar structure. 
The proportion of fibrils observed in intracellular vesicles does not vary significantly over 
time.  The proportion observed at the plasma membrane drops somewhat at the longest 
exposure time examined.  In contrast, the proportion of aggregates observed in the cell 
cytoplasm increases appreciably at the longest exposure time investigated (figure 6.17).  
Similar trends are detected in the change in frequency (aggregates/µm3) for these 
aggregates (figure 6.15).  The increase in aggregates localised in the cytoplasm at 24 hours 
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may reflect exocytosed, degraded aggregates that can enter the cytoplasm in a manner 
similar to the prefibrillar aggregates.  The complete absence of aggregates in the nuclei of 
cells that have been treated with fibrils suggests that membrane penetrance is significantly 
lower for this aggregate species than for the prefibrillar aggregates.  Mandrekar et al. have 
reported that fibrillar Aβ is largely internalised via phagocytosis whereas the oligomeric 
form of the peptide enters phagocytic cells through different mechanisms [164], consistent 
with what has been observed here. 
The results presented here demonstrate a significant difference in the ability of phagocytic 
cells to interact with and deal with proteins at different stages during their aggregation, 
which correlates with the observed differences in cytotoxicity of the aggregate species 
examined.  The mature fibrils, which were non-toxic in this and other studies [2, 15, 16, 105, 
256, 257], appear to be more efficiently phagocytosed by the cells, which has also been 
previously suggested in other studies [145, 158, 164].  The mature fibrils are most 
commonly observed associated with the plasma membrane and in intracellular vesicles, 
implying that they are undergoing the normal phagocytic process.  The prefibrillar 
aggregates, however, were observed to be highly cytotoxic and their intracellular 
distribution and apparent structural stability within cells imply that the cells are less capable 
of efficiently phagocytosing and degrading these aggregates.  The fact that the proportions 
of aggregates in different subcellular locations do change with time suggests that the cells 
may be suffering from frustrated phagocytosis.  This can result in serious damage of the 
host tissue and could potentially account for some of the deleterious effects of these 
aggregates in diseases such as AD.  Their appearance in the cell cytoplasm and cell nucleus 
suggests an ability to enter the cells either through the plasma membrane before uptake 
through phagocytosis or through the vesicular membrane after uptake to intracellular 
vesicles.  The dense, compact structure of these aggregates when they appear in the cell 
cytoplasm and nucleus (figures 6.8, 6.9 and 6.10) implies that they are able to escape or 
bypass the phagocytic process before degradation takes place.  By contrast, the fragmented 
appearance of the mature fibrils (figures 6.5, 6.6 and 6.7) implies that the cells are capable 
of degrading these aggregates to a significant extent before they are cleared into the 
extracellular space.  Moreover, the localisation of the prefibrillar aggregates in the cell 
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cytoplasm and nucleus means that they are well placed to undergo interactions with 
organelles, such as the endoplasmic reticulum and mitochondria, and potentially to inhibit 
cellular function.  
These results are consistent with previously reported data [145, 158, 159, 164].  However, 
here the interactions of protein aggregates and cells have been visualised at a higher spatial 
resolution than previously.  This has allowed the direct visualisation of the morphologies 
and subcellular locations of specific aggregates.  The results presented here suggest that it 
may be possible to draw a link between the previously reported dependence on aggregate 
size for cellular uptake [158, 159], the reported differences in uptake mechanisms for 
different aggregate species [145, 164] and the species-dependence of protein aggregate 
toxicity [1, 2, 15, 16, 24, 158, 159]. 
The results presented in this chapter demonstrate the potential of the selenium-
enhancement of biomolecules as a technique for the imaging of specific proteins or other 
biomolecules within the cellular environment.  In this work it has been possible to visualise 
peptide aggregates directly in different regions of subcellular space, from the nucleus to 
the exterior of the plasma membrane.  It has not been necessary to use any dyes or tags 
that could alter the chemistry of the peptides or that may influence the interactions of the 
proteins with the cells.  This visualisation technique could be utilised to image any peptide 
or naturally sulfur-containing biomolecule at a subcellular level with an unprecedented 
level of spatial resolution. 
6.4 Conclusions 
The toxicity of Aβ(25-36) was found to be dose-dependent, time-dependent and 
dependent on the aggregate species in question.  Prefibrillar aggregates of the peptide are 
cytotoxic whereas the monomeric and mature fibril forms of the peptides exhibit 
significantly lower levels of toxicity.   
The interactions of different peptide aggregate species and HMMs have been imaged 
directly.  Significant differences in the behaviours of different aggregate types were 
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observed and these were visualised with a spatial resolution that has not previously been 
possible.   
The relatively non-toxic mature fibrils localise mainly in intracellular vesicles and at the 
plasma membrane.  The aggregates are not observed as fibrils after 24 hours of cell 
exposure; they appear to lose their fibrillar structure and appear heterogeneous and 
disconnected with no distinct structural pattern.  In contrast, prefibrillar aggregates are 
observed in intracellular vesicles and at the plasma membrane, but they also appear in the 
cell cytoplasm and occasionally in the cell nucleus.  These aggregates appear as compact, 
dense structures.  These observations, as well as the higher cytotoxicity of the prefibrillar 
aggregates, suggest that the mature fibrils are more efficiently phagocytosed than the 
prefibrillar aggregates. 
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7. Tomography of Cells Exposed to Se-Aβ(25-36) 
7.1 Introduction 
Electron tomography is an extension of traditional transmission electron microscopy which 
generates two-dimensional (2-D) projections of the samples being imaged.  The problem 
with 2-D imaging is that features at different depths within a sample are superimposed on 
top of one another and it is not possible to assess their position along the direction of the 
electron beam.  In electron tomography a number of 2-D projections of the area of interest 
in a sample are acquired at incremental tilt angles and the information collected is used to 
reconstruct a three-dimensional (3-D) volume to represent the original object.  Electron 
tomography has previously been used generate essential information about the 3-D 
structure of biological specimens [262-265].  Knowledge of the 3-D structure of cells and 
biomolecules is essential for the understanding of biological function in both physiologically 
healthy and disease conditions [266]. 
Electron tomography was exploited in this work in order to gain further insights into the 
intracellular distribution of protein aggregates and the 3-D structure of the aggregates after 
uptake by cells.  The electron tomography carried out for this project is described in this 
chapter.  The preparation of samples for electron tomography as well as the collection, 
reconstruction and visualisation of electron tomographic data used in this work are 
discussed in chapter 3. 
7.2 Collection, Reconstruction and Visualisation of Tomography Data 
Data for tomographic reconstructions were acquired from two kinds of TEM samples: 
sections of resin-embedded cells and freeze-dried whole cells.  Tomography datasets were 
obtained on the Titan microscope operating in STEM mode.  Images were collected at 
incremental tilt angles around a single tilt axis perpendicular to the electron beam.  The 
specimen was tilted to as high an angle as possible for data acquisition; however, it is not 
possible to acquire projections up to tilt angles of ±90°.  At a tilt angle of 60° the path-length 
of the electron beam through the sample is double that of the sample thickness, making 
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image acquisition at high tilt angles impossible in all but the thinnest samples.  At high tilt 
angles it is possible that the area of interest in the specimen may be obscured by another 
part of the sample, such as a grid bar.  Even if only part of the region of interest is obscured 
these images cannot be used for data reconstruction.  Therefore, while an angular range of 
±70° was attempted in the collection of each tomographic dataset, this was not always 
possible in practice. 
Cells were exposed to aggregates of Se-Aβ(25-36) at a protein concentration of 10 μM for a 
period of 24 hours. Prior to exposure to cells the peptide was maintained under aggregation 
inducing conditions for a period of 3 hours to generate cytotoxic prefibrillar aggregates or 
for a period of at least 12 hours in order to produce the relatively non-toxic mature amyloid 
fibrils.  Four tomography datasets are presented in this chapter: two acquired from sections 
of cells, one exposed to mature Se-Aβ(25-36) fibrils and one to prefibrillar aggregates of the 
peptide; and two acquired from freeze-dried whole cells, one of which was exposed to 
mature fibrils and one to prefibrillar aggregates of the Se-Aβ(25-36) peptide. 
All tomographic datasets presented here were aligned and reconstructed with Inspect 3D 
reconstruction software using the simultaneous iterative reconstruction technique (SIRT) 
[213, 214] following the methods described in chapter 3.  The reconstructed volumes were 
visualised using Amira 3D visualisation software.  The visualisation techniques used to 
generate the images presented in this chapter are discussed in chapter 3. 
7.3 Results 
7.3.1 Electron Tomography of Cell Sections 
The cell sections that were used for the collection of tomography series were 200 – 300 nm 
in thickness (sections used for other imaging purposes were less than 100 nm thick) in order 
to increase the total volume available for examination.  In order to avoid a background of 
useless volume information that would serve only to obscure images of the region of 
interest these sections were mounted on grids without any support film.  The area of 
interest within these sections could be examined at a relatively high magnification so it was 
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possible to examine, for example, an aggregate within the cell cytoplasm or aggregates 
associated with the cell plasma membrane and assess the structure and localisation of the 
aggregates in three dimensions.   
The tomographic datasets of cell sections were acquired using collection angles between 
13 mrad and 64 mrad.  At this angular range image contrast is influenced by both variations 
in the mass-thickness of the sample and differences in atomic number.  Thus, denser cell 
organelles such as the cell nucleus could be visualised and the selenium-enhanced 
aggregates could also be identified and visualised.  The influence of STEM collection angles 
over the electron beam/sample interactions that affect image contrast is discussed in 
chapters 3 and 5. 
7.3.1.1 Cells Exposed to Mature Fibrils 
Figure 7.1 shows a HAADF-STEM image acquired from a 250 nm thick section of cells that 
were exposed to mature Se-Aβ(25-36) fibrils for a period of 24 hours before fixation.  Areas 
of particularly high image intensity within the cellular environment indicate the presence of 
selenium-enhanced protein aggregates. 
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Figure 7.1: A HAADF-STEM image of a relatively thick section of cells exposed to mature Se-Aβ(25-36) fibrils 
for 24 hours.  A STEM tomography dataset of the boxed region was acquired from –52° to +58°.  ES = 
extracellular space. 
A tilt series of the region indicated by a white box in figure 7.1 was collected from -52° to 
+58° with an interval of 2° between successive images.  Figure 7.2 shows selected images 
from the tilt series.  Cell cytoplasm (marked C) and extracellular space (marked ES) can be 
seen.  Se-Aβ(25-36) aggregates (marked A) can be seen associated with the cell’s plasma 
membrane (marked PM). 
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Figure 7.2: Selected images from the raw dataset of a HAADF-STEM tomography series of mature Se-Aβ(25-
36) fibrils associated with the plasma membrane of a cell.  Cells were fixed after 24 hours of exposure to the 
selenium-enhanced fibrils.  ES = extracellular space; C = cytoplasm; PM = plasma membrane; A = aggregate. 
The dataset was aligned and reconstructed into a 3-D volume using the SIRT reconstruction 
technique [213, 214] with Inspect 3D reconstruction software.  The reconstructed volume 
was visualised using Amira visualisation software.  The reconstructed volume is shown in 
figure 7.3.  The cell and the selenium-enhanced aggregates, which have a higher image 
intensity, were visualised using voltex projections at different intensities so that one voltex 
projection displayed both the cells and the selenium-enhanced aggregates (shown in green 
in figure 7.3) and the other showed only regions of particularly high intensity and therefore 
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displayed only the regions representing the selenium-enhanced aggregates (shown in gold in 
figure 7.3). 
 
Figure 7.3: The 3-D reconstruction of a tomographic dataset of a region of a section of cells that were 
exposed to mature Se-Aβ(25-36) fibrils for 24 hours.  The cell is shown in green and the areas of high 
intensity are shown in gold. 
Visualisation of the 3-D reconstruction of this tomographic dataset allowed the assessment 
of the interactions between the cell’s plasma membrane and the selenium-enhanced 
aggregates in three dimensions.  This dataset was acquired from a section of HMMs exposed 
to mature Se-Aβ(25-36) fibrils for 24 hours.  However, no fibrillar structure is apparent in the 
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aggregates associated with the plasma membrane, regardless of the angle from which they 
are viewed. 
7.3.1.2 Cells Exposed to Prefibrillar Aggregates 
Figure 7.4 shows a HAADF-STEM image acquired from a 250 nm section of cells that were 
exposed to prefibrillar Se-Aβ(25-36) aggregates for a period of 24 hours before fixation.  This 
image was acquired with inner and outer collection angles of 13 mrad and 64 mrad 
respectively.  This range of collection angles means that image intensity is affected by the 
atomic numbers of the elements in the sample (allowing the visualisation of the selenium-
enhanced peptide aggregates), as well as the density and thickness of the specimen 
(allowing the visualisation of cell organelles, such as the nucleus).  A tilt series for 
tomographic reconstruction was collected from the region of interest, indicated by a white 
box in figure 7.4. 
 
Figure 7.4: A HAADF-STEM image of a relatively thick section of cells exposed to prefibrillar selenium-
enhanced Aβ(25-36) aggregates for a period of 24 hours before fixation.  A STEM tomography dataset of the 
boxed region was acquired at tilt angles from –36° to +42°.  ES = extracellular space. 
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A tomography dataset was collected from the region that is indicated with a white box in 
figure 7.4.  Images were acquired over the tilt range of -36° to +42° with an interval of 2° 
between successive images.  Figure 7.5 shows selected images from the tilt series.  Se-
Aβ(25-36) aggregates (marked A) can be seen in the cell cytoplasm (marked C). 
 
Figure 7.5: Selected projections from a tilt series acquired of prefibrillar Se-Aβ(25-36) aggregates in the 
cytoplasm of a cell.  ES = extracellular space; C = cytoplasm; A = aggregate. 
The dataset was aligned and reconstructed into a 3-D volume which was visualised using 
Amira 3D visualisation software.  Figure 7.6 shows the reconstructed volume.  A voltex 
projection was employed to observe the cell cytoplasm (shown in blue) and a surface was 
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rendered in which only points within the volume which were of particularly high intensity 
were visualised.  Therefore only the selenium-enhanced peptide aggregates contributed to 
this surface (shown in black).  The protein aggregates can be observed to be within the cell 
cytoplasm. 
 
Figure 7.6: The reconstructed volume of a tomographic dataset of a region of a section of cells that were 
exposed to prefibrillar Se-Aβ(25-36) aggregates for 24 hours.  The cell cytoplasm is shown in blue and the 
areas of high intensity are shown in black. 
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7.3.2 Electron Tomography of Whole Cells 
Cells grown directly on TEM grids were exposed to Se-Aβ(25-36) aggregates for a period of 
24 hours before fixation by freeze-drying and carbon coating so that electron tomography 
datasets could be acquired of whole cells.  This made it possible to examine the three 
dimensional distribution of aggregates within an entire cell after uptake.  Datasets from 
freeze-dried whole cells were collected at a lower magnification than those that were 
acquired using cell sections in order to examine an entire cell in one dataset.  This meant 
that it was not possible to resolve the structural detail of individual aggregates but it was 
possible to assess the distribution of areas of high intensity throughout the volume of the 
cell. 
Tomography datasets of whole cells were collected with inner and outer STEM collection 
angles of 32 and 64 mrad respectively.  Higher collection angles were employed for the 
collection of these datasets than were used for the collection of tomography datasets 
acquired of regions of interest within cell sections.  This was in order to decrease the 
contribution of mass-thickness to image contrast.  Thus only the cell and the selenium-
enhanced protein aggregates were visible while cell organelles, such as the nucleus, did not 
contribute to image intensity.  
7.3.2.1 Cells Exposed to Mature Fibrils 
A tomography series of a freeze-dried cell that had been exposed to mature Se-Aβ(25-36) 
fibrils for 24 hours was acquired over the tilt range of -70° to +70° about a single tilt axis.  
Between 0° and ±50° an interval of 2° was left between each image; from ±50° to ±70° 
images were collected at an increment of 1°.  A smaller increment was employed at higher 
tilt angles to compensate for the increase in sample thickness [212].  Selected projections 
from the raw data of this tomography series are shown in figure 7.7.  The cell can be clearly 
identified against the background of the carbon support film.  Regions of particularly high 
intensity can be observed in some parts of the cell; these appear to be mainly located close 
to the surface of the cell. 
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Figure 7.7: Selected projections from tilt series acquired for a tomographic dataset of an entire cell that was 
exposed to mature Se-Aβ(25-36) fibrils for 24 hours before fixation by freeze-drying. 
This tomography series was aligned and reconstructed to produce a 3-D volume.  Snapshots 
of the reconstructed volume viewed using Amira 3D visualisation software as it rotates 
about an axis in the vertical direction are shown in figure 7.8.  The orientation of the volume 
has been arbitrarily chosen.  The volume has been visualised by rendering a transparent 
yellow isosurface at one intensity level to represent the whole cell and an opaque blue 
isosurface at a higher intensity level to represent only those regions within the cell volume 
that were of particularly high intensity and therefore contain heavier elements than the rest 
of the sample.  The blue isosurface in figure 7.8 therefore indicates the presence of 
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selenium-enhanced protein aggregates.  The aggregates are mainly localised close to the 
cell’s surface and do not appear to be well distributed throughout the interior of the cell.  
The blue surface appears within the transparent yellow surface.  It is possible that the 
aggregates are, in fact, at or outside the cell’s surface and simply appear within it because 
the intensity of the aggregates falls away rather than disappearing instantly, partly as a 
result of the averaging that occurs in the reconstruction process and partly due to the data 
collection.   
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Figure 7.8: Snapshots of the 3-dimensional reconstruction of a HAADF-STEM tomography series of a cell that 
was exposed to mature Se-Aβ(25-36) fibrils for 24 hours.  Snapshots were taken every 30° as the 
reconstructed volume rotated on the vertical axis.  The surface of the cell is represented by a transparent 
yellow isosurface and the areas of high intensity due to the presence of selenium are represented by an 
opaque blue isosurface. 
7.3.2.2 Cells Exposed to Prefibrillar Aggregates 
Figure 7.9 shows a selection of images from a tilt series of a freeze-dried whole cell that was 
exposed to prefibrillar Se-Aβ(25-36) aggregates for 24 hours.  Images were acquired over an 
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angular range of -70° to +70° about a single tilt axis.  Images were acquired every 2° 
between 0° and ±50° and every 1° between ±50° and ±70°.  In these images the cell can be 
clearly identified against the background of the carbon support film.  Regions of higher 
intensity can also be observed in the cell. 
 
Figure 7.9: Selected HAADF-STEM images from a tomographic dataset of a freeze-dried whole cell that was 
exposed to prefibrillar Se-Aβ(25-36) aggregates for 24 hours.   
This tomography series was aligned and reconstructed with the SIRT reconstruction 
technique [213, 214] using Inspect 3D reconstruction software to produce a 3-D volume that 
was viewed using Amira 3D visualisation software.  The surface of the cell was visualised 
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with a transparent yellow isosurface and the selenium-enhanced aggregates were visualised 
by an opaque blue isosurface at a higher intensity threshold.  Snapshots of the visualisation 
of the reconstructed volume as it rotates about the vertical axis are shown in figure 7.10.  
The selenium-enhanced aggregates can be seen distributed throughout the interior of the 
cell.  They are not localised close to the cell surface as was observed for the mature fibrils. 
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Figure 7.10: Snapshots of the 3-dimensional reconstruction of a HAADF-STEM tomography series of a cell 
that was exposed to prefibrillar selenium-enhanced Aβ(25-36) aggregates for a period of 24 hours before 
fixation by freeze-drying.  Snapshots were taken every 30° as the reconstructed volume rotated on the 
vertical axis.  The surface of the cell is represented by a transparent yellow isosurface and the areas of high 
intensity due to the presence of selenium are represented by an opaque blue isosurface. 
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7.4 Discussion 
The two 2-D visualisation of selenium-enhanced peptide aggregates inside cells was 
illustrated in chapter 5.  The results presented in this chapter demonstrate that this 
visualisation technique can be extended to three dimensions. 
The cytotoxicity of the different types of Aβ(25-36) aggregates was discussed in chapter 6.  
The prefibrillar aggregate exhibits a significantly higher level of cytyotoxicity than the 
mature fibril.  The results of an examination of uptake and intracellular distribution of these 
two aggregate species carried out in two dimensions were also presented in chapter 6.  It 
was found that the majority of prefibrillar aggregates localise to the cell cytoplasm, whereas 
mature fibrils localise mainly at the cell plasma membrane and in intracellular vesicles, and 
suffer a loss of fibrillar structure.  These findings have been confirmed in three dimensions 
by the results presented in this chapter. 
The first tomographic dataset presented in this chapter was acquired from a section of cells 
that were exposed to mature fibrils for 24 hours before fixation (figures 7.1, 7.2 and 7.3).  In 
this dataset selenium-enhanced aggregates can be seen associated with the outer surface of 
the cell’s plasma membrane.  Examination of the reconstructed dataset demonstrates that 
no fibrillar structure is present in these aggregates (figure 7.3).  This correlates with the 
observations of 2-D images presented in chapter 6. 
The second dataset presented was acquired from a section of cells that were exposed to 
prefibrillar Se-Aβ(25-36) aggregates for 24 hours (figures 7.4, 7.5 and 7.6).  The aggregates 
can be seen in the cytoplasm of the cell.  Examination of the reconstructed volume shows 
that the aggregates are indeed inside the cell cytoplasm (figure 7.6). 
The final two datasets presented in this chapter demonstrate the distribution of mature 
fibrils and prefibrillar aggregates throughout entire cells.  The first of these was acquired 
from a cell that was exposed to mature fibrils of Se-Aβ(25-36) for 24 hours before freeze-
drying, allowing examination of the entire cell (figures 7.7 and 7.8).  Examination of the 
reconstructed volume reveals that the majority of the regions of particularly high image 
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intensity, indicating the presence of Se-Aβ(25-36) aggregates, are localised close to the cell 
surface (figure 7.8).  In contrast, examination of the reconstructed volume of a tomography 
dataset acquired from a cell that was exposed to prefibrillar aggregates reveals that the 
regions of high image intensity are distributed throughout the interior of the cell (figure 
7.10).   
These findings correlate with the results of the 2-D study of the interactions of protein 
aggregates and cells presented in the previous chapter, confirming that the observations 
presented there were not projection artefacts arising from the examination of 2-D images.  
These results are also in agreement with previously published work in which the interactions 
of aggregates formed from the full chain Aβ peptide with neuronal cells and with 
macrophage cells were examined using 3-D reconstructions of confocal microscopy data  
[158, 159].  It was found that smaller aggregates are internalised by cells more readily than 
larger ones.  This corresponds with what has been presented in this chapter. 
7.5 Conclusions 
The selenium-enhancement of peptides facilitates the visualising of protein aggregates 
inside cells in three dimensions.  This technique has allowed the differences in uptake and 
intracellular distribution that had been observed in the two-dimensional examination of 
sections of cells to be confirmed in three dimensions. 
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8. Conclusions and Future Work 
In this thesis a novel approach to the visualisation of the protein aggregates related to AD 
within cells at high spatial resolution has been presented.  The findings acquired using this 
technique have also been presented.  This chapter summarises the main conclusions this 
work has yielded and presents some suggestions for future work. 
8.1 Aggregation of Aβ(25-36) and Se-Aβ(25-36) 
In this thesis I have shown that the Aβ(25-36) peptide aggregates in a solution of 50 mM 
phosphate buffered saline with 100 mM NaCl at pH 7.4 at a protein concentration of 
100 µM, when incubated at 37°C.  This is similar to conditions that induce aggregation for 
the Aβ(25-35) peptide [56, 243] whose primary structure is very similar to that of Aβ(25-36).  
Under these conditions the Aβ(25-36) solution exhibits an increase in thioflavin-T 
fluorescence, starting after approximately 7 hours and peaking at approximately 12 hours.  
TEM examination of the peptide reveals that branched aggregates of various sizes with no 
distinct structure are generated after 3 hours.  After 10 hours, long, thin amyloid fibrils, with 
lengths up to several hundred nanometres and which tend to bundle together, are formed.  
The structure of these fibrils does not change after longer periods in solution.   
It has been clearly established that the replacement of the naturally occurring sulfur atom in 
the methionine amino acid at residue 35 of the peptide does not affect the rate of 
aggregation of the protein.  The presence of selenium does not affect the structure of the 
aggregates generated. 
8.2 Visualisation of Selenium-enhanced Peptide Aggregates inside Cells 
The results presented in chapter 5 demonstrate that the replacement of the naturally 
occurring sulfur atom in the methionine amino acid of the Aβ(25-36) peptide makes the 
visualisation of the selenium-enhanced aggregates within the cellular environment possible 
without the use of the any other stains or tags.  The atomic number of the selenium atom 
increases the electron scattering cross-section of the atom in question by a factor of 
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approximately 4.5 relative to sulfur.  This allows the visualisation and identification of the 
aggregates inside cells.  The presence of selenium can be confirmed by EDX. 
Varying the STEM collection angles means that the electron beam/specimen interactions 
that dominate image contrast can be controlled.  This makes it possible to examine cell 
structure and identify the subcellular location of selenium-enhanced peptide aggregates as 
well as to assess aggregate structure and stability within the cell. 
The visualisation of selenium-enhanced peptide aggregates inside cells can be extended into 
three dimensions, as demonstrated in chapter 7. 
8.3 Cytotoxicity of Aggregates 
Prefibrillar aggregates of Aβ(25-36) were found to be significantly more cytotoxic to HMMs 
than mature fibrils or monomeric peptide.  This was found to be the case with both the 
MTT viability assay, which measures mitochondrial function, and the live/dead viability 
assay, which is based on the incorporation of propidium iodide into the nuclei of dead cells.  
The observed higher cytotoxicity of the prefibrillar aggregates is consistent with previous 
studies on similar aggregate species [2, 15, 16, 105, 256, 257].  The toxicity of all aggregate 
species was found to be dose-dependent and time-dependent, up to 24 hours.  The 
replacement of the sulfur atom in the peptide with a selenium atom did not affect the 
cytotoxicity of any aggregate species. 
8.4 Uptake and Intracellular Distribution of Se-Aβ(25-36) Aggregates 
The time-dependent study of the uptake and intracellular distribution of Se-Aβ(25-36) 
aggregates revealed significant differences in the behaviours of the cytotoxic prefibrillar 
aggregates and the non-toxic mature fibrils.  Differences were observed in both the 
subcellular locations in which the aggregates were observed and their structure after cell 
exposure. 
The relatively non-toxic mature fibrils localise mainly in intracellular vesicles, most likely 
endosomes or lysosomes, and at the plasma membrane.  The aggregates are not observed 
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as fibrils after 24 hours of cell exposure; they appear to lose their fibrillar structure and are 
observed to be heterogeneous and disconnected with no distinct structural pattern.  After 
just 2 hours of cell exposure some fibrillar structure was still observed for these aggregates, 
though selenium-rich regions that are observed at this time point are not exclusively 
fibrillar in structure suggesting that some of the aggregates have already lost their fibrillar 
structure after 2 hours of cell exposure. 
Prefibrillar aggregates were observed in intracellular vesicles and at the plasma membrane, 
but they also appear in the cell cytoplasm and occasionally in the cell nucleus.  These 
aggregates appear as compact, dense structures.  These observations, as well as the higher 
cytotoxicity of the prefibrillar aggregates, suggest that the mature fibrils are more 
efficiently phagocytosed and processed by the cells than the prefibrillar aggregates. 
The intracellular distribution of Se-Aβ(25-36) aggregates observed in two dimensions using 
HAADF-STEM imaging was confirmed in three dimensions using HAADF-STEM tomography, 
which also showed differences between the distributions of the two kinds of aggregate. 
In summary, the results presented in this thesis represent a novel approach for the label-
free visualisation of protein aggregates within the cellular environment at high spatial 
resolution.  This technique could be extended to the visualisation of any specific 
biomolecule that naturally contains a sulfur atom within a cellular or tissue environment.  
8.4 Future Work 
Future directions for this work should include improving the technique and extending it to 
investigations of other systems. 
The method of HAADF-STEM visualisation of protein aggregates by the selenium-
enhancement of proteins could be improved by automating the mapping and quantification 
of the intracellular distribution of selenium-enhanced aggregates.  Pattern recognition for 
cell organelles and aggregate structure would allow further insights into the interactions of 
aggregates with cells.  Markers such as immunocytochemical tags would allow the user to 
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identify the specific cell organelles, such as mitochondria or endoplasmic reticulum, to 
which aggregates localise. 
Among the systems to which the selenium-enhancement of proteins could be extended are 
investigations into the interactions between aggregates formed from the selenium-
enhanced version of the full chain Aβ42 peptide and neurons or microglial cells.   
The Aβ42 peptide has been implicated in AD more than any other isoform of the Aβ peptide 
[3-6, 50], therefore its interactions with cells and tissues are highly relevant to AD 
pathogenesis.  Numerous studies have been carried out to investigate the aggregation and 
toxicity of the full chain of the Aβ42 peptide [7, 53-59].  Therefore, more homogeneous 
aggregate solutions could be created for cell exposure studies.  Also, flourophores for 
fluorescence and confocal microscopy studies are available for working with the full chain 
Aβ42 peptide [159, 164].  Therefore correlative confocal microscopy studies could be carried 
out in order to visualise the uptake of Se-Aβ42 and Aβ42 aggregates by live cells to 
complement HAADF-STEM studies of the interactions of Se-Aβ42 aggregates with cells.  
Uptake of aggregates and their structural degradation within cells could be correlated with 
changes in cell metabolism, such as the production of reactive oxygen species or calcium 
concentration.  Furthermore, it is essential to establish a relationship between aggregate 
size and neurotoxic potency by developing techniques to study not only the intracellular 
distribution of protein aggregates, but also the size distributions of the aggregates and how 
this correlates with their subcellular locations. 
Neurons and microglial cells are the most relevant cell types for this work.  Significant 
neuronal loss occurs in AD and therefore an understanding of how Aβ42 aggregates interact 
with these cells is essential.  Microglial cells are the CNS equivalent of the macrophage cell 
and therefore are a phagocytic cell type more relevant to AD.  As such, studies into their 
interactions with and ability to phagocytose protein aggregates would be highly pertinent. 
The interactions of other disease-related protein aggregates with cells could be investigated 
employing the selenium-enhancement of peptides.  For example, intraneuronal aggregates 
of the protein α-synuclein are associated with Parkinson’s disease.  As with AD, the exact 
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role these aggregates play in the disease is not yet fully understood.  The replacement of 
sulfur with selenium in α-synuclein and its disease-associated mutants would allow the 
investigation of the protein’s interactions with neurons at a high spatial resolution. 
The selenium-enhancement of peptides is a new technique that could be utilised to visualise 
any specific peptide that naturally contains a methionine or cysteine amino acid, as these 
both contain a single sulfur atom, within the cellular or tissue environment.  For example, 
this method could be employed to visualise the nascent peptide chain as it is expressed by 
the ribosome.   
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Appendix A 
Aβ42 Amino Acid Sequence 
Aspartic acid – Alanine – Glutamic acid – Phenylalanine – Arginine – Histidine – Aspartic acid 
– Serine – Glycine – Tyrosine – Glutamic acid – Valine – Histidine – Histidine – Glutamine – 
Lysine – Leucine – Valine – Phenylalanine – Phenylalanine – Alanine – Glutamic acid – 
Aspartic acid – Valine – Glycine – Serine – Asparagine – Lysine – Glycine – Alanine – 
Isoleucine – Isoleucine – Glycine – Leucine – Methionine – Valine – Glycine – Glycine – 
Valine – Valine – Isoleucine – Alanine 
Aβ(25-36) Amino Acid Sequence 
Glycine – Serine – Asparagine – Lysine – Glycine – Alanine – Isoleucine – Isoleucine – Glycine 
– Leucine – Methionine – Valine 
Appendix B 
Atomic Force Microscopy 
Atomic force microscopy (AFM) was also employed to examine the structure and size of 
aggregates formed from Se-Aβ(25-36).  Tapping mode AFM imaging was carried out for all 
AFM data presented in this thesis.  All measurements were carried out on a DI Nanoscope IV 
using Pointprobe silicon cantilevers (Nanosensors, Switzerland).  Figure A.1 shows AFM 
images of the prefibrillar aggregates formed after 3 hours of incubation.  The observed 
aggregates had a range of sizes and did not show any fibrillar structure.  Some of these 
aggregates appeared to be grouped together in a similar fashion to that which was observed 
in the TEM images (figures 4.7 (b) and (c) and 4.9 (a) and (b)).  Other aggregates appear to 
have lined up in what resembles a chain.  However, these were distinct particles implying 
that this was as a result of the drying process rather than further aggregation or the 
beginning of fibrillation.  Analysis of the heights of the aggregates was also carried out 
(figure A.2).  The aggregates had heights ranging from 7 to 24 nm, with a mean height of 
17.25 nm and standard deviation 4.2 nm.  Height differentials (marked XY) were examined 
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across individual aggregates in each of the images and are presented as histograms to 
demonstrate the heights of the aggregates. 
 
Figure A.1: (a) and(c) AFM images of Se-Aβ(25-36) aggregates formed after 3 hours of incubation in 50mM 
PBS at pH 7.4 with 100mM NaCl at a protein concentration of 100µM.  (b) and (d) show the variations in 
height along the lines XY in (a) and (c) respectively. 
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Figure A.2: Height distribution of aggregates of Se-Aβ(25-36) formed after 3 hours of aggregation.  A size 
range of 7 – 24 nm is observed with a mean height of 17.25 ± 4.2 nm. 
Examination of mature fibrils of Se-Aβ(25-36) using AFM revealed long, thin fibrillar 
structures (figure A.3).  There appeared to be two distinct fibril structures visible.  In one of 
these the twisted protofilaments that form the fibrils are clearly visible.  The other structure 
is thinner and shorter, and twisting is not apparent.  It has previously been observed that 
more than one aggregate structure is often detected from a single preparation technique 
[25]. 
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Figure A.3: (a) and (c) AFM images of Se-Aβ(25-36) aggregates formed after more than 10 hours of 
incubation in 50 mM PBS at pH 7.4 with 100 mM NaCl at a protein concentration of 100 µM.  (b) and (d) 
show the variations in height along the lines XY in (a) and (c) respectively. 
The height and length distributions of the aggregates observed were analysed.  A histogram 
demonstrating the distributions in the heights of the fibrils is shown in figure A.4.  Again, 
two distinct fibril structures are indicated.  One of these fibrillar structures has a height 
ranging from 4.5 to 6 nm suggesting that these are the thinner structures (in which no 
protofilaments could be distinguished) that were observed in figure A.3.  The second 
structure had heights ranging from 7 to 9.5 nm indicating that it may be the structure that 
consisted of protofilaments twisted together in figure A.3.  The length distribution of these 
fibrils is shown in figure A.5.  The fibrils have lengths ranging from 110 to 158 nm, far 
greater than the heights measured, indicating that these aggregates are fibrillar in nature. 
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Figure A.4: The height distribution of fibrils of Se-Aβ(25-36) formed after more than 10 hours of incubation 
from AFM measurements.  Fibrils had appeared to have two distinct structures, one with heights ranging 
from 4.5 to 6 nm and the other with a height range of 7 to 9.5 nm. 
   
Figure A.5: A histogram indicating the length distribution of fibrils of Se-Aβ(25-36) formed after more than 
10 hours of aggregation as measured by AFM.  Fibrils were found to have lengths over the range 110 to 
158 nm. 
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AFM measurements yielded smaller aggregate widths than TEM measurements.  The TEM 
images from which fibril widths were measured were of samples that were negatively 
stained with uranyl acetate, which binds to the outside of fibrils leading to a larger 
measurement of the width of the fibrils.  The widths of the fibrils measured in the AFM are 
their heights above the mica substrate whereas the widths measured in the TEM are parallel 
to the carbon support film.  One would expect, therefore, smaller widths to be measured in 
the AFM due to the effects of gravity and the drying process. 
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